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Eukaryotic mRNA precursors are processed at their 5’ and 3’ ends and are spliced
prior to their export from the nucleus to the cytoplasm. Although all three processing
reactions can be studied separately in vitro, they are coupled in vivo.
3’ end processing of most mammalian pre-mRNAs involves endonucleolytic
cleavage followed by polyadenylation of the upstream cleavage product. Cleavage
and polyadenylation specificity factor (CPSF) is a multiprotein complex, which
together with cleavage factor Im and IIm (CF Im, CF IIm), cleavage stimulatory factor
(CstF), poly(A) polymerase (PAP) and nuclear poly(A) binding protein 1 (PABPN1)
is required for 3’ end formation.
We have found that the U2 snRNA and subunits of the splicing factors 3a and
3b (SF3a, SF3b), which are components of the U2 snRNP, were also present in highly
purified CPSF fractions. GST pull-down experiments indicated a direct interaction of
CPSF subunits with SF3b49 and SF3b130. Furthermore, antibodies directed against
CPSF100 co-immunoprecipitated subunits of SF3a and SF3b and the U2 snRNA
Taken together our results show that subunits of CPSF and the U2 snRNP directly
interact with each other.
In order to analyze whether this interaction plays a role in the coupling of 3’
end processing and splicing, we depleted CPSF subunits from HeLa cell nuclear
extract and tested the extracts for splicing activity. CPSF100-depleted extract showed
no detectable cleavage activity and its splicing activity was significantly reduced in
coupled assays but not in un-coupled assays. Moreover, pre-mRNAs containing
mutations in the binding site of SF3b were not only less efficiently spliced but they
also showed reduced cleavage activity. Interestingly, efficient cleavage required the
presence of the U2 snRNA in coupled but not in un-coupled assays. Based on our
studies, we propose that the interactions between CPSF and U2 snRNP contribute to
the coupling of splicing and 3’ end formation.
Furthermore, we depleted CPSF100 and the U2 snRNP subunits SF3b155 and
SF3b130 by means of RNAi. We observed that knock down of both SF3b proteins
caused high lethality of the cells indicating that these polypeptides are essential.
However, depletion of CPSF100 did not result in a significant increase in cell
5mortality, suggesting that the protein is either not essential that the knock down was
not efficient enough to result in cell lethality or that CPSF100 shares redundant
functions with another protein. We were able to show that SF3b155 and SF3b130 are
required for efficient splicing in vivo but did not detect a splicing deficiency in
CPSF100 depleted cells. Knock down of neither of the proteins resulted in an
observable 3’ end processing deficiency. Further work is required to address the
question if the U2 snRNP and CPSF couple splicing and 3’ end processing in vivo.
Splicing and 3’ end formation are highly conserved mechanisms from
mammals to yeast and the two organisms share homologues of most of the proteins
involved in the two reactions. To test whether the coupling mechanism mediated by
CPSF and the U2 snRNP is conserved between different organisms, we focused on
the yeast system. The essential protein Rse1p is the yeast homolog of SF3b130.  We
show that the rse1-1 strain is sensitive to cordycepin, which suggests that Rse1p
might be involved in 3’ end processing. Furthermore, Rse1p and 3’ end processing
factors interacted genetically and Northern blot analysis suggested that strains
carrying mutations in Rse1p and subunits of CPF had increased levels of unspliced
pre-mRNA at restrictive temperature compared to the single mutants. We therefore
suggest that the coupling of 3’ end processing and splicing mediated by CPSF and U2
snRNP is conserved between mammals and yeast.
Precursor tRNAs (pre-tRNAs) must undergo a number of processing steps
before they become mature tRNAs and some tRNAs contain introns. tRNA splicing
is a three step reaction and each step requires an individual set of proteins. In the first
step the pre-tRNA is cut at its two splice sites. This reaction is catalyzed by the so
called tRNA splicing endonuclease complex. Recently this complex was purified
from mammalian cells and interestingly hClp1 (a subunit of the 3’ end processing
factor CF IIm) was identified as one of its components. Furthermore, hSen2 a subunit
of the endonuclease complex was shown to be required for efficient 3’ end
processing in vivo. A model was proposed suggesting that the tRNA endonuclease
complex is involved in 3’ end processing. In collaboration with S. Paushkin and C.
Trotta we continued to investigate if this model is indeed correct. We found that
biochemically purified CF IIm indeed carried tRNA endonuclease activity. However,
tRNA endonuclease complexes were not able to reconstitute cleavage activity of
CF IIm-depleted HeLa nuclear extract, unless they were purified with His-Flag tagged
6hClp1. Taken all our results into account we cannot exclude that the tRNA
endonuclease complex is indeed involved in 3’ end processing. However, we believe
that the evidence supporting this model is rather weak. We think it is more likely that
hClp1 is part of the tRNA endonuclease complex as well as a subunit of CF IIm, and
that the two complexes are not functionally related.
As mentioned earlier, 3’ end processing is highly conserved form mammals to
yeast. In S. cerevisiae cleavage and polyadenylation factor (CPF) is a multiprotein
complex, which together with the cleavage factor IA (CF IA) and the cleavage factor
IB (CF IB) is required for both the cleavage and the polyadenylation step of the 3’
end formation reaction.
Ydh1p/Cft2p is an essential component of CPF. Cleavage and
polyadenylation reactions revealed that the protein is required for both reactions to
occur in vitro. Previously, it was demonstrated that an important function of CPF lies
in the recognition of poly(A) site sequences and previous RNA binding analyses with
recombinant Ydh1p/Cft2p suggested that the protein may interact with the CYC1
poly(A) site region. In accordance, we found that mutant ydh1 strains were deficient
in recognition of the ACT1 cleavage site in vivo.
Transcription by RNA polymerase II (RNAP II) and 3’ end processing
reactions are tightly linked. The C-terminal domain (CTD) of RNAP II plays a major
role in coupling the two events, as it tethers the factors involved in polyadenylation to
the polymerase. We provide evidence that Ydh1p/Cft2p interacts with the CTD,
several subunits of CPF and with Pcf11p, a component of CF IA. We propose that
Ydh1p/Cft2p contributes to the formation of important interaction surfaces that
mediate the dynamic association of CPF with RNAP II, the recognition of poly(A)
site sequences and the assembly of the polyadenylation machinery on the RNA
substrate.
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81.1 Pre-mRNA processing
The genome of eukaryotes is transcribed by three different highly related RNA
polymerases (RNAP). The ribosomal RNAs (rRNAs) are transcribed by RNAP I
whereas RNAP III transcribes several RNAs including the small 5S rRNA and the
transfer RNAs (tRNAs). Messenger RNA precursors (pre-mRNAs) are transcribed by
RNAP II.
Pre-mRNAs have to undergo a number of processing steps in the nucleus
before they are exported to the cytoplasm and translated by the ribosome. The 5’ end
of the pre-mRNA is capped as soon as the transcript has reached a length of about 20
to 25 nucleotides (Jove and Manley, 1984; Rasmussen and Lis, 1993). A 7-methyl
guanine cap is added to the 5’-triphosphate end of the nascent RNA by a series of
three enzymatic reactions. The 5’-triphosphate end of the pre-mRNA is hydrolyzed to
a 5’-diphosphate by an RNA triphosphatase, then capped with GMP by an RNA
guanylyltransferase, and methylated by an RNA (guanine-N7) methyltransferase
(reviewed in Gu and Lima, 2005).
The coding sequence of RNAs (exons) in eukaryotic cells are interrupted by
non coding sequences (introns), which are removed by the spliceosome in a lariate
structure and the exons are ligated together. The mammalian introns average a length
of 3x103 nucleotides (nt) whereas the exons are much shorter, in average less than 300
nt in length. The spliceosome consists of small nuclear ribonucleoprotein particles
(snRNP), which assemble anew onto each individual intron in a stepwise fashion in
order to form the catalytically active spliceosome. Alternative splicing enables
eukaryotes to increase the coding potential of their genome. In humans more than
59% of the genes seem to be alternatively spliced (Reed, 2000; Hastings and Krainer,
2001; Will and Lührmann, 2001; Jurica and Moore, 2003).
All eukaryotic primary mRNAs (with the exception of replication-dependent
histone transcripts in higher eukaryotes) are endonucleolytically cleaved, followed by
poly(A) addition to the upstream fragment of the cleavage reaction, and the
downstream fragment is rapidly degraded. Cis and trans acting factors are involved in
the two steps of the 3’-end processing reaction which will be discussed in further
detail in the following chapters.
9The poly(A) tails, and the proteins associated with them, affect the stability,
turnover, export to the cytoplasm and translation of the mRNA (reviewed in Zhao et
al., 1999a; Edmonds, 2002). Figure 1.1 shows a schematic representation of the three
different pre-mRNA processing steps.
Figure 1.1 The three pre-mRNA processing steps.
The gray cylinders represent the exons and the lines the introns of the pre-mRNA. The black “head” to
the right symbolizes the exonuclease.
1.1.1 3’ end processing
3’ end processing is highly conserved form mammalians to yeast and most of the
mammalian subunits have homologues in yeast. Figure 1.2. shows a schematic
representation of cis and trans acting elements required for 3’ end processing in
mammals and yeast. The different RNA sequence elements and the 3’ end processing













Figure 1.2 Schematic representation of the mammalian and yeast pre-mRNA cleavage
complexes.
With the exception of CstF the arrangement of the subunits within the different factors is not known.
Homologous subunits are shown in the same color. Subunits for which no homologues have been
identified are in white. Double-headed arrows represent protein-protein contacts. Modified from a slide
provided by B. Dichtl.
1.1.1.1 Mammalinan cis acting elements
In mammalian cells the core polyadenylation signal consists of three sequence
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nucleotides upstream of the cleavage site, the G/U rich sequence element downstream
of the cleavage site and the cleavage site itself (Figure 1.2).
The AAUAAA consensus sequence can be found in almost all polyadenylated
mRNAs (Proudfoot and Brownlee, 1976; Wahle and Kuhn, 1997). In vivo deletion
mutations confirmed that the signal is required for 3’ end formation (Fitzgerald and
Shenk, 1981) and in vitro point mutations and RNA modification experiments showed
that alteration of any of the six nucleotides strongly effected 3’ end processing. The
only variant to the AAUAAA sequence that showed significant activity is the
AUUAAA hexanucleotide (Zarkower et al., 1986; Conway and Wickens, 1987;
Bardwell et al., 1991).
The downstream sequence element (DSE) is located approximately 30
nucleotides downstream of the poly(A) site. This element if poorly conserved and two
different types have been described; the U-rich element is a short run of U residues
(Chou et al., 1994; Gil and Proudfoot, 1987) and the G/U rich element consists of the
consensus sequence YGUGUUYY (Y = pyrimidine; McLauchlan et al., 1985). In
agreement with its poor conservation large deletions of the DSE are required to result
in an inhibition of 3’ end processing (Zarkower and Wickens, 1988). However, the
distance of the DSE to the poly(A) site was shown to effect 3’ end cleavage efficiency
and poly(A) site selection (Mason et al., 1986; McDevitt et al., 1986; Gil and
Proudfoot, 1987; MacDonald et al., 1994;)
The sequences surrounding the polyadenylation site are not conserved. In 70%
of the pre-mRNAs the cleavage site contains an adenosine and the penultimate
nucleotide is most often a C residue (Sheets et al., 1990). The poly(A) site selection is
determined mainly by the distance between the AAUAAA and the DSE (Chen et al.,
1995). Recently it was shown that CF Im preferentially binds the sequence UGUAN
(Brown and Gilmartin, 2003) and it was proposed that these sequence elements are
also important for poly(A) site selection (Venkataraman et al., 2005).
U-rich upstream sequence elements (USEs) are auxiliary sequences that can
modulate the efficiency of 3’ end formation but are not essential for processing.
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1.1.1.2 Yeast cis acting elements
Polyadenylation signals in yeast are not as highly conserved as in higher eukaryotes;
however, common elements are found in the untranslated regions of genes, which
direct the site of cleavage and polyadenylation. These sequences are the efficiency
element (EE), positioning element (PE), U-rich elements located immediately up- and
downstream of the cleavage site and the poly(A) site itself (Figure 1.2.)
The EE is found at variable distances upstream of the cleavage site. Computer
analyses revealed that more than half of the 1000 yeast nuclear genes examined
contain UAUAUA sequences in their 3’ region (Graber et al., 1999), in comparison to
related EE sequences, this motive seems to be most efficient for mRNA 3’ end
formation (Irniger and Braus, 1994). In addition, the U residues at the first and fifth
positions were found to be the most crucial nucleotides in this sequence (Guo and
Sherman, 1995). Other genes carry the related sequences UAUUUA, UAUGUA,
UAUUUA or UUUUUAUA (Egli et al., 1995; Guo and Sherman, 1995).
The PE is often located approximately 20 nucleotides upstream of the
cleavage site and consists of an A-rich sequence (Russo et al., 1991). The sequences
UUAAGAAC, AAUAAA or AAAAAA are the most efficient positioning elements
(Guo and Sherman, 1995).  The PE contributes to the efficiency of 3’ end processing
and to poly(A) site selection (Abe et al., 1990; Hyman et al., 1991; Irniger et al.,
1992; Duvel et al., 1999).
U-rich elements are located immediately up- and downstream of the poly(A)-
site (Graber et al., 1999). The U-rich element upstream of the cleavage site consists of
the sequence UUUUCU or UUUUUU. It contributes to cleavage site selection and
enhances 3’ end processing efficiency (Dichtl and Keller, 2001).
The poly(A) site often contains Py(A)n sequences (Py=pyrimidine; Heidmann et al.,
1994). Many yeast genes contain a cluster of poly(A) sites downstream of the
efficiency and positioning elements (Aranda et al., 1998).
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1.1.1.4 Mammalina trans acting factors
Biochemical purification from HeLa cells and calf thymus identified the factors
involved in 3’ end processing. The cleavage and polyadenylation specificity factor
(CPSF), cleavage stimulatory factor (CstF), Cleavage Factor Im and IIm (CF Im and
CF IIm) and the poly(A) polymerase (PAP) are required for the cleavage reaction.
CPSF, PAP and the nuclear poly(A) binding protein (PABPN1) are required for
processive polyadenylation and for controlling the length of the poly(A) tails.
Cleavage and polyadenylation specificity factor
CPSF is required for the cleavage and the polyadenylation steps of the 3’ end
processing reactions. The factor was shown to bind to the highly conserved
AAUAAA hexanucleotide signal and all six nucleotides are necessary for binding
(Bardwell et al., 1991; Bienroth et al., 1991; Keller et al., 1991). CPSF binds only
weakly to the AAUAAA signal but the binding can be enhanced by a cooperative
interaction with CstF bound to the downstream signal sequence (Wilusz et al., 1990;
Weiss et al., 1991; Gilmartin and Nevins, 1991; MacDonald et al., 1994). Purification
of CPSF activity from HeLa cells and calf thymus lead to the identification of its five
main subunits: CPSF160, CPSF100, CPSF73, CPSF30 and hFip1 (Barabino et al.,
1997; Bienroth et al., 1991; Murthy and Manley, 1992; Jenny et al., 1994; Jenny and
Keller, 1995; Jenny et al., 1996; Kaufmann et al., 2004).
CPSF160 was shown to bind preferentially to AAUAAA containing RNAs
(Moore et al., 1988; Murthy and Manley, 1995). This is in agreement with the idea
that this subunit is crucial for recognition of the conserved hexanucleotide. However,
recombinant CPSF160 binds weaker to the AAUAAA signal compared to purified
CPSF, suggesting that other CPSF subunits are involved in the recognition of this
sequence as well (Murthy and Manley, 1995). CPSF160 was shown to interact with
CstF77 and PAP which is consistent with the cooperative interactions of CPSF with
CstF or PAP in forming stable complexes on the RNA precursor (Murthy and
Manley, 1995).
CPSF100 is 23% identical and shares 49% similarity with CPSF73 (Jenny et
al., 1996). Like CPSF73, CPSF100 shares similarity with the metallo-β-lactamase / β-
CASP enzymes which cleave nucleic acids with a distinctive structure that
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coordinates two zinc ions (Callebaut et al., 2002). However, unlike CPSF73,
CPSF100 is predicted to be inactive in endonuclease activity as it lacks part of all the
conserved amino acids that should be involved in the enzymatic function. The
function of CPSF100 is largely unknown. It can be UV cross-linked to RNA
(Edwalds-Gilbert and Milcarek, 1995), however RNA-binding experiments did not
reveal a role of CPSF100 in RNA binding (Bernhard Dichtl, unpublished results).
CPSF73 is the candidate for the long sought endonuclease. As stated above
CPSF73 is a member of a subfamily of metallo-β-lactamase / β-CASP enzymes
(Callebaut et al., 2002). The ELAC proteins, also members of the metallo-β-lactamase
family, share sequence similarity with CPSF73 (Aravind, 1999; Tavtigian et al., 2001)
and ELAC2 was shown to be an endonuclease that cleaves 3’ extensions from pre-
tRNAs in mammalian cells (Takaku et al., 2003). Ryan and coworkers have recently
shown that the putative active site of CPSF73 is essential for viability of yeast cells
and a protein with the approximate size of CPSF73 was reported to UV cross-link to
the cleavage site (Ryan et al., 2004). However, direct evidence for the catalytic
activity of CPSF73 is still missing. Interestingly not all CPSF73 proteins present in a
cell are associated with CPSF as determined by gel filtration columns. This could
indicate additional functions of CPSF73 independent of CPSF.
The antibody directed against CPSF30 coimmunoprecipitates the other CPSF
subunits and immunodepletes cleavage and polyadenyltion activity from HeLa cell
nuclear extract (Barabino et al., 1997). This protein contains five zinc finger repeats
and a zinc knuckle. Both sequences have been implied with binding nucleic acids. In
agreement with this CPSF30 binds to RNA with a preference to poly(U) (Barabino et
al., 1997). Interestingly CPSF30 has also been proposed to be the endonuclease since
its Drosophila homologue clipper (clp) showed an endonucleolytic activity (Bai and
Tolias, 1996). However, a similar enzymatic activity could not be demonstrated with
recombinant CPSF30 or its yeast homologue Yth1p (M. Ohnacker, S. Barabino and
W. Keller, unpublished results).
hFip1 was only recently identified as a subunit of CPSF. Antibodies directed
against hFip1 co-precipitated CPSF and CstF subunits and depleted cleavage and
polyadenylation activity from HeLa nuclear extract. GST pull-down experiments
showed that hFip1 interacts directly with CPSF30, CstF77 and PAP. Interestingly,
hFip1 binds preferentially to U-rich RNA sequences and can stimulate the
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polyadenylation activity of PAP in an AAUAAA independent manner. Upon addition
of PABPN1 to the polyadenylation reaction hFip1 stimulates the reaction to a similar
extent as observed with CPSF, PAP and PABPN1 (Kaufmann et al., 2004).
Cleavage stimulation factor
CstF binds to the downstream element and is required for the cleavage but not the
polyadenylation reaction. The factor contains three polypeptides of 77, 64 and 50 kDa
(Gilmartin and Nevins, 1991; Takagaki et al., 1990)
CstF77 contains so called HAT repeats (half a TPR) which might be involved
in mediating protein-protein interactions (Preker and Keller, 1998). CstF77 interacts
with CstF64 and CstF50, whereby the factor arranges in a linear fashion (Takagaki
and Manley, 1994). It furthermore interacts with CPSF160 and this interaction is
believed to stabilize the CPSF-CstF-RNA complex (Murthy and Manley, 1995).
CstF64 contains an N-terminal RNA binding domain (RBD) which binds to
the downstream element. CstF64 was originally implicated in binding to the
AAUAAA signal  (Moore et al., 1988; Wilusz and Shenk, 1988) However, SELEX
experiments with the recombinant protein or only its RBD showed that CstF binds to
GU-rich downstream elements (Beyer et al., 1997; Takagaki and Manley, 1997).
CstF64 was also found to interact with symplekin, a protein suggested to be involved
in mammalian 3’ end processing (Takagaki and Manley, 2000; Hofmann et al., 2002).
It was proposed that CstF77 and symplekin compete for the same binding site on
CstF64.
CstF50 contains seven WD-40 (β-transducin) repeats, which were implicated
in binding to the phosphorylated C-terminal domain of RNA polymerase II (CTD)
and the BRCA1-associated protein BARD1 (McCracken et al., 1997; Kleiman and
Manley, 1999; Takagaki and Manley, 2000). CstF50 also binds to itself and to CstF77
(Takagaki and Manley, 2000).
Cleavage factor Im
The subunits of CF Im have no known yeast homologues. The factor is composed of a
small subunit of 25 kDa and a large subunits of either 57, 68 or 72 kDa (Rüegsegger
et al., 1996). The 59 and 68 kDa subunits are encoded by paralogous genes, whereas
the nature of the 72 kDa subunits remains unclear. The CF Im59 and CF Im68 kDa
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proteins contain an N-terminal RNP-type RNA-binding domain (RBD), a central
proline-rich domain and a C-terminal RS-like domain which is similar to that of the
SR proteins involved in splicing (Graveley, 2000). The CF Im 68/25 kDa heterodimer
has been shown to be sufficient to reconstitute CF Im activity in vitro (Rüegsegger et
al., 1998) and SELEX analysis has indicated that the 68/25 kDa heterodimer
preferentially binds the sequence UGUAN (Brown and Gilmartin, 2003). The 68 kDa
on its own does not  seem to bind RNA even though it contains an RNA recognition
motif. This subunit interacts with Srp20, 9G8 and hTra2β, members of the SR family
of splicing factors (Dettwiler et al., 2004).
The 25 kDa subunit can bind RNA and was shown to interact with the large
subunits of CF Im, with PAP (Kim and Lee, 2001) and PABPN1 (Dettwiler et al.,
2004).
Cleavage factor IIm
Upon purification of CF IIm from HeLa cells the factor separated into an essential
fraction CF IIA and a stimulatory fraction CF IIB of the cleavage reaction. Mass
spectrometry analysis of the CF IIA fraction revealed amongst other proteins
homologues of the yeast 3’ end processing subunits Clp1 and Pcf11. Accordingly, the
two human subunits were called hClp1 and hPcf11 (de Vries et al., 2000).
The N-terminus of hPcf11 contains a DSI-consensus motif, which has been
shown to bind to the CTD in yeast (Sadowski et al., 2003). Two zinc-finger motifs
and 30 repeats of the consensus sequence (LRFDG) can also be found in the sequence
of hPcf11. Depletion of hPcf11 with antibodies directed against the protein decreased
the cleavage but not the polyadenylation activity of the extract. The activity could be
reconstituted upon addition of recombinant hPcf11 (Isabelle Kaufmann, unpublished
results).
hClp1 contains Walker A and B motifs. These motifs have been implicated to
function in nucleotide binding. Indeed hClp1 can be UV crosslinked to ATP and GTP
and these binding activities are dependent on metal ions (Henk de Vries, unpublished
results). HeLa nuclear extract depleted of hClp1 is inactive in cleavage but not in




PAP is the enzyme that catalyzes the poly(A) addition to the upstream cleavage
product. PAP on its own is a template-independent polymerase; however, its activity
is low due to its low affinity for the RNA primer. PAP has a higher activity when
Mg2+ is substituted with Mn2+ (Wahle, 1991b; Wittmann and Wahle, 1997). PAP
specifically polyadenylates AAUAAA-containing RNAs in the presence of CPSF,
which binds to the enzyme and the RNA. Under these conditions polyadenylation also
becomes more efficient (Bienroth et al., 1993).
The RNA binding domain of bovine PAP was shown to overlap with the
nuclear localization signal and three aspartates essential for catalysis could be
identified. The three aspartates ligate two of the three active site metals. One of these
metals also contacts the adenine ring (Martin and Keller, 1996; Martin et al., 2000).
The crystal structure of mammalian PAP showed that the catalytic domain at the N-
terminus of the protein shares substantial structural homology with other nucleotidyl
transferases. The C-terminal domain binds the RNA and folds into a compact
structure. The central domain is located in between these two domains (Martin et al.,
2000). The exact mechanism how PAP specifically selects for ATP is not known yet.
Nuclear poly(A) binding protein 1 (PABPN1)
PABPN1 (formerly called PAB II or PABP2) is a 33 kDa protein. It consists of an
acidic N-terminus rich in glutamates, a RNP-motif, and an arginine-rich C-terminus
(Wahle et al., 1993). The protein was identified based on the observation that after a
certain lag-phase polyadenylation becomes AAUAAA-independent, but oligo(A)-
dependent (Sheets and Wickens, 1989; Wahle, 1991a). In agreement with this,
PABPN1 stimulates PAP activity and binds to the enzyme and to oligo(A).
Furthermore, PABPN1 is believed to play an important role in poly(A) tail length
control, probably through oligomerization on the growing poly(A) tail (Wahle, 1995;
Keller et al., 2000) and may additionally contribute to export of mRNAs from the
nucleus to the cytoplasm (Chen et al., 1999; Calado et al., 2000).
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1.1.1.2 Trans acting factors in yeast
The pre-mRNA 3’ end processing reaction in yeast requires the cleavage and
polyadenylation factor IA (CF IA), cleavage and polyadenylation factor IB (CF IB),
cleavage factor II (CF II), polyadenylation factor I (PF I) and the poly(A) binding
protein (Pab1p; Chen and Moore, 1992; Kessler et al., 1996). It was shown that CF II
and PF I form a functional unit in vivo (Ohnacker et al., 2000) and therefore this
factor has been renamed as cleavage and polyadenylation factor (CPF). Site specific
cleavage in vitro requires CF IA, CF IB and CF II. CF IA, CF IB, Pab1p and PF I are
essential for specific polyadenylation in vitro. (For simplicity, subunits carrying two
names will only be referred to with one of the names).
Cleavage and polyadenylation factor IA (CF IA)
CF IA consists of four subunits: Rna14p, Rna15p, Clp1p and Pcf11. The RNA14 gene
is essential and the protein is homologous to the mammalian CstF77 subunit (24%
identity; Minvielle-Sebastia et al., 1991; Kessler et al., 1996). Extracts from yeast
mutants carrying a temperature sensitive rna14 or rna15 allele show a defect in
cleavage and polyadenylation (Minvielle-Sebastia et al., 1994) indicating that the
affected proteins are involved in both steps of the 3’ processing reaction. Rna14p
interacts with Rna15p (Minvielle-Sebastia et al., 1994), Nab4p (Gross and Moore,
2001a) and Fip1p (Preker et al., 1995). Mutants in RNA14 and RNA15 displayed
inefficient transcription elongation and genetically interacted with the THO-complex
that acts at the interface between transcription and mRNA export (Luna et al., 2005).
RNA15 is an essential gene. The 38 kDa protein is the yeast homologue of
CstF64 (43% identity in the RNA binding domain (RBD); (Takagaki and Manley,
1994). The RBD is located in the amino-terminal region and can be UV cross-linked
to RNA (Minvielle-Sebastia et al., 1991; Takagaki and Manley, 1994; Kessler et al.,
1996). The subunit is thought to bind specifically to the positioning element upon
interaction with Rna14p which bridges Rna15p and Nab4p (Gross and Moore, 2001a).
Mutant yeast extracts carrying a temperature sensitive pcf11 allele are
defective in cleavage and polyadenylation. The 70 kDA protein interacts with both
Rna14p and Rna15p (Amrani et al., 1997b). Pcf11 binds to the phosphorylated form
of the CTD and is involved in transcription termination (Sadowski et al., 2003).
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Furthermore the protein was shown to be involved in the dismantling of the RNA
polymerase II elongation complex (Zhang et al., 2005). The CTD-interacting domain
is located at the N-terminus of Pcf11. This domain can interact with RNA also and it
was proposed that competition between the protein-CTD and the protein-RNA
interaction is important for the disengagement of polyadenylation factors from
RNAP II (Hollingworth et al., 2006).
The 50 kDa protein Clp1p is the yeast homologue of hClp1 (26% identity; de
Vries et al., 2000). It contains a P-loop motif implicated in ATP/GTP binding (Preker
et al., 1997).
Cleavage and polyadenylation factor IB (CF IB)
CF IB consists of the single 73 kDa protein Nab4p/Hrp1p (Kessler et al., 1996;
Kessler et al., 1997) which is related to the A/B group of metazoan heterogeneous
nuclear ribonucleoproteins (hnRNPs). Nab4p can be UV-crosslinked to RNA
(Minvielle-Sebastia et al., 1998), and the efficiency element was shown to be the
likely binding site of the protein ( Kessler et al., 1997; Chen et al., 1998; Valentini et
al., 1999).
It was shown that Nab4p is not required for the cleavage reaction but
contributes to cleavage site selection by suppressing the use of alternative poly(A)
sites (Minvielle-Sebastia et al., 1998). The protein is also found in the cytoplasm
where it is directly involved in modulating the activity of the nonsense-mediated
mRNA decay pathway (NMD; Gonzalez et al., 2000).
Cleavage and polyadenylation factor (CPF)
CPF contains all subunits of CF II and PF I and in addition Ref2p (60 kDa), Pti1p (47
kDa), Swd2 (37 kDa), Glc7p (36 kDa), Ssu72p (23 kDa) and Syc1 (21 kDa). By
tagging different subunits of CPF it was shown that not all polypeptides pulled-down
the entire CPF complex (Nedea et al., 2003). Therefore CPF was divided into one
further sub-complex called associated with Pta1 (APT). Figure 1.3 shows an
illustration of the different sub-complexes found in CPF.
Ref2p is essential for viability in some strain backgrounds (Dheur et al., 2003)
and is required for normal growth but not for viability in others (Russnak et al., 1995).
REF2 encodes a nucleic acid-binding protein that stimulates the cleavage reaction,
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particularly of pre-mRNAs with inefficient 3’ processing signals (Russnak et al.,
1995). It is furthermore involved in the length control of the poly(A) tail and for
snoRNA 3’ end maturation (Dheur et al., 2003; Mangus et al., 2004). Ref2p is also
believed to be important for the recruitment of Glc7p and Swd2p to CPF (Nedea et
al., 2003).
Figure 1.3 Schematic representation of the organization of CPF into different sub-complexes.
PTI1 is an essential gene that is well conserved in eukaryotes. It shares homology
with CstF64 (Wolfgang Hübner unpublished results). It contains an RRM-type RNA-
binding domain (RBD) and several potential phosphorylation sites. PTI1 is a
multicopy suppressor of a pcf11 temperature-sensistive mutant. Furthermore, Pti1p
plays a role in snoRNA 3’ end formation (Dheur et al., 2003).
Swd2p is an essential WD repeat protein. It is a subunit of CPF as well as a
subunit of the SET-complex, which modifies lysine 4 of histone H3. The protein is
involved in 3’ end formation of specific mRNAs and snoRNAs and swd2 mutants
were also deficient in transcription termination. Furthermore, methylations on lysine 4
of histone H3 were altered in SWD2 mutant strains. Moreover, the role of the protein
in 3’ end formation and histone tail modification seams to be functionally



















Glc7p is the catalytic subunit of type 1 protein phosphatase (PP1; Feng et al.,
1991). The protein is involved in the regulation of many physiological processes.
Glc7p itself has little substrate specificity (Lenssen et al., 2005). It obtains specificity
by regulatory subunits that target Glc7p to different substrates (Cui et al., 2004). It is
thought to be involved in the polyadenylation but not the cleavage step of 3’ end
processing. Depletion of Glc7p causes shortened poly(A) tails and accumulation of
phosphorylated Pta1, its potential target (He and Moore, 2005). Npl3p, which is
involved in mRNA export is activated by Glc7p-dependent dephosphorylation
(Gilbert and Guthrie, 2004).
Ssu72p is an essential protein (Sun and Hampsey, 1996). It interacts with the
general transcription factor TFIIB and RNAP II (Wu et al., 1999; Pappas and
Hampsey, 2000). Ssu72p was suggested to bridge Pta1p and Ydh1p, TFIIB and
RNAP II via Rpb2p. It is involved in 3’ end cleavage as well as in transcription
elongation and termination (Dichtl et al., 2002a; Ganem et al., 2003; Steinmetz and
Brow, 2003). Ssu72p was furthermore shown to be a CTD phosphatase
(Krishnamurthy et al., 2004).
SYC1 is a non-essential gene, but its removal improves the growth of other
processing mutants at restrictive temperature. It is highly homologous to the C-
terminal domain of Ysh1p, a part of the protein that shares no homology to the beta-
lactamase family. Addition of recombinant Syc1p can restore processing activity to
cleavage and polyadenylation-defective ysh1-1 extract (Zhelkovsky et al., 2006).
Cleavage factor II
CF II has been purified by taking advantage of its ability to reconstitute the cleavage
reaction in the presence of purified CF IA and CF IB (Zhao et al., 1997).
CF II consists of the four subunits Yhh1p/Cft1p (150 kDa; Stumpf and
Domdey, 1996; Zhao et al., 1997), Ydh1p/Cft2p (105 kDa; Jenny et al., 1994),
Ysh1p/Brr5p (100 kDa; Jenny et al., 1996) and Pta1p (90 kDa; Preker et al., 1997).
The genes coding for the four subunits are essential.
Yhh1p is the yeast homologue of CPSF160 (24% identity; Jenny and Keller,
1995; Stumpf and Domdey, 1996) and interacts with multiple subunits of CPF and CF
IA. Therefore, it might be important for the assembly of the processing machinery.
The protein contains an RNA binding domain that is composed of β-propeller
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forming repeats and interacts with poly(A) site sequences. In agreement with this
fnding, Yhh1p acts in cleavage site selection and is essential for recognition of weak
poly(A) sites (Dichtl et al., 2002b).
Ysh1p is the yeast homologue of CPSF73 (23% identity), over the first 500 aa
it is even 53% identical to the bovine CPSF73 subunit (Chanfreau et al., 1996; Jenny
et al., 1996). Ysh1p is a member of a subfamily of metallo-β-lactamase enzymes that
cleaves nucleic acids (Callebaut et al., 2002). It has recently been shown that the
putative active site of Ysh1p is essential for viability of yeast cells (Ryan et al., 2004)
and the authors proposed that this protein is the endonuclease. Mutant yeast extracts
carrying a conditional ysh1  allele have been reported to be deficient in
polyadenylation but not in cleavage (Jenny et al., 1996). This observation is not
necessarily in discrepancy with the model that Ysh1p could be the endonuclease
given that mutations that abolish the cleavage activity of the protein could be lethal at
any temperature.
The essential protein Pta1p is involved in polyadenylation (Preker et al., 1997)
and in cleavage (Zhao et al., 1999b). The phosphorylation status of Pta1p was implied
to regulate polyadenylation (He and Moore, 2005).
Ydh1p is the 105 kDa subunit of CPF. It has 24.4% identity and 43%
similarity with the mammalian protein CPSF100. It is also significantly related to
Ysh1p and to CPSF73 (Jenny et al., 1994). Ydh1p is essential for cell viability (Preker
et al., 1997). Its amino acid sequence was examined for known RNA binding motifs,
but none could be found.  The protein carries numerous potential serine/threonine
phosphorylation sites, a possible tyrosine kinase site CYL at amino acid 32 as well as
two putative single cluster type nuclear localization signals (Zhao et al., 1997). Even
though no known RNA binding domain could be found, Ydh1p, in the presence of the
other CF II subunits and ATP, was shown to UV-crosslink to wild-type GAL7-1 RNA
substrate but not to a mutated version of the full-length precursor which lacks the
(UA)6 repeat upstream of the poly(A) site nor to precleaved GAL7-9 substrate lacking
the sequences downstream of the cleavage site (Zhao et al., 1997). Furthermore, GST
pull down experiments revealed that recombinant Ydh1p binds to full length CYC1
RNA, precleaved CYC1 lacking sequences downstream of the poly(A) site, and to
CYC1-512, which has a 38nt deletion encompassing both EE and PE (Dichtl and
Keller, 2001). The binding site of Ydh1p on CYC1 RNA substrate was determined by
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RNase H protection experiments. The protein binds with high affinity at sequences
surrounding the poly(A) site and weaker at the EE (Dichtl and Keller, 2001).
Poyadenylation factor I (PF I)
PF I was originally identified as an activity which supported poly(A) addition but not
cleavage (Chen and Moore, 1992). It contains the four subunits of CF II, Yth1p (26
kDa), Mpe1p (58 kDa; Vo et al., 2001), Pfs2p (53 kDa), Fip1p (55 kDa) and Pap1p
(64 kDa). All genes coding for these subunits are essential.
Yth1p is the yeast homologue of CPSF30 (40% identity; Barabino et al., 1997)
and is required for both steps of 3’ end processing and tethers Fip1p and the poly(A)
polymerase to the rest of CPF. It binds to pre-mRNA around the poly(A) site and
participates in the recognition of the cleavage site (Barabino et al., 2000).
Seven WD repeats can be found in the protein sequence of Pfs2p. This protein
plays an essential role in cleavage and polyadenylation. It bridges CPF with CF IA
through its interaction with Ysh1p, Fip1p and Rna14p (Ohnacker et al., 2000).
FIP1 (Factor Interacting with Poly(A) polymerase) is an essential gene. The
protein can be phosphorylated by the protein kinase CK2 (Zielinski et al., 2006). fip1
mutant extracts cleave pre-mRNA substrates in vitro, but are deficient in
polyadenylation (Preker et al., 1995). The protein interacts both with Pap1p (with
which it forms a 1:1 complex in vitro) and with Rna14p (Preker et al., 1995). Fip1p
possibly tethers Pap1p to the RNA substrate. Furthermore, Fip1p might interact more
weakly with phosphorylated than with unphosphorylated CPF, which in turn could
influence polyadenylation efficiency (He and Moore, 2005).
The protein sequence of Mpe1p contains a putative RNA-binding zinc knuckle
motif. The polypeptide interacts genetically with Pcf11p and is required for poly(A)
site selection. Mpe1p is involved in polyadenylation (Vo et al., 2001). Controversial
data exist on whether the protein plays a role in cleavage as well (Vo et al., 2001;
Martin Sadowski, Dissertation 2002).
The yeast poly(A) polymerase (Pap1p) is 47% identical to mammalian PAP
within the first 400 aa, a region which comprises the catalytic domain and includes
the nucleotidyltransferase active site (Martin and Keller, 1996). An RNA binding site
at the carboxyl terminus is believed to be essential for processive activity
(Zhelkovsky et al., 1995). In addition two other contacts with the RNA substrate exist,
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one is thought to recognize the last three nucleotides of the RNA primer and to help
the enzyme discriminate against deoxyribonucleotide substrates, and another base-
specific site is proposed to interact with the primer 12 to 14 nucleotides upstream of
the 3’ end (Zhelkovsky et al., 1995). At either end of Pap1 two specific domains were
identified, which might be necessary to recruit Pap1 to the polyadenylation machinery
by interacting with specificity factors and to regulate its activity (Zhelkovsky et al.,
1995).
In contrast to the mammalian poly(A) polymerase yeast Pap1p is not required
for cleavage (Mandart and Parker; 1995). The crystal structure of the protein has also
been solved (Bard et al., 2000).
Poly(A) binding protein (Pab1p)
Pab1p associates with the poly(A) tails of mRNAs in the nucleus and the cytoplasm
(Adam et al., 1986; Setyono and Greenberg, 1981). It was shown to limit the length of
poly(A) tails as cells bearing a pap1 mutation, conferring temperature-sensitive
growth show an aberrantly long poly(A) tail in vivo and in vitro (Amrani et al., 1997a;
Minvielle-Sebastia et al., 1997). Moreover, the protein is involved in the
polyadenylation activity of the complex, as poly(A) tail addition in reconstituted
assays only occurs in the presence of Pab1p. It also plays a crucial role in translation
initiation (Tarun and Sachs, 1995; Tarun and Sachs, 1996; Tarun et al., 1997) and in
deadenylation-dependent mRNA turnover (Caponigro and Parker, 1995).
1.1.1.4 Histone 3’ end processing
In metazoans most histone transcripts are not polyadenylated but like the pre-
mRNAs they undergo endonucleolytic cleavage. (Birchmeier et al., 1984). The cis
elements involved in histone 3’ end processing are a conserved stem-loop, positioned
upstream of the cleavage site and a purine-rich histone downstream element (HDE)
(for review see Marzluff and Duronio, 2002). The U7 snRNP binds through base
pairing of the 5’ end of the U7 snRNA to the HDE (Schaufele et al., 1986). The stem
loop binding protein (SSLBP) binds to the stem loop and helps recruiting the
U7 snRNP to the RNA (Dominski et al., 1999). ZFP100, a zinc finger protein
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facilitates this recruitment by bridging between SLBP and Lsm11 (Dominski et al.,
2002; Pillai et al., 2003). Lsm11 is a unique component of the U7-specific Sm core.
The site of endonucleolytic cleavage is located 10 to 11 nucleotides upstream of the
intermolecular U7/HDE RNA duplex (Scharl and Steitz, 1994; Scharl and Steitz,
1996). Recently a protein complex required for histone processing was purified that
contained all five subunits of CPSF, CstF77, CstF64 and symplekin. Furthermore
symplekin was identified as the heat-labile factor (Kolev and Steitz, 2005). Moreover,
it was shown that CPSF73 cross-links to the upstream and downstream fragment of
the cleavage products and the authors suggested that CPSF73 is both the
endonuclease and 5’-3’ exonuclease in histone pre-mRNA processing (Dominski et
al., 2005a).
1.1.2 Splicing
The excision of the intron and subsequent ligation of the exons is achieved in two
transesterification reactions. First the 2’OH of the branchpoint adenosine acts as a
nucleophile attacking the 5’ exon-intron border. This results in a free 5’ exon and a
lariate-shaped intron that is still attached to the 3’ exon. In the second step, the 3’ OH
of the freed 5’ exon attacks the intron-3’ exon border. This second transesterification
results in the ligation of the exons and release of the intron as a shorter lariat. The
lariat is then subsequently degraded.
1.1.2.1 Splice site recognition and cis acting elements
In mammals the spliceosome has to recognize the relatively short exons amid much
longer introns. Despite of this challenge, the cis acting elements in vertebrates are
poorly conserved and the splice sites sequences in mammals are even less conserved
than their yeast counterparts (Guthrie, 1991; Ruby and Abelson, 1991).
The most common sequences involved in splice site selection are the 5’ splice
site, the branchpoint sequence (BP), the polypyrimidine tract (py) and the 3’ splice
site. The overwhelming majority of the 5’ splice site contains the consensus
AG↓GUPuAGU (Pu=Purine). The arrow marks the exon-intron junction and the
underlined positions mark the most highly conserved residues. In most introns the
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5’ splice site is followed thousands of basepairs downstream, by the BP and Py-tract
sequences. The BP sequence in humans is not highly conserved. A common
consensus sequence often found is CUPuAPy, the underlined A is highly conserved.
The Py-tract is a run of pyrimidines, which can vary significantly in length and
sequence composition. The average length however is eight nucleotides. The 3’ splice
site is often located immediately downstream of the Py-tract. The distance between
the highly conserved A of the BP sequence and the 3’ splice site is usually eighteen
bases. However, there are many introns where the distance between the BP and the
3’ splice site can be hundreds of nucleotides (Smith and Nadal-Ginard, 1989). The
3’ splice site often contains the consensus sequence PyAG↓Pu. The arrow marks the
exon-intron boundary and the underlined nucleotides are highly conserved; all
reviewed in (Sharp and Burge, 1997; Goldstrohm et al., 2001).
Although many sequences within the mammalian transcripts match the
consensus splice sites most of them are not used. It is believed that many of these
pseudo-splice sites have multiple defects and are inhibited by surrounding splicing
silencer sequences (Sun and Chasin, 2000). Whether a splice site is used or not is
probably dependent on the arrangement of positive and negative cis acting elements.
The SR proteins and hnRNP proteins are believed to be involved in splice site
selection by binding to these regulatory elements.
The exon definition model proposes that the exons are recognized by the
splicing machinery which searches for a pair of closely spaced splice sites in an
exonic polarity. The exon is then defined by the binding of the U1 and U2 snRNP and
associated splicing factors to the RNA and their interaction with each other (reviewed
in Berget, 1995).
1.1.2.2 The spliceosome
The spliecosome consists of several small nuclear ribonucleoproteins (snRNPs) and
numerous non-snRNP splicing factors. Each snRNP consists of a snRNA, seven Sm
or Sm-like proteins and several particle-specific proteins (Will and Lührmann, 1997).
The five spliceosomal snRNAs U1, U2, U4, U5 and U6 exist as individual RNA-
protein complexes; however, the sequences of U4 and U6 are quite complementary
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and these snRNAs are mainly found base-paired together in a U4/U6 di-snRNP
(Forne et al., 1996).
The precursors of U1, U2, U4 and U5 snRNAs are transcribed by RNAP II in
the nucleus. The primary transcripts are then transported to the cytoplasm, where they
are bound by the core proteins and a trimethyl guanosine cap is added to their 5’ ends.
These core snRNPs are re-imported to the nucleus, where the snRNAs are internally
modified at several positions, primarily by pseudouridylation and 2’-O-methylation.
Finally the snRNP-specific proteins bind to the core snRNP. The U6 snRNA is
transcribed by RNAP III and has a γ-monomethyl phosphate cap. The U6 snRNA
does not contain an Sm site and formation of the U6 snRNP involves the association
of seven so-called Sm-like proteins. Assembly of the U6 snRNP is believed to take
place entirely in the nucleus (Kambach et al., 1999; Will and Lührmann, 2001).
In addition to the snRNPs many proteins involved in splicing are members of
the serine/arginine-rich (SR) protein family. At their N-terminus SR proteins contain
one or more RRMs. The C-terminus consists of an arginine (R) and serine (S) rich
domain, the so called RS domain, which is essential for splicing in vitro and might
have a role in nuclear localisation. The serines can be phosphorylated which might
alter the RNA or protein binding specificity (Will and Lührmann 2001).
The spliceosome assembles on the pre-mRNA in a stepwise manner. In an
ATP-independent step the U1 snRNP recognizes and binds the 5’ splice site. This
interaction is mediated by the U1 snRNA base-pairing with the pre-mRNA as well as
protein-RNA interactions. The U2AF proteins bind to the Py-tract and SF1 to the BP
sequence. Binding of SF1 to the BP sequence is weak but its affinity is significantly
increased by a simultaneous interaction with U2AF65 (Will and Lührmann, 1997;
Selenko et al., 2003). SR proteins promote E-complex formation and apparently
mediate a functional interaction between the 5’ and 3’ splice sites, forming a protein
link between the U1 snRNP and U2AF65. The U2 snRNP is also associated with this
so-called E-complex by protein-protein but not by RNA-protein interactions (Das et
al., 2000).
The A-complex is formed in an ATP-dependent step in which the U2 snRNP
is bound to the branch site, displacing SF1. This interaction is facilitated by snRNA-
pre-mRNA and protein-RNA interactions, involving SF3a and SF3b subunits, as well
as the splicing factors U2AF and SF1. The U2 snRNA base pairs with the BP
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sequence and in doing so buldges out the branchpoint adenosine and enhances the
first nucleophilic attack. U2AF and the U1 snRNP are thought to be less tightly bound
in the A-complex than in the E-complex (reviewed in Will and Lührmann, 2001).
According to the currently accepted model the B-complex is formed upon
addition of the U4/U6-U5 tri-snRNP. However, recent data indicated that the tri-
snRNP recognized the 5’ splice site together with U1 snRNP at the earliest stages of
spliceosome assembly (Maroney et al., 2000). The U1 snRNP-5’ splice site
interaction is weakened or disrupted and often the U1 snRNP is missing from this
complex.
The complex B undergoes many conformational changes leading to the
formation of an intricate RNA-RNA network within the spliceosome. At this point the
U2 snRNA, U6 snRNA and the pre-mRNA seem to interact with each other and form
a catalytic core. By doing so they place the 5’ splice site and branchpoint in close
proximity. This complex is catalytically active and is reffered to as complex C
(Madhani and Guthrie, 1992; Staley and Guthrie, 1998; Will and Lührmann, 2001).
Figure 1.4 shows a schematic representation of the different spliceosome assembly
steps.
In addition to the finding mentioned above that the tri-snRP was found already
in the E-complex, preparation of cell-free extracts from S. cerevisiae led to the
discovery of a high molecular-mass spliceosome complex, containing all five snRNAs
and more than 85% of all splicing factors identified, that apparently assembled
functionally on a pre-mRNA as a whole (Stevens et al., 2002). This favors a model in
which a pre-assembled splicing machinery recognizes the pre-mRNA and then
rearranges into a catalytically active form. However, it has recently been reported that
cotranscriptional spliceosome assembly occurs in a step wise fashion (Gornemann et
al., 2005; Tardiff and Rosbash, 2006).
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1.1.2.3 Splicing in yeast
A mammalian nucleus contains 105 – 106 snRNPs compared to about 100 found in a
yeast cell. In S. cerevisiae, only 5% of the genes contain introns. Usually they have
only one single intron located near the 5’ end of the gene (Lopez and Seraphin, 1999;
Spingola et al., 1999).
In yeast the cis acting RNA elements are more conserved than in humans.
According to the more stringent splice site selection no alternative splicing has been
found in these organisms yet. The 5’ splice site contains the sequence GUAUGU. The
branchpoint sequence consists of the highly conserved nucleotides UACUAAC; the
underlined A marks the branchpoint andenosine. The 3’ splice site consensus
sequence is PyAG. In most genes a Py-tract between the BP and the 3’ splice site can
be found (Kuhn and Kaufer, 2003).
The splicing apparatus, spliceosome assembly and mechanism are strongly
conserved from higher eukaryotes to yeast. However there are variations that
probably reflect functional distinctions such as alternative splicing.
1.2 Coupling between transcription, capping, splicing and 3’ end
processing
Transcription, capping, splicing and 3’ end processing can be studied separately from
each other in vitro. However, it is now clear that all these reactions are coupled and
influence one another in vivo.
1.2.1 Coupling of capping with splicing and 3’ end formation
That 5’ end capping has an influence on splicing became clear when it was shown,
that in an in vitro system the addition of a cap structure to the pre-mRNA can enhance
splicing. The cap was shown to have a bigger influence on the first than on the
internal introns. It was found that the cap binding complex (CBC) is involved in
mediating the coupling of the two reactions, when depletion of the 80 kDa subunit of
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the CBC resulted in inhibition of splicing. Furthermore, the interaction of the U1
snRNP with the 5’ splice site is enhanced by the CBC (Izaurralde et al., 1994; Lewis
et al., 1996; Lewis and Izaurralde, 1997). The CBC was also suggested to facilitate
the U6 snRNA 5’ splice site interaction possibly by affecting the displacement of the
U1 snRNP (O'Mullane and Eperon, 1998). Furthermore the coupling of capping and
splicing was also shown in yeast, suggesting that these interconnections are conserved
in evolution (reviewed in Shatkin and Manley, 2000).
The cap was also demonstrated to have a positive effect on 3’ end processing.
The presence of the CBC enhanced the 3’ end cleavage but not the polyadenylation
reaction and similar to splicing, the CBC appeared to have a stabilizing effect on the
polyadenylation complex and its target pre-mRNA (Flaherty et al., 1997; Lewis and
Izaurralde, 1997).
1.2.2 Coupling between splicing and 3’ end processing
See introduction to Chapter 2
1.2.3 Coupling between transcription and pre-mRNA processing
All three processing reactions are taking place co-transcriptionally and there is strong
evidence that the processing reactions are coupled to transcription. The connection
between transcription and pre-mRNA processing starts as early as at the promoter.
Specific types of promoters seam to recruit specific processing activities that
determine how the pre-mRNA is processed. It was shown that capping, splicing and
3’ end formation were prevented or partially repressed when a RNAP II promoter was
replaced by RNAP I or RNAP III promoters. Similarly, exchanging the promoter of a
protein encoding gene with a promoter of an snRNA gene impaired pre-mRNA
processing (Proudfoot et al., 2002).
The main player in coupling transcription to pre-mRNA processing events is
the C-terminal domain (CTD) of RNAP II. The CTD is separated from the main body
of RNAP II and is attached to it by a relatively unstructured linker sequence (Cramer
et al., 2001). The CTD consists of a heptad amino acid sequence that is repeated 52
times in mammals and 26 times in yeast. The repeat contains two serine residues (ser2
and ser5) and they show different phosphorylation states depending on the progress of
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the transcription reaction (Dahmus, 1996). At the initiation of transcription the CTD
is not phosphorylated and the RNAP II interacts with a number of general
transcription factors. Upon transcription elongation however, the CTD is
phosphorylated, generating the elongation-competent RNAP II (Reines et al., 1996;
Price, 2000). Ser5 of the heptad repeat is phosphorylated mainly at early stages of
elongation whereas phosphorylated ser2 is found at later stages (Komarnitsky et al.,
2000). Proteins of all three processing reactions are interacting with the
phosphorylated CTD and travel along with the elongating RNAP II.
The capping enzymes associate with the CTD at the beginning of transcription
but are not found any more as the elongation progresses further into the gene
(Komarnitsky et al., 2000). It was also shown that the phosphorylated CTD can
enhance the capping reaction (Ho et al., 1999). Interestingly, the polymerase pauses
transcription at around the time when the capping reaction occurs. It is therefore
possible that this pausing occurs to allow time for 5’ capping, and that the RNAP II
will not proceed elongation until the protective modification has been added
(Woychik and Hampsey, 2002).
It is an established fact now that splicing occurs co-transcriptionally (Beyer
and Osheim, 1988; Misteli et al., 1998; Misteli and Spector, 1998; Gornemann et al.,
2005; Das et al., 2006). It was shown that the phosphorylated form of the CTD can
enhance splicing efficiency (Corden and Patturajan, 1997; Hirose et al., 1999) and
exon definition might even require the RNAP II given that phospho-CTD only
activated RNA substrates with complete exons bordered by introns (Zeng and Berget,
2000). A series of protein factors sharing homology to SR proteins and a subunit of
the U1 snRNP are known to directly interact with the phosphorylated CTD (Corden
and Patturajan, 1997; Morris and Greenleaf, 2000). Given that splicing occurs co-
transcriptionally the 5’ splice site appears before the 3’ splice site on the nascent
RNA. It was proposed that the 5’ splice site might pair with the first 3’ splice site to
appear or if more 3’ splice sites appear in short succession more than one choice may
be possible. Also, it was shown that the elongation rate of RNAP II can influence the
3’ splice site choice. If RNAP II transcribes more slowly the more proximal site is
favored over the more distal 3’ splice site (Howe et al., 2003; de la Mata et al., 2003).
These results suggest that elongation rate and the lag time between the appearance of
different splice sites can modulate alternative splicing. It was also recently suggested
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that the exons are tethered to the transcribing RNAP II, facilitating splice site
selection (Dye et al., 2006).
In mammals the CTD was proposed to facilitate efficient 3’ end cleavage also
in the absence of transcription (Hirose and Manley, 1998; Ryan et al., 2002). The
phosphorylated CTD was shown to interact with the 3’ end formation proteins and
surprisingly the 3’ end processing factors were found associated with the transcribing
RNAP II from the 5’ end till the 3’ end of the genes (Gall et al., 1999; Licatalosi et
al., 2002; Kim et al., 2004). There is also a network of interactions between 3’ end
processing subunits and general transcription factors localized at the promoters. CPSF
subunits were shown to interact with the transcription factor TFIID (Dantonel et al.,
1997). The transcriptional coactivator PC4/Sub1, which can act to inhibit CTD
phosphorylation by CDKs (Schang et al., 2000), interacts with CstF64 and its yeast
homologue Rna15 (Calvo and Manley, 2001). Furthermore, Ssu72, a subunit of CPF
interacts with the general transcription factor TFIIB and RNAP II (Wu et al., 1999;
Pappas and Hampsey, 2000), Ssu72 was also shown to be involved in transcription
elongation and termination, as well as in 3’ end cleavage (Dichtl et al., 2002a; Ganem
et al., 2003; Steinmetz and Brow, 2003). Ssu72p was furthermore shown to be a CTD
phophatase (Krishnamurthy et al., 2004).
Transcription termination and 3’ end processing are strongly coupled. First
evidence for this coupling emerged when it was shown that termination requires a
correct poly(A) site (Zaret and Sherman, 1982; Whitelaw and Proudfoot, 1986; Logan
et al., 1987). Furthermore, yeast strains carrying mutations in the CF I subunits
Pcf11p, Rna14p and Rna15p (Birse et al., 1998; Sadowski et al., 2003) as well as in
the CPF subunits Yhh1p, Ssu72p and Swd2p were shown to be deficient in
transcription termination (Dichtl et al., 2002a; Dichtl et al., 2002b; Ganem et al.,
2003; Steinmetz and Brow, 2003; Cheng et al., 2004; Dichtl et al., 2004). Pcf11p
appears to play a very interesting part in transcription termination, as it was proposed
to be involved in the dismantling of the RNA polymerase II elongation complex
(Zhang et al., 2005; Hollingworth et al., 2006). Recently RNAP II pause sites were
also suggested to be involved in transcription termination (Gromak et al., 2006).
However, it is not clear at present what exactly triggers transcription termination.
Two main models exist, the so called “torpedo” model and the “antiterminator”
model. The torpedo model suggests that after 3’ end cleavage the exonucleases
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degrading the downstream cleavage product eventually catch up with the still
transcribing polymerase and that this event subsequently triggers transcription
termination. The antitermiator model proposes that the 3’ end processing factors
induce conformational changes within RNAP II upon recognition of the poly(A) site,
which leads to termination (Figure 1.5; reviewed in Hirose and Manley, 2000;
Proudfoot et al., 2002) Recently a combination of both models has also been proposed
(Luo et al., 2006).
Figure 1.5 Schematic representation of the Antiterminator and the Torpedo model. The drawing
at the top shows the transcribing RNAP II.
1.3 tRNA splicing
In order to generate mature tRNAs the precursor molecules must go through several
processing steps. The 5’ leader is removed by the RNase P (Frank and Pace, 1998;
Xiao et al., 2002) and  the 3’ trailer is cut off by the ELAC2 enzyme (Takaku et al.,
2003) and a CCA trinucleotide is added to the cleaved 3’ end. Furthermore, numerous
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nucleotides of the pre-tRNA are modified (reviewed in Hopper and Phizicky, 2003).
In addition, some pre-tRNAs contain introns, which need to be spliced out (reviewed
in Abelson et al., 1998).
In humans, only 6% and in lower eukaryotes approximately 25% of all tRNA
genes contain introns (Lowe and Eddy, 1997; Trotta et al., 1997). The introns are 14
to 60 nucleotides long and interrupt the anticodon loop immediately 3’ of the
anticodon (Ogden et al., 1984). The 3’ splice site is invariably located in a bulged
loop but otherwise there is no sequence conservation at the splice junction (Baldi et
al., 1992).
tRNA splicing is a three-step reaction and each step requires an individual set
of proteins. In the first step the pre-tRNA is cut at its two splice sites, leading to two
tRNA half molecules and the linear intron. The 90 kDa tRNA ligase subsequently
ligates the two tRNA half molecules (Phizicky et al., 1986; Westaway et al., 1988).
After the ligation reaction a 2’-phosphate remains at the spliced junction and must be
removed to complete the splicing reaction (McCraith and Phizicky, 1990; McCraith
and Phizicky, 1991; Culver et al., 1997).
The yeast tRNA splicing endonuclease contains four essential subunits: Sen2,
Sen34, Sen54 and Sen15 (Rauhut et al., 1990; Trotta et al., 1997). The archeal and
yeast Sen2 and Sen34 proteins are highly conserved, indicating an enzymatic role for
both proteins. Indeed, yeast strains carrying mutations in Sen2p resulted in deficient
cleavage of the 5’ splice site (Ho et al., 1990) and mutations in Sen34p did not cleave
the 3’splice site (Trotta et al., 1997). Sen2p interacts with Sen54p and Sen34p
interacts with Sen15p (Trotta et al., 1997). The Sen54p and Sen15p subunits carry at
their C-terminus a domain required for the dimerization of the two yeast heterodimers
Sen45p-Sen2 and Sen15p-Sen34p (Lykke-Andersen and Garrett, 1997; Li et al.,
1998). In yeast tRNA splicing is believed to take place in the cytoplasm (Yoshihisa et
al., 2003: Huh et al., 2003), whereas in humans the reaction is likely occurring in the
nucleus (Paushkin et al., 2004). Nethertheless the tRNA endonuclease subunits are
conserved from yeast to humans (Paushkin et al., 2004).
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Chapter 2: Direct interactions between subunits of CPSF and the
U2 snRNP contribute to the coupling of pre-mRNA 3’ end processing
and splicing
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Eukaryotic pre-mRNAs are capped at their 5’ ends, polyadenylated at their 3’ ends
and spliced before being exported from the nucleus to the cytoplasm. Although the
three processing reactions can be studied separately in vitro, they are coupled in vivo.
We identified subunits of the U2 snRNP in highly purified CPSF and showed that the
two complexes physically interact. We therefore tested whether this interaction
contributes to the coupling of 3’ end processing and splicing. We found that CPSF is
necessary for efficient splicing activity in coupled assays and that mutations in the
pre-mRNA binding site of the U2 snRNP resulted in impaired splicing and in much
reduced cleavage efficiency. Moreover, we showed that efficient cleavage required
the presence of the U2 snRNA in coupled assays. We therefore propose that the
interaction between CPSF and the U2 snRNP contributes to the coupling of splicing
and 3’ end formation.
2.2 Introduction
Eukaryotic messenger RNA precursors (pre-mRNAs) are capped at the 5’ end,
spliced, and polyadenylated at the 3’ end before they are exported from the nucleus to
the cytoplasm as mature messenger RNA (mRNA).
3’ end processing is a two-step reaction. First, the pre-mRNA is
endonucleolytically cleaved, followed by poly(A) addition to the upstream fragment
of the cleavage reaction, and the downstream fragment is rapidly degraded. Cis
elements on the pre-mRNA direct the factors involved in 3’ end processing to the
correct cleavage site. The highly conserved AAUAAA hexanucleotide, located about
10-30 nucleotides upstream of the cleavage site, is bound by the cleavage and
polyadenylation specificity factor (CPSF; Keller et al., 1991). The cleavage
stimulation factor (CstF) binds the G/U-rich sequence element downstream of the
cleavage site (MacDonald et al., 1994). In addition, the 3’ end processing reaction
requires cleavage factor Im (CF Im), which binds to UGUAN sequences ((Brown and
Gilmartin, 2003; Venkataraman et al., 2005), cleavage factor IIm (CF IIm; (de Vries et
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al., 2000), poly(A) polymerase (PAP), and nuclear poly(A)-binding protein 1
(PABPN1; reviewed in Zhao et al., 1999a; Edmonds, 2002).
Pur i f ied  CPSF conta ins  f ive  polypept ides :  CPSF160,
CPSF100, CPSF73, CPSF30 and hFip1 (Bienroth et al., 1991; Murthy and Manley,
1992; Jenny et al., 1994; Jenny and Keller, 1995; Jenny et al., 1996; Barabino et al.,
1997; Kaufmann et al., 2004). CPSF is required for both steps of the 3’ end
processing reaction and plays a crucial role in poly(A) site recognition by binding to
the AAUAAA hexanucleotide (Keller et al., 1991) and also to upstream sequence
elements (USEs; Gilmartin et al., 199); Graveley et al., 1996; Brackenridge and
Proudfoot, 2000).
Splicing involves the excision of introns and the subsequent ligation of the
exons by the spliceosome, which is composed of the U1, U2, U4, U5 and U6 small
ribonucleoprotein particles (snRNPs) and many non-snRNP proteins (reviewed in
Will and Lührmann, 2001; Hastings and Krainer, 2001). Binding of U1 snRNP to the
5’ splice site initiates spliceosome assembly by forming the E-complex. The E-
complex also contains the U2 snRNP, which at this stage associates via protein-
protein interactions (Das et al., 2000). Formation of the A-complex is achieved upon
base pairing of the U2 snRNA with the branch site of the pre-mRNA. The B-complex
is generated upon the addition of the U4/U6.U5 tri-snRNP and this complex
undergoes an additional conformational change that leads to the catalytically active C-
complex (reviewed in (Will and Lührmann, 2001; Hastings and Krainer, 2001).
The 12S U2 snRNP consists of the seven Sm proteins common to the
spliceosomal snRNPs and the U2-specific proteins U2-A’ and U2-B’’(Will and
Lührmann, 2001).  Binding of the splicing factor 3b (SF3b) to the 12S U2 snRNP
results in formation of the 15S particle. The active 17S U2 snRNP is formed after
subsequent binding of the splicing factor 3a (SF3a; Brosi et al., 1993; Kramer et al.,
1999). Subunits of SF3a and SF3b contribute to branch site recognition by interacting
with the branch site adenosine and surrounding sequences. Both SF3a and SF3b are
thought to play an essential role during pre-spliceosome assembly (Gozani et al.,
1996; Query et al., 1996; Gozani et al., 1998; Will et al., 2001).
Transcription, capping, splicing and 3’ end processing can be studied
separately in vitro; however, in the last years it became apparent that all these
processes are coupled events in vivo. For example, transcription itself has been linked
40
to all three pre-mRNA processing reactions and the CTD of the RNA polymerase II
(RNAP II) seems to play a critical role in mediating this coupling by serving as a
protein assembly platform. Furthermore, all three pre-mRNA processing reactions
were shown to be coupled to each other (reviewed in Proudfoot et al., 2002; Zorio and
Bentley, 2004).
Evidence that 3’ end formation and splicing influence each other emerged
when it was shown that mutations in cis acting elements involved in splicing affected
pre-mRNA splicing and also 3’ end processing. For example, mutations of the
3’ splice site or the pyrimidine tract decreased splicing efficiency and 3’ end
processing activity in vitro (Cooke and Alwine, 1996; Vagner et al., 2000). Similarly,
mutations in the highly conserved polyadenylation signal AAUAAA and downstream
sequences decreased polyadenylation activity as well as splicing efficiency (Niwa and
Berget, 1991; Cooke et al., 1999). It was proposed that splicing near the 3’ end of a
transcript is prevented until the RNA is released from the site of transcription by
poly(A) site cleavage (Bird et al., 2005). In addition, in vivo studies confirmed that
introns affect 3’ end formation and that polyadenylation may play a role in splice site
selection (Chiou et al., 1991; Nesic et al., 1993; Nesic and Maquat, 1994; Scott and
Imperiale, 1996; Tsai et al., 1998). The mechanism by which this coupling takes place
is not well understood; however a number of studies suggested the involvement of the
U1 snRNP in coupling splicing and 3’ end formation. Crosslinking of the U1 snRNP
to cleavage and polyadenylation efficiency elements correlated with 3’ end processing
efficiency (Wassarman and Steitz, 1993). In agreement with this study, the U1A
protein of the U1 snRNP was shown to stimulate polyadenylation via its interaction
with CPSF160 (Lutz et al., 1996). On the other hand, the U1A protein also inhibits
polyadenylation of its own pre-mRNA by interacting with PAP (Gunderson et al.,
1994); similarly, the U1 70 protein of the U1 snRNP was shown to inhibit
polyadenylation by interacting with PAP (Gunderson et al., 1998). Furthermore it has
been reported that the U1 snRNP interacts with CF Im (Awasthi and Alwine, 2003).
Here we present experiments that show an interaction between CPSF and the
U2 snRNP. We found that proteins of the U2 snRNP are associated with CPSF and
we demonstrate that subunits of SF3b directly interact with subunits of CPSF. We
also provide evidence that both the U2 snRNP and CPSF are involved in coupling
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splicing and 3’ end processing in vitro. We propose that their direct interaction
mediates this coupling.
2.3 Results
2.3.1 Subunits of the U2 snRNP are associated with CPSF
To identify proteins associated with CPSF we purified the factor by chromatography
on five columns. CPSF-containing fractions were identified by their polyadenylation
activity and Western blot and pooled after each column. We identified the proteins by
mass spectrometry and found that the complex contained all the previously identified
CPSF subunits: CPSF160, CPSF 100, CPSF73, hFip1 and CPSF30 (Figure 2.1.A).
Surprisingly, we also detected several subunits of SF3b, namely SF3b155, SF3b130
and SF3b49. Western blot analysis revealed the presence of several other
polypeptides of the U2 snRNP: SF3b14/14a, SF3a120, SF3a60 and the U2-specific
protein B’’ (results not shown). We did not find SF3b125 by Western blotting. In
addition, the CPSF-containing fractions contained U2 snRNA as shown by Northern
blotting (Figure 2.1.C, lowest panel, load).
The following proteins were also present in our purified fractions: fibronectin,
SWI/SNF related matrix associated actin dependent regulator of chromatin
subfamily E member 1 (SMARCE1), SWI/SNF related matrix associated actin
dependent regulator of chromatin subfamily B member 1 (SMARCB1), actin beta and
pyrroline 5 carboxylate reductase. At present we do not know if these proteins are
truly associated with CPSF.
To test whether polypeptides of the U2 snRNP are stably associated with CPSF, we
fractionated the purified factor on a gel filtration column, which separates molecules
according to their sizes. The column was calibrated with proteins of known molecular
weight as indicated at the top of Figure 1B. We assayed the individual fractions for
their polyadenylation activity in reconstitution assays (Figure 2.1.B) and checked the
elution profile of the proteins by Western blotting (Figure 2.1.C). The
polyadenylation activity peaked between fractions 57 and 69, correlating with the
elution profile of CPSF100. SF3b130, SF3a60 and the U2 snRNA were found in the
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same fractions as the CPSF100 polypeptide, indicating that they are stably associated
with CPSF. In contrast fibronectin eluted between fractions 63 to 68.
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A) Polypeptide composition of CPSF that was purified on DEAE-Sepharose followed by Blue-
Sepharose, Heparin-Sepharose, Mono-Q and Poly(A) Sepharose columns. The proteins were separated
on a 10% SDS gel, stained with colloidal blue and analyzed by mass-spectrometry. The migration of
the molecular weight markers in kilodaltons are indicated.
B) Separation of CPSF by gel filtration chromatography. Purified CPSF was run on a S200 gel
filtration column and equal amounts of the load (load) and the individual fractions (indicated at the
bottom of the gel) were tested in a polyadenylation assay with 1 ng of recombinant PAP. In the lane
labeled NXT, nuclear extract was added to the reaction mixture instead of the fractions. Input lanes
represent mock-treated reactions. The migration positions of the internally [32P]-labeled L3-pre RNA
(L3-pre) and the polyadenylated product (poly(A) are indicated on the left. The molecular weight
markers of the gel filtration column are indicated at the top.
C) Western blot analysis of the S200 fractions (indicated on top of the gel) with the antibodies
indicated at the left. The lowest panel shows a Northern blot probed with a radioactive DNA oligo
directed against the U2 snRNA.
2.3.2 Subunits of SF3b directly interact with components of CPSF
To confirm that subunits of the U2 snRNP interact with polypeptides of CPSF, we
carried out co-immunoprecipitation experiments using HeLa cell nuclear extract. As
shown in Figure 2.2A (left panel), antibodies directed against CPSF100 but not the
pre-immune serum efficiently co-immunoprecipitated SF3b155, SF3b130, SF3a120
and SF3a66 in an RNA and DNA independent manner. Furthermore, the CPSF100
antibody pulled down the U2 snRNA (right panel) whereas the pre-immune serum or
the Protein A-Sepharose beads without antibodies did not. Because the RNase A
treatment digested the U2 snRNAs present in the nuclear extract, these co-
immunopreciptitation experiments were done without RNase A.
To investigate if polypeptides of the U2 snRNP and CPSF directly interact
with each other we carried out three independent GST-pull down experiments with
recombinantly expressed GST-tagged SF3b49 and SF3b130. Both proteins interacted
with CPSF160; CPSF100 interacted with SF3b130 and more weakly with SF3b49;
CPSF30 was pulled down by SF3b49 and to a lower extent by SF3b130 (Figure
2.2B). Neither SF3b49 nor SF3b130 pulled down significant amounts of CPSF73 or
PAP. As has been previously shown, SF3b130 interacted with SF3b155 (Das et al.,
1999). All proteins interacted in an RNA and DNA independent manner. Taken
together, our results show that CPSF and the U2 snRNP physically interact with each
other.
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Figure 2.2 Subunits of the U2 snRNP directly interact with subunits of CPSF
A) The left panel shows a co-immunoprecipitation experiments with polyclonal antibodies directed
against CPSF100 (α-CPSF100) or pre-immune serum (pre-serum) as indicated on top of the panel. The
precipitates were separated on an 8% SDS gel and subjected to Western blot analysis with the
antibodies indicated on the left of each panel.
The right panel shows a Northern blot of RNA extracted from nuclear extract (NXT), nuclear extract
that was previously treated with RNase A and DNase I (NXT + RNase A) or co-immuoprecipitates of
antibodies directed against CPSF100 (α-CPSF100), pre-immune serum (pre-serum) or Protein A-
Sepharose only (Protein A-S) in the absence of RNase A and Dnase I.
B) GST pull-down experiments with 1 µg GST, 100 ng recombinant GST-tagged SF3b49 or SF3b130




























































the left). The first lanes (Input) show 10% of the in vitro translated protein used in the binding
reactions.
2.3.3 Depletion of CPSF100 inhibits splicing in a coupled splicing and
3’ end cleavage assay
To examine if CPSF is required for efficient splicing we depleted HeLa cell nuclear
extract of CPSF100 and tested these extracts in a coupled assay using the MXSVL
RNA substrate (Niwa et al., 1990); Figure 2.3A). This RNA contains two exons
separated by an intron and the second exon carries a SV40 polyadenylation signal. S-
C- represents the unprocessed MXSVL substrate; S−C+ represents RNA that has been
cleaved but not spliced; S+C− refers to RNA that has been spliced but not cleaved;
and S+C+ represents RNA that has been fully processed. CPSF100-depleted extract
showed no cleavage activity (lane 4, S−C+, S+C+) and its splicing activity was
significantly reduced (lane 4, S+C−, S+C+). In comparison, extract depleted of
hPcf11 (a subunit of CF IIm) resulted in a decrease of cleavage activity (lane 5, S−C+,
S+C+) but spliced the substrate efficiently (lane 5, S+C−). Untreated nuclear extract
(lane 1), extract which had been incubated with Protein A-Sepharose only (lane 2),
and extract that was incubated with pre-immune serum (lane 3) were active in
cleavage (S−C+, S+C+) and in splicing (S+C−, S+C+). These results indicate that it is
not the cleavage reaction itself that is required for stimulation of splicing but rather
the proteins involved in 3’ end processing.
Importantly, the CPSF100-depleted extract (α -CPSF100) contained
significantly lower amounts of CPSF100 and CPSF73 (Figure 2.3B) compared to the
extract that was treated with pre-immune serum (pre-serum). However the amounts of
SF3b155, SF3b130, SF3a120 and SF3a66 were not significantly lowered, indicating
that the splicing deficiency of this extract is indeed due to the lack of CPSF and not a
result of lower amounts of U2 snRNP subunits.
Furthermore, addition of partially purified CPSF to CPSF100-depleted extract
was able to reconstitute the cleavage (Figure 2.3C, S−C+, lane 4-6) and the splicing
activity (S+C−, lane 4-6). CPSF on its own showed no processing activity (lane 7).
We were not able to reconstitute the cleavage activity nor the splicing activity by
addition of highly purified CPSF. Depletion of CPSF100 could result in co-depletion
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of other factors of the 3’ end processing machinery which are most likely not present
in highly purified CPSF fractions.
We also tested the splicing activity of CPSF100-depleted extracts on the
MINX RNA substrate. This RNA contains the same exons and intron as the MXSVL
RNA but lacks the SV40 polyadenylation cassette. Interestingly, CPSF100-depleted
extract showed no significant reduction in its splicing activity when tested on the
MINX substrate (Figure 2.3D, compare lane 6 with lane 5; intron and mRNA levels)
but had reduced splicing activity when assayed with the MXSVL RNA (compare lane
3 with lane 2; S+C+ and intron levels). Taken together these results imply that CPSF
is required for the efficient splicing in coupled but not in uncoupled reactions.
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Figure 2.3 CPSF is required for efficient splicing of the MXSVL substrate in vitro
A) Coupled 3’ end cleavage and splicing assay with the internally [32P]-UTP-labeled MXSVL RNA.
The migration position of the unprocessed S−C−, cleaved but not spliced S−C+, spliced but not cleaved
S+C− and spliced and cleaved S+C+ RNAs are indicated on the left. Nuclear extract (NXT) was either
mock treated with Protein A-Sepharose (Protein A-S) or treated with pre-immune serum (pre-serum),
or depleted of CPSF100 (∆CPSF100) or hPcf11 (∆hPcf11) as indicated at the top and incubated with
the RNA as described in Experimental Procedures. The RNA products were separated on a 4%
polyacrylamide gel.





































































































B) Western blot analysis of NXT depleted of CPSF100 (∆CPSF100) or NXT treated with pre-immune
serum (pre-serum) as indicated at the top. The antibodies used for the Western blot are indicated at the
left.
C) Coupled splicing and 3’ end cleavage assay. Input represents mock treated RNA. The cleavage and
splicing activity of CPSF100-depleted extract (lanes 3-6) was reconstituted by addition of partially
purified CPSF (lanes 4-6; S−C+, S+C−). CPSF represents RNA that has been incubated with CPSF
alone (lane 7). The RNA products were separated on a 4% polyacrylamide gel.
D) Comparison between the splicing activity of CPSF100-depleted extract on the MXSVL versus the
MINX RNA substrate. MXSVL (lanes 1-3) and MINX (lanes 4-6) RNAs were incubated with nuclear
extract that was mock treated with Protein A-Sepharose (lanes 2 and 5) or depleted of CPSF100 (lanes
3 and 6). Input lanes represent mock treated reactions (lanes 1 and 4). For explanations of the migration
positions of the MXSVL processing products see legend to panel A. The scheme to the right represents
the migration positions of the MINX RNA processing products.
2.3.4 Mutations in the U2 snRNA binding site inhibit 3’ end cleavage
in a coupled splicing and 3’ end cleavage assay
The interaction of CPSF with the U2 snRNP implied that components of the U2
snRNP might be involved in pre-mRNA 3’ end processing. To address this
hypothesis, we mutated the U2 snRNP binding site on the MXSVL substrate. We
generated two pre-mRNAs with mutations in the branch point sequence (Figure 2.4B
and 2.4D, mut-BP and mut-BPII) and one RNA with mutations downstream of the
branch point sequence (Figure 2.4C, down-BP).
Figure 2.4A shows a time-course assay with the wild-type (wt; MXSVL) and
the mut-BP substrate. We quantified the RNA products of three individual
experiments and calculated the percentage of splicing (sum of S+C− and S+C+) and
cleavage (sum of S−C+ and S+C+) activities in relation to the total RNA used in the
assay (sum of S−C− and S−C+ and S+C− and S+C+). As can be seen in Figure 2.4B,
the mut-BP RNA was not spliced and showed an average reduction in cleavage
activity of 52% with a standard deviation (SD) of 10% compared to the wild-type
substrate after one hour incubation at 30°C.  Figure 2.4C shows the splicing and the
cleavage activity of the down-BP RNA. This mutation resulted in an average
reduction of the splicing activity of 55% (SD 15%) and in an average decrease of the
cleavage activity of 40% (SD 14%) compared to the wild-type RNA after one hour
incubation at 30°C.
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Interestingly, not all mutations in the branch point sequence affected 3’ end
processing. The mut-BPII mutations had a similar effect on splicing as the down-BP
mutation but did not result in a significant reduction of the cleavage activity (Figure
2.4D). This indicates that it is not the reduced splicing activity that leads to the
decrease of 3’ end processing, but rather the proteins involved in the splicing and
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Figure 2.4 Mutations in the branch point sequence inhibit 3’ end cleavage activity in vitro
A) Time course experiment of coupled splicing and cleavage assay with MXSVL (wt) and mut-BP
(mut-BP) RNA substrate (indicated on top of the gel). The products were separated on a 4%
polyacrylamide gel. For explanations of the migration positions of the RNA products see legend to
figure 2.3.A
B) The scheme at the top represents the wild-type branch point sequence of the MXSVL substrate. The
larger letters mark the conserved branch point sequence. Below is the sequence of the mut-BP RNA
substrate; the mutations are indicated in bold. Three gels from individual experiments were quantitated
and the splicing and 3’ end cleavage activities were calculated as follows: percent splicing activity =
100/(S−C− + S−C+ + S+C− + S+C+) x (S+C− + S+C+); percent cleavage activity = 100 / (S−C− +
S−C+ + S+C− + S+C+) x (S−C+ + S+C+).
C) See legend to panel B, the assays were carried out with the substrate down-BP.


















































0 10 20 30 40 50 60
51
2.3.5 Complexes involved in the coupling of 3’ end processing and
splicing do not form efficiently on mutant RNA substrates deficient
in splicing and 3’ end cleavage
It has been shown before that specific RNA-protein complexes correlating with the
coupling of 3’ end processing and splicing form on the MXSVL RNA (Cooke and
Alwine, 2002). We therefore carried out RNA band shift experiments with our mutant
substrates in order to find out if the mutations had an effect on complex formation. As
shown in Figure 2.5A the nonspecific complex N is formed on the RNAs at the time
point zero. After one minute incubation at 30°C the so called AC complex appears
which is thought to be a precursor of the coupling complex BC. Note that the AC and
BC complexes differ from the A and B complexes that form on splicing substrates that
contain no polyadenylation cassette.
We calculated the percentage of BC complex formation compared to the
amount of complex N present at time 0. The quantitative evaluation of four
independent experiments can be seen in Figure 2.5B. The amount of BC complex
formation after 60 minutes did not change compared to the 30 minutes time point
(results not shown). The mut-BPII mutation, which did not affect cleavage activity
significantly, resulted in a decrease of BC complex formation of only 25% (SD 7)
compared to the wild-type. At present we do not know why this RNA was spliced less
efficiently. The formation of the BC complex was significantly reduced compared to
the wild-type substrate: 45% (SD 5) with the mut-BP RNA and 47% (SD 11) with the
down-BP substrate after 30 minutes. This agrees with the observation that both
mutants are spliced and cleaved with lower efficiency.
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Figure 2.5 The coupling complex BC forms less efficiently on the mut-BP and down-BP RNA
substrates
A) Time course complex formation on the different RNA substrates indicated at the top. The migration
positions of the complexes are shown on the left.
B) Quantitative evaluation of the BC complex formation over time. The percentage of the BC complex
formation was calculated in comparison to the amount of complex N at time zero.
2.3.6 Digestion of the U2 snRNA results in a decrease of 3’ end
cleavage activity in coupled assays
Given that mutations in the RNA substrate could affect not only the interaction of the
U2 snRNP with the RNA but also the interactions of other proteins with the RNA or
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could influence the RNA secondary structure, we wanted to confirm that the
U2 snRNP itself is involved in the coupling of 3’ end processing and splicing. To this
end, we digested the U2 snRNA of nuclear extract with RNase H and two different
DNA oligo nucleotides complementary to the U2 snRNA (U2a, U2b; Black et al.,
1985) and carried out a coupled cleavage and splicing assay (Figure 2.6A, upper
panels). The control DNA oligo R5S is complementary to putative single-stranded
regions of 5S ribosomal RNA (Black et al., 1985). We determined the extent of the
digestion of the U2 snRNA by staining the gel with ethidium bromide (lower panels).
As has been shown before, the treatment of nuclear extact with the U2a DNA oligo
and RNase H resulted in a truncated form of the U2 snRNA (Black et al., 1985; U2*,
lanes 1-6). The treatment of nuclear extract with RNase H and the U2b DNA oligo
resulted also in digestion of the U2 snRNA and a faint band representing the digestion
product is visible on the gel (Black et al., 1985, U2**, lanes 7-12). In comparison,
nuclear extract treated with the R5S DNA oligo and RNase H had no effect on the
levels of the U2 snRNA present in the extract (lanes 13-18). All extracts contained the
same amount of U1 snRNA. Figure 2.6B shows the quantitative evaluation of two
independent experiments. As expected, the U2 snRNA-depleted extract lost its
splicing activity and its cleavage activity was significantly reduced compared to the
control extract to an average of 30% (SD 4%) with U2a, and 45% (SD 2%) with U2b
after one hour incubation at 30°C.
If the different effects on splicing and 3’ end cleavage of the mutated RNA
substrates shown in Figure 2.4 are indeed resulting form the involvement of the
U2 snRNP in coupling splicing and 3’ end processing one would expect that the
different substrates show the same splicing and cleavage activity when assayed with
U2 snRNA-depleted extract. We therefore tested U2 snRNA-depleted nuclear extract
in coupled assays with the different mutant RNAs. Figure 2.6C shows the quantitative
evaluation of three independent experiments. In this set of experiments treatment of
the nuclear extract with RNase H resulted in an inhibition of 3’ end cleavage activity
on the wild-type RNA of 46% (SD 15) with the U2a oligo and 54% (SD 7) with the
U2b oligo after one hour incubation at 30°C compared to extract treated with the
control oligo 5RS. Upon U2 snRNA digestion the wild-type and the different mutant
RNAs all showed similar splicing and cleavage activities. This observation
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strengthens the hypothesis that the mut-BP and down-BP mutations affect the role of
the U2 snRNP in coupling splicing and 3’ end formation.
U2 snRNA-depleted extracts were not deficient in 3’ end cleavage when we
tested them on the SV40 RNA substrate (Figure 2.6D). This RNA contains no introns
but the SV40 polyadenylation cassette – the same sequence which is present in the
MXSVL RNA. This shows that the U2 snRNA is required for efficient 3’ end
cleavage in coupled but not in uncoupled reactions. In summary, these results support
the notion that CPSF and the U2 snRNP are involved in mediating the coupling of
3’ end processing and splicing by their direct interaction.
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Figure 2.6 U2 snRNA is required for efficient 3’ end cleavage in coupled assays
A) Upper panels: Coupled splicing and 3’ end cleavage time course experiment with extract that was
treated with RNase H and the U2a DNA oligo (U2a), U2b DNA oligo (U2b) or the R5S DNA oligo
(R5S) as indicated on top. For explanation of the migration positions of the RNA substrate and
products see legend to figure 3A. The products were separate on a 10% polyacrylamide gel.
Lower panels: Ethidium bromide staining of the gel shown in the upper panels. The migration positions
of the U1 and U2 snRNAs are indicated on the right. The U2* and U2** indicate the migration
position of the U2 snRNA digestion product resulting after treatment with the U2a or the U2b DNA
oligo respectively.
B) Quantitative evaluation of the splicing and 3’ end cleavage activities. The graph represents an
average of two individual experiments. For explanation of the calculation see legend to figure 4B.
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C) The graph represents the quantitative evaluation of three independent experiments of the 3’ end
cleavage and splicing activites of nuclear extract that has been treated with Rnase H and the DNA
oligos indicated at the bottom. The different substrates used in the assays are also indicated at the
bottom. The error bars represent the standard deviation.
D) The graph shows the quantitative evaluation of two independent experiments of the 3’ end cleavage
activity of nuclear extract that has been treated with Rnase H and the DNA oligos indicated at the
bottom. SV40 was used as RNA substrate. The error bars represent the standard deviation.
2.4 Discussion
Splicing and 3’ end formation are coupled processes. As has been reported earlier, the
U1 snRNP, U2AF65, the SR-related nuclear matrix protein of 160 kDa (SRm160),
PAP and CPSF30 have been implied to participate in this coupling (Wassarman and
Steitz, 1993; Gunderson et al., 1994; Lutz et al., 1996; Blencowe et al., 1998;
Gunderson et al., 1998; Vagner et al., 2000; Millevoi et al., 2002; Awasthi and
Alwine, 2003). However, the U2 snRNP has so far not been known to play a role in
coupling splicing and 3’ end formation.
In order to identify proteins, which associate with CPSF we purified the factor
over five columns and found that many subunits of the U2 snRNP co-purified with
CPSF. We did not address the question if the entire U2 snRNP was present in these
fractions. However, we detected the U2 snRNA and all the tested subunits of the
U2 snRNP except SF3b125 in the purified complex. Interestingly SF3b125 is thought
to dissociate from SF3b upon formation of the 17S U2 snRNP (Will et al., 2002) and
is therefore not present in the fully assembled U2 snRNP. The U2 snRNP proteins
were present in lower amounts compared to the CPSF polypeptides in our purified
fractions. This implies that only a part of all the CPSF complexes present in a cell are
associated with subunits of the U2 snRNP. This could mean that a subset of CPSF
complexes could be permanently associated with U2 snRNPs; however we think it is
more likely that the two complexes interact with each other in a dynamic fashion.
The purified complex was size fractionated on a gel filtration column on
which SF3b130, SF3a60 and the U2 snRNA were found in the same fractions as
CPSF100. We confirmed that CPSF interacts with the U2 snRNP by co-
immunoprecipitation experiments and showed that this association is mediated by a
direct interaction between subunits of SF3b and polypeptides of CPSF. To our
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knowledge this is the first demonstration of a physical interaction between CPSF and
the U2 snRNP. The previously known and the new protein-protein interactions
between the splicing machinery and the 3’ end processing factors on the last exon of a
pre-mRNA are summarized in Figure 2.7
Figure 2.7 Model of protein-protein interactions on the last exon
Arrows indicate the previously known and the new protein-protein interactions of the splicing
machinery with the 3’ end processing factors on the last exon (see text for details).
The interaction between CPSF and the U2 snRNP suggested that the two complexes
might be involved in mediating the coupling of 3’ end processing and splicing. It has
been shown earlier that mutations in the highly conserved CPSF binding site
AAUAAA lead to decreased splicing efficiency (Niwa and Berget, 1991; Cooke et al.,
1999). To confirm that this effect can be explained by the involvement of CPSF in
splicing, we depleted CPSF100 from nuclear extract. We found that depletion of
CPSF100 not only abolished cleavage but also significantly decreased the splicing
activity in coupled assays. Both activities were reconstituted upon the addition of
partially purified CPSF. Furthermore, depletion of the CF IIm subunit hPcf11 resulted
in a strong decrease of 3’ end cleavage but not in reduced splicing activity. This
shows that it is not the cleavage reaction itself that is required for efficient splicing
but that the presence of proteins involved in 3’ end processing are responsible for the
stimulatory effect.
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SF3a and SF3b were shown to bind to the branch point and surrounding
sequences during spliceosome assembly (Query et al., 1996; Gozani et al., 1996;
Gozani et al., 1998; Will et al., 2001). We showed here that two independent
mutations in these sequences significantly reduced splicing and cleavage activities.
Protein complexes involved in the coupling of splicing and 3’ end processing did not
form efficiently on these mutated substrates. Furthermore, we found that one mutation
in the branch point sequence reduced the splicing activity but had no significant effect
on the cleavage activity. This indicates that it is indeed the proteins involved in
splicing which affect 3’ end processing and not the splicing reaction per se. In
addition depletion of the U2 snRNA from nuclear extract also resulted in decrease of
the splicing and cleavage activities in coupled assays. These results corroborate the
unanticipated role of the U2 snRNP in mediating the coupling of splicing and 3’ end
formation. This is the first time that a snRNP binding in the proximity of the 3’ splice
site was shown to be involved in this coupling mechanism.
The exon definition model suggests that the boundaries of internal exons are
defined by the binding of the U1 and U2 snRNPs and associated splicing factors.
Interestingly, the role of the U2 snRNP is therefore to define the 5’ border of the exon
whereas the U1 snRNP demarcates the 3’ border. In the case of the last exon, the
3’ end processing complex is thought to be responsible to define the 3’ border of the
exon. This model implies that the coupling of 3’ end processing and splicing comes
primarily into play at the last exon (Berget, 1995; Cooke et al., 1999). In accordance
with this, we found that depletion of CPSF100 reduced the splicing efficiency when
assayed with the MXSVL but had no significant effect on the splicing efficiency
when tested with the MINX RNA, which does not contain a polyadenylation cassette.
Furthermore, we showed that digestion of the U2 snRNA resulted in inefficient 3’ end
cleavage of the MXSVL substrate but had no effect on 3’ end cleavage of the
intronless SV40 RNA substrate. This implies that CPSF and the U2 snRNP play a
role in mediating the coupling of 3’ end formation and splicing on the last intron but
that CPSF is most likely not involved in the splicing of internal introns and that the
U2 snRNP is not required for efficient 3’ end cleavage of an intronless RNA
precursor. However, further experiments are needed to prove that the coupling
mechanism mediated by CPSF and the U2 snRNP is mainly required for the splicing
of the last intron.
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Given that the factors involved in splicing and in 3’ end formation are
recruited to the transcribing RNAP II by binding to the CTD (Gornemann et al., 2005;
reviewed in Proudfoot et al., 2002; Zorio and Bentley, 2004) it is possible that CPSF
and the U2 snRNP already interact with each other while traveling with the elongating
RNA polymerase in vivo. Interestingly CPSF plays an important role in cleavage site
selection (Keller et al., 1991; Gilmartin et al., 1995; Graveley et al., 1996;
Brackenridge and Proudfoot, 2000)  and the U2 snRNP is required for splice site
selection (Gozani et al., 1996; Query et al., 1996; Gozani et al., 1998; Brackenridge
and Proudfoot, 2000; Will et al., 2001). The fact that they directly interact with each
other as well as with the pre-mRNA leads us to propose that this is a mechanism to
promote the coupling between splicing and 3’ end processing by facilitating their
recruitment to the RNA and the mutual stabilization of the splicing and 3’ end
processing machineries.
2.5 Experimental Procedures
2.5.1 Purification of cleavage and polyadenylation specificity factor
from calf thymus and MALDI-TOF MS analysis
CPSF was purified from one kilogram of calf thymus by chromatography on DEAE-
Sepharose, Blue-Sepharose, Heparin-Sepharose, Mono-Q and Poly(A)-Sepharose
essentially as described by(Bienroth et al., 1991). The peak fractions of the poly(A)-
Sepharose column were pooled and the proteins were identified by mass spectrometry
as described (de Vries et al., 2000).
Peak fractions of the Poly(A)-Sepharose were pooled, concentrated on a 5 ml
DEAE column, and separated on a Superdex S200 gel-filtration column. The buffer
used for the gel-filtration contained: 100 mM KCl, 50 mM Tris-HCl pH 8, 0.2 mM
EDTA, 3 mM MgCl, 10% glycerol, 0.02% NP40, 0.5 mM DTT, 1 mM PMSF,
0.4 µg/ml leupeptin, 0.7 µg/ml pepstatin.
Partially purified CPSF used for the reconstitution of the cleavage and splicing




Fractions of the Superdex S200 gel-filtration column and the co-immunoprecipitates
were incubated with a final concentration of 100 mM Tris-HCl pH 7.9, 150 mM
NaCl, 12.5 mM EDTA, 1% SDS, 1 mg/ml Proteinase K and 0.7 µg/µl glycogen at
42°C for 1.5 hrs. Two phenol-chloroform extractions were performed and the upper
phases incubated with a final concentration of 85 mM NaOAc and 70% ethanol at -
20°C overnight. The RNA was precipitated, washed with 70% ethanol and run on a
8.3 M urea/12% polyacrylamide gel and transferred to Hybond N+ (Amersham
Pharmacia Biotech). Oligonucleotides anti-U2 (tattgtcctcggatagaggacgta) and anti-
U2-2 (ttagccaaaaggccgagaagc) were labeled with [γ-32P]ATP and T4 polynucleotide
kinase. Both oligonucleotides recognized the same band in the Northern blots (results
not shown).
2.5.3 Co-immunoprecipitations and immunodepletions of HeLa cell
nuclear extract
Co-immunoprecipitations and immunodepletions of HeLa cell nuclear extract were
performed as described (Barabino et al., 1997). For the co-immunoprecipitation
experiments 50 µl nuclear extract was incubated with 0.1 mg/ml RNase A and 0.2 U
DNase I (Promega) at 30°C for 30 min. prior to addition to the Protein A-Sepharose
bound antibodies.
2.5.4 Expression of recombinant proteins in Escherichia coli
Recombinant proteins were expressed in E.coli BL21 Lys(S) and purified as
described (Kyburz et al., 2003).
2.5.5 GST-pulldown experiments
GST-pulldown experiments were carried out as described (Kyburz et al., 2003) with
binding buffer containing 0.1 mg/ml RNase A and 0.2 U DNase I (Promega).
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2.5.6 Preparation of RNA substrates
RNA substrates were prepared as described (Rüegsegger et al., 1996). Mutations in
the branch point and in downstream sequences were generated by site directed PCR
mutagenesis, followed by DpnI digestion of the parent plasmid. The PCR products
were transformed into E. coli and sequenced.
2.5.7 Polyadenylation assay
In vitro polyadenylation assays were carried out as described (Bienroth et al., 1991).
2.5.8 Coupled cleavage and splicing assay
Nuclear extract (NXT) was prepared as described (Ruegsegger et al., 1996). The NXT
was dialyzed against 20 mM Tris-HCl pH 7.9, 20 mM (NH4)2SO4, 3 mM MgCl2, 20%
glycerol, 0.2 mM EDTA, 0.02% NP40, 0.5 mM DTT, 0.5 mM PMSF, 0.4 µg/ml
leupeptin, 0.7 µg/ml pepstatin. 15 fmol RNA substrate and 6 µl NXT were incubated
with 0.25 mM ATP, 1 mM Cordycepin triphosphate, 20 mM creatine phosphate, 2.6%
polyvinylalcohol, 1 mM MgCl2, 0.01% NP40, 2 mM DTT, 0.01 mg/ml creatine
kinase, 0.2 U RNase guard (Amersham) and 0.1 µg/µl tRNA in a total volume of 25
µl for one hour at 30°C unless indicated otherwise. The proteins were digested with
Proteinase K and the RNA was separated by elecrophoresis on 4% or 10% acrylamide
gels as described (Minvielle-Sebastia et al., 1994).
2.5.9 Complex formation analysis
15 fmol RNA substrate and 2 µl nuclear extract were incubated at 30°C in the
reaction mixture used for the coupled cleavage and splicing assay in a total volume of
25 µl. The reaction was stopped by addition of 5 µl termination buffer containing
40% glycerol, 3 µg/µl heparin and 30 mM EDTA. The complexes were separated on
native 3.5% polyacrylamide gels as described (Cooke and Alwine, 2002).
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2.5.10 Oligodeoxynucleotide-directed RNase H cleavage
The synthetic oligonucleotides U2a (E15), U2b (L15) and R5S has been described
previously (Black et al., 1985). 10 µl NXT was incubated with 4 µM of the
oligonucleotides, 0.5 U RNase H (Invitrogen) and the reaction mixture described in
the coupled cleavage and splicing assay without the tRNA in a total volume of 23 µl
for one hour at 30°C. The reaction was started by addition of 15 fmol RNA substrate
dissolved in 2 µl tRNA [0.1 µg/µl] and continued as explained in the coupled
cleavage and splicing assay. The gel was stained with ethidium bromide and the
snRNAs were visualized by illumination with UV light.
2.5.11 Plasmids
pAK 33 (GST-Tev-SF3b 49-His6): SF3b 49 was PCR amplified with the primers
A G T A T C C C G G G T A T G G C T G C C G G G C C G A T C T  a n d
TAGACTGCGGCCGCTCAGTGGTGGTGGTGGTGGTGCTGAGGGAGAGGGCC
TCGA followed by digestion with XmaI and NotI and ligated into pGDV1 (Dichtl
and Keller, 2001). pAK 35 (GST-Tev-SF3b 130-His6): SF3b 130 was PCR amplified
with the primers AGTATCCCGGGTATGTTTCTGTACAACTTAACCTTG and
TAGACTGCGGCCGCTCAGTGGTGGTGGTGGTGGTGGAAGGCGTAGCGGGT
CCGG digested with XmaI and NotI and ligated into pGDV1.
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2.6 Supplemental material
2.6.1 Results and discussion
2.6.1.1 Mutations in AAUAAA
(Niwa and Berget, 1991; Cooke et al., 1999) showed, that mutations in the highly
conserved CPSF binding site AAUAAA to AAGAAA and downstream sequences
lead to decreased splicing efficiency and abolished the 3’ end cleavage activity on
these mutated MXSVL substrates. In order to confirm their results, we generated
MXSVL RNA substrates with mutations in the AAUAAA hexanucleotide sequence
(Figure 2.8.).
Figure 2.8 Schematic representation of RNA substrates with mutations in AAUAAA.
The scheme represents the different RNA substrates carrying mutations in the AAUAAA
hexanucleotide sequence. The name of the substrates are indicated at the left. The mutations are shown
in bold letters. MXSVL is the wild-type substrate.
Figure 2.9 shows the quantitative evaluation of two independent time course
experiments with the wild-type and mutated RNAs. Of all three mutations the
CAUAAA had the weakest effect on 3’ end cleavage activity. The AGUAAA RNA
mutation caused a strong reduction in the cleavage activity as did the AAGAAA










cleavage reaction. And most surprisingly, we found that none of the mutations
affected the splicing activity.




































































Quantitative evaluation of the splicing and 3’ end processing activities on the different RNA substrates
indicated at the right. For explanation of the calculation see legend to figure 2.4.
Niwa and Berget (1991) proposed that the coupling between 3’ end formation and
splicing is dependent on the MgCl2 concentration in the reaction buffer. In order to
find out if our AAGAAA mutation would display an effect on splicing activity under
different MgCl2 concentrations, we performed the assay with the MgCl2 concentration
ranging from 0.7 mM to 7.7 mM. However, under none of these conditions did the
AAGAAA mutation influence the splicing efficiency (results not shown).
The MXSVL RNA substrate contains three USEs upstream of the AAUAAA
hexanulceotide sequence. The RNA substrate that (Niwa and Berget, 1991) used in
their assay was a shorter version of the MXSVL RNA substrate and lacked the first
and half of the second USEs. Cooke and coauthors (1999) only tested the AAGAAA
mutation in combination with a deletion of all three USEs. We therefore assume that
the AAGAAA mutation only abolishes the cleavage activity on the MXSVL RNA in
combination with a deletion of all or parts of the USEs. CPSF160 has been shown to
bind to the USE of the HIV1 pre-mRNA (Gilmartin et al., 1995). It is not known if
CPSF binds also to the USE of the MXSVL pre-mRNA. However, it is intriguing that
this might be the case. If so, this could explain why we still observed some cleavage
activity with the AAGAAA mutation whereas the two other groups did not. If CPSF
binds to the USE, cleavage at aberrant cleavage sites could take place. Furthermore
the presence of CPSF on the pre-mRNA could be sufficient to allow the coupling of
splicing and 3’ end processing which would explain why our AAGAAA RNA
substrate was spliced efficiently.
2.6.1.2 Deletion of the U1 and U4 snRNA resulted in impaired 3’ end cleavage
In addition to the U2 snRNA we depleted nuclear extract of the U1 and U4 snRNAs
with RNaseH and DNA oligonucleotides complementary to the snRNAs. We tested
these extracts in the coupled splicing and 3’ end processing assay (Figure 2.10A). The
specific digestion of the individual snRNAs was controled by staining the gel shown
in the upper panel with ethidiumbromide (lower panel). The U1 snRNA was partially
digested and the digestion product is indicated as U1*. The U4 snRNA stained very
weakly with ethidium bromide. However, a faint band was visible which disappeared
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in the extract that was treated with RNaseH and a DNA oligo complementary to the
U4  snRNA. We do not know what the faint band represents which was running at
approximately the hight of the U1* digestion product in the extract treated with the
U4 DNA oligonucleotide
Figure 2.10.B shows the quantitative evaluation of two independent
experiments. Depletion of the U1 snRNA resulted in an inhibition of splicing of
approximately 50% and in a reduction of cleavage activity of only 25% compared to
the untreated nuclear extract after one hour incubation at 30°C. Depletion of the
U4 snRNA abolished the splicing activity and resulted in a reduction of 3’ end
cleavage of approximately 50% after one hour.










































A) The upper panel shows a time course coupled splicing and 3’ end cleavage assay with extract
treated with DNA oligonucleotides complementary to the U1 snRNA, U4 snRNA or 5S rRNA and
Rnase H. For explanation of the migration positions of the RNA products see legend to figure 2.3.. The
lower panel shows an ethidium bromide staining of the upper gel. To the left the migration position of
the U1, U2 and U4 snRNAs are indicated. U1* indicates the migration position of the digestion product
resulting from digestion of the U1 snRNA with RNase H and the oligonucleotide complementary to the
U1 snRNA.
B) Quantitative evaluation of the splicing and 3’ end cleavage activity. The graph shows the average of
two independent experiments. For explanations to the calculations see legend to figure 2.4..
The U1 snRNP has previously been shown to be involved in coupling 3’ end
formation and splicing (Wassarman and Steitz, 1993; Gunderson et al., 1994; Lutz et
al., 1996; Gunderson et al., 1998) and it was surprising that deletion of this snRNA
did not result in a more dramatic effect on 3’ end processing. However, given that the
splicing activity was not abolished, it is possible that the U1 snRNA was not fully
digested in the nuclear extract and the remaining level of intact U1 snRNPs could
have been sufficient to maintain a cleavage activity of 75% compared to the untreated
nuclear extract after one hour incubation at 30°C. On the other hand the U1 snRNP
was shown to be mainly involved in the polyadenylation step of the 3’ end prcessing
reaction. Raising the possibility that this snRNP is not involved in coupling the
splicing and 3’ end cleavage reaction. It would be interesting to investigate the effect
of U1 snRNA depletion on the polyadenylation activity in the future.
So far the U4 snRNP has not been shown to be involved in coupling 3’ end
processing and splicing. We found a strong effect on 3’ end cleavage activity upon
depletion of the U4 snRNA. This raises the possibility that this snRNP could also be
directly involved in coupling 3’ end processing and splicing. However, given that the
different snRNPs interact with and influence each other, we cannot exclude that the
effect of the U4 snRNA depletion on 3’ end cleavage activity was an indirect effect,
and future work is required to investigate if the U4 snRNP indeed plays a direct role
in coupling 3’ end processing and splicing.
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Two-hybrid interactions
In the beginning of the project we were interested to find new interaction partners of
the 3’ end processing machinery with proteins involved in other reaction mechanisms.
Therefore we performed two hybrid screens in collaboration with Hybrigenics S.A.
(Paris) with CPSF100, CPSF73 and hClp1 as baits. To a later time point we wanted to
investigate with which proteins the U2 snRNP subunits SF3b155, SF3b130 and
SF3b49 interact. The results of the different screens are summarized below.
Unfortunately the screen with SF3b130 did not provide any protein-protein
interactions.
The number of hits show how often a certain protein was fished out during the
screen. The score spans from “A” to “E” where “A” indicates that this interaction is








3xB Methyl-Cpg binding domain protein 1(hMBD1): Binds specifically to
methylated DNA; can repress transcription from methylated gene
promoters.
2xB SWI/SNF-related, matrix-associated, actin-dependent regulator of
chromatin, subfamily E, member 1 (SMARCE1): Subunit of the
BRG1-associated factors (BAF) which is thought to facilitate
transcriptional activation of specific genes by antagonizing chromatin-
mediated transcriptional repression. The complex contains an ATP-
dependent nucleosome disruption activity that can lead to enhanced
binding of transcription factors.
2xB Metal-regulatory transcription factor (MTF1): Transcription factor that
binds to metal-responsive promoter elements and is required for
transcription of metallothioneins.
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binds to metal-responsive promoter elements and is required for
transcription of metallothioneins.
2xC Transcription termination factor, RNA polymerase I (hTTF1):
Transcription termination by RNA polymerase I is largely the result of
binding of a transcription termination factor to a DNA element called a
transcriptional terminator. TTF1 binds to the transcription terminatior
sequences and thereby promotes transcription termination.
2xD Musculin / activated B-cell factor 1 (hMSC): Contains the basic
helix—loop-helix motif (bHLH); binds DNA and is involved in
transcription repression.
1xD Transcription enhancer factor 5 (TEF5): Binds to multiple functional
sites in the CSH2 enhancer. Mutations in these sites that disrupted TEF5
binding also inactivated the transcription-enhancing activity of the
element.
1xD Zinc finger protein 350 (hZNF350): Interacts with BRCA1 which is
implicated in the transcriptional regulation of DNA damage-inducible
genes that function in cell cycle arrest. ZNF350 represses transcription in a
BRCA1-dependent manner
1xD Hypothetical protein FLJ10713
1xD Hypothetical protein HSPC195
1xD Similar to hypothetical protein FLJ25467
2xE hHairy-related transcription factor 3 (hHEYL): Contains the basic
helix-loop-helix (bHLH) and orange domains conserved in HEY proteins.
1xE Hairy/enhancer of split-related with YRPWmotif 1 (hHEY1):
Transcription factor implicated in cell fate decisions. It contains the basic
helix-loop-helix motif (bHLH). HEY genes are direct transcriptional
targets of the Notch signaling pathways in Drosophila and vertebrates.
It was striking how many proteins involved in transcription were found to interact
with CPSF100. Suggesting that CPSF100 might play a role in transcription initiation,
elongation and/or termination. It would be interesting in the future to verify which of
the above interactions are indeed true interactions and investigate their functional
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relevance.  Interestingly, the protein SMARCE1 (a subunits of the BAF complex) was
found in this two hybrid-screen but did also co-purify with CPSF (Figure 2.1.).
Furthermore, the SMARCB1 protein also a subunits of the BAF complex was
identified in purified CPSF. This indicates that CPSF and the BAF complex might
indeed be associated with each other and it would be intriguing to analyze the
functional role of this association.
Bait: CPSF73
Numbers of
hi ts  and
score
Interacting proteins
64xA hSymplekin: homologue of Pta1p. Was shown to interact with CstF
and is also associated with CPSF. The protein was shown to be
involved in 3’ end processing.
3xB Human Plectin (PLEC1): Interlinks Intermediate Filaments with
Microtubles and Microfilaments and anchors Intermediate Filaments to
Desmosomes or Hemidesmosomes. Could also bind actin to membrane
complexes in muscles. Involved in crosslining, stabilization and
regulation of the cytoskeletal intermediate Filaments network and
possibly in the  regulation of their dynamics. Loss causes epidermolysis
bullose with muscular dystrophy.
2xC Proteasome 26S subunit, ATPase, 6 (hPSMC6): The 26S protease is
involved in the ATP-dependent degradation of ubiquitinated proteins.
The regulatory (or ATPase) complex confers ATP dependency and
substrate specificity to the 26S complex.
6xD Pleckstrin homology domain-containing protein, family M,
Member 2 (PLEKHM2): Binds to the Salmonella SifA protein
localized to the cytosol in HeLa cells and was partially recruited to
membranes upon ectopic expression of SifA.
2xD Step II splicing factor SLU7: associates with the spliceosome
relatively late in the assembly process. The association of SLU7 with
the spliceosome is coupled to the catalysis of step 1. Depletion of SLU7
resulted in the accumulation of novel intermediate C-type spliceosomal
complexes that were blocked before step 2.
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resulted in the accumulation of novel intermediate C-type spliceosomal
complexes that were blocked before step 2.
1xD hAXIN2: regulates stability of beta-catenin an adherens juncion
protein. Possibly involved in DNA mismatch repair
1xD DnaJ (Hsp49) homolog, subfamily C, member 3 (DNAJc3):
Inhibitor of the interferon-induced, dsRNA-activated protein kinase.
1xD Metal- regulatory transcription factor 2 (MTF2): Binds to metal
response elements in a zinc dependent manner..
1xD Steroid hormone receptor Ner-I (hNR1H2): Nuclear receptor, binds
to specific response elements upon activation.
1xD Transcription factor-like 4 (hTCFL4): The protein contains basic
helix-loop-helix and leucine zipper domains. It is a transcription factor
with a role in proliferation, determination and differentiation.
1xD Hypothetical protein Hpp13624
1xD Hypothetical protein DKFZp762L0311
1xD Hypothetical protein FLJ10713
6xE hHairy-related transcription factor 3 (hHEYL): contains the basic
helix-loop-helix and orange domains conserved in HEY proteins
Symplekin was previously shown to be associated with CPSF (Hofmann et al., 2002)
however, a direct interaction was not known. The strong two hybrid interaction of
symplekin with CPSF73 suggests that CPSF73 directly interacts with symplekin.
Given that symplekin is not thought to be an integer part of CPSF (Hofmann et al.,
2002) (Isabelle. Kaufmann, dissertation 2002) it is possible that this interaction could
have a regulatory effect on CPSF73.
Another interesting interaction in the context of coupling 3’ end processing
and splicing was the finding that hSLU7 interacted with CPSF73. However to this









36xA ADP-Ribosylation factor 1 (ARF1): Small guanine nucleotide-binding
protein. Guanine exchange-activated ARF1 at the Golgi membrane
recruits and binds cytoplamic COP1 to the membranes.
24xA MET Protooncogene (MET): MET is in the tyrosine kinase receptor
family of oncogenes. Localized at the cell-surface. Receptor for
hepatocyte growth factor (HGF).
9 x A Heat-Shock 27-kD Protein 1 (hHSPB1): Synthesis has been shown to be
correlated with the acquisiton of thermotolerance. Approximately 20% of
its residues are susceptible to phosphorylation. The MAPKAPK5 stress
activated kinase was shown to phosphorylate HSPB1.
3xB Protein Kinase, cAMP-dependent catalytic, Inhibitor Beta (PKIB):
May interact with the catalytic subunit of cAMP-dependent protein kinase
and act as a competitive inhibitor.
2xD Tyrosine-protein kinase receptor Tie-1 (hTIE1): Probable protein
tyrosine-kinase transmembrane receptor.
2xD Gamma-Actin (ACTG): Actins are highly conserved proteins that are
involved in various types of cell motility and are ubiquitously expressed in
all eukaryotic cells.
1xD Cyclin dependent kinase 2 (hCDK2): Might play a unique role in cell
cycle regulation of vertebrate cells. Probably involved in the control of the
cell cycle. Interacts with cyclins A, B3, D, or E. Activity of CDK2 is
maximal during S phase and G2.
1xD Chorionic somatomammotropin hormone-like 1 (hCSHL1): May be a
novel gestational hormone required to compensate for absence of other
members of the GH/CS cluster during gestation.
1xD Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48
kDa subunit (hDDOST): Essential subunit of N-oligosaccharyl
transferase enzyme which catalyzes the transfer of a high mannose
oligosaccharide to an asparagine residue within an Asn-X-Ser/Thr
consensus motif in nascent polypeptide chains.
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kDa subunit (hDDOST): Essential subunit of N-oligosaccharyl
transferase enzyme which catalyzes the transfer of a high mannose
oligosaccharide to an asparagine residue within an Asn-X-Ser/Thr
consensus motif in nascent polypeptide chains.
1xD Solute carrier family 9 (sodium/hydrogen exchanger), isoform 9
(SL9A3): Involved in pH regulation to eliminate acids generated by active
metabolism or to counter adverse environmental conditions. Major proton
extruding system driven by the inward sodium ion chemical gradient.
Plays an important role in signal transduction.
1xD NK-tumor recognition protein (hNKTR): Component of a putative
tumor-recognition complex. Involved in the function of NK cells.
1xD Rho GDP-dissociation inhibitor 1 (ARHGDIA): Regulates the
GDP/GTP exchange reaction of the Rho proteins by inhibiting the
dissociation of GDP from them, and the subsequent binding of GTP to
them.
1xE Mortality factor 4-like protein 1 (hMRG15): Component of the NuA4
histone acetyltransferase (HAT) complex, which is involved in
transcriptional activation of selected genes principally by acetylation of
nucleosomal histone H4 and H2A. This modification may both alter
nucleosome - DNA interactions and promote interaction of the modified
histones with other proteins which positively regulate transcription.
3xN/A Cat eye syndrome chromosome region, candidate 1 (hCECR1): May
be involved in growth regulation through an adenosine deaminase activity.
1xN/A Triggering receptor expressed on myeloid cells-like 2 (TREML2):
hypothetical protein
hClp1p interacted with a wide range of proteins involved in different processes. It is a
component of CF IIm and of the tRNA splicing endonuclease complex (see Chapter 5)
and it might be a subunit of even more complexes, which would explain, why it
interacted with such a broad number of proteins involved in different pathways.
Like ARF1 hClp1 was indicated to bind single nucleotides. A future project could








145xA Splicing factor 3b 145 kDa (hSF3b145): Subunit of the Splicing factor
3b and the U2 snRNP. Cross-links to pre-mRNA at a 20-nucleotide
region, the anchoring site, upstream of the branch site. Interacts with
SF3b145.
15xA Zinc finger CCHC domain-containing protein 8 (hZCCHC8)
11xA NEDD8 ultimate buster-1 (hNYREN18): Specific down-regulator of the
NEDD8 conjugation system. Recruits NEDD8 and its conjugates to the
proteasome for degradation.
10xA NEDD4-like E3 ubiquitin-protein ligase (hWWP1): E3 ubiquitin-
protein ligase, which accepts ubiquitin from an E2 ubiquitin-conjugating
enzyme in the form of a thioester and then directly transfers the ubiquitin
to targeted substrates.
2xC NEDD4-like E3 ubiquitin-protein ligase (hWWP2): WWP2 contains 4
tandem WW domains, a complete HECT (homologous to the E6-
associated protein carboxyl terminus) domain, associated with ubiquitin-
protein ligase activity, and a C2 (calcium-dependent phospholipid-
binding)-like domain characteristic of a large family of proteins including
protein kinase C.
2xD Hypothetical protein hDKFZp77901
2xD Zinc finger protein 553 hFLJ31751
2xD Hypothetical protein hLOC339324
1xD Coatomer protein complex, subunit epsilon (hCOPE):
Subunit of the heptameric coatomer protein complex, or COPI, which
mediates transport between the Golgi complex and endoplasmic reticulum.
1xD Golgin subfamily B member 1 (hGOLGB1): May participate in forming
intercisternal cross-bridges of the Golgi complex.
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As has been shown before by (Champion-Arnaud and Reed, 1994) we found that
SF3b49 interacted with SF3b145. The identified proteins were not very relevant in
regards to the coupling of 3’ end processing and splicing. The same was the case for






4xA Smad nuclear-interacting protein 1 (hSNIP1): SNIP1 interacts with
several SMADs. SNIP1 may regulate access of transcription factors to
the coactivators p300 and CBP in select cells and regulate the pattern of
gene expression in embryogenesis.
1xD Nuclear inhibitor of protein phosphatase 1 (hPPP1R8): Inhibitor
subunit of the major nuclear protein phosphatase-1 (PP-1). It has RNA-
binding activity but does not cleave RNA and may target PP-1 to RNA-
associated substrates. May also be involved in pre-mRNA splicing. Binds
DNA and might act as a transcriptional repressor. Seems to be required
for cell proliferation.
1xD Cytochrome P450 19A1 (hCYP19): Catalyzes the formation of aromatic
C18 estrogens from C19 androgens.
1xD Keratin, type I cytoskeletal 23 (hKRT23)
1xD Putative helicase MOV-10 (hMOV10): May be a helicase with an
important function in development and/or control of cell proliferation.
1xE Myosin-9 (hMYH9): Cellular myosin that appears to play a role in
cytokinesis, cell shape, and specialized functions such as secretion and
capping.
2xE 26S proteasome non-ATPase regulatory subunit 11 (hPSMD11): Acts
as a regulatory subunit of the 26S proteasome which is involved in the
ATP-dependent degradation of ubiquitinated proteins.
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2.6.2. Experimental procedures
2.6.2.1. Mutant AAUAAA RNA substrates
Mutations in the AAUAAA hexanucleotide were generated with site directed
mutagenic PCR, followed by DpnI digestion of the parent plasmid. The PCR products
were transformed into E.coli for ligation and amplification. The sequence was verified
by sequenzing.
The coupled assay was performed as described in 2.5.8.
2.6.2.2. Oligodeoxynucleotide-directed RNase H cleavage
The assay was performed as described previously except that the U1 DNA
oligodeoxynucleotide was used in a final concentration of 10 µM. The sequences of
the U1 and U4 oligos are described in (Frendewey et al., 1987).
2.6.2.3. Plasmids
CPSF73 and CPSF100 were cut out from the plasmids Htp-73 and Htp-100 and
ligated into the pB27 vector (provided by Hybrigenics) using the restriction enzyme
NotI. The sequences of hClp1, SF3b49, SF3b130 and SF3b155 were PCR amplified
and ligated into pB27 using the restiction enzymes SpeI and PacI. hClp1 was PCR
amplified with the primers hClp1-PacI (atattaattaagctacttcagatccatg) and hClp1-Spe1
(ccggttcatggatctgaagtag). SF3b49 was amplified with the primers SF3b49-SpeI
( a a g c g c a c t a g t g a t g g c t g c c g g g c c g a t )  a n d  S F 3 b 4 9 - P a c I
(caattcttaattaattactgagggagagggcct). The primers used to amplify SF3b130 were
SF3b130-SpeI  ( cgcac tag tga tg t t t c tg t acaac )  and  SF3b130-Pac I
(atattaattaagtcagaaggcgtagcg). SF3b155 was amplified with the primers SF3b155-speI
(cgcactagtgatggcgaagatcgcc) and SF3b155- PacI (atattaattaagttataagatatagtc). The
sequence of the inserts was verified by sequencing.
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3.1 Introduction
The 12S U2 snRNP consists of the seven Sm proteins common to the spliceosomal
snRNPs and the U2-specific proteins U2-A’ and U2-B’’. In addition the splicing
factors 3a and 3b (SF3a / SF3b) associate with the particle to form the fully assembled
17S U2 snRNP (Brosi et al., 1993; Krämer et al., 1999; Will and Lührmann, 2001).
Relatively little is known about how these functionally important complexes are
tethered to the U2 snRNP. It has been suggested that the U2 snRNP consists of two
globular structures of which one contains SF3b and a 5’ portion of the U2 snRNA,
whereas the other contains the Sm core, U2-A, U2-B’’, SF3a and the 3’ part of the
U2 snRNA (Behrens et al., 1993; Krämer et al., 1999). SF3a consists of the three
proteins SF3a120, SF3a66 and SF3a60. SF3b contains the seven proteins SF3b155,
SF3b145, SF3b130, SF3b49, SF3b14a/p14, SF3b14b and SF3b10 (Gozani et al.,
1996; Das et al., 1999; Krämer et al., 1999; Will et al., 2001; Will et al., 2002).
Subunits of SF3a and SF3b interact with pre-mRNA and are believed to play an
essential role in splice site recognition and tethering of the U2 snRNP to the pre-
mRNA (Gozani et al., 1996; Query et al., 1996; Gozani et al., 1998; Will et al., 2001).
SF3b49, SF3b145, SF3b155 and all three SF3a subunits can be cross-linked to a 20
nucleotide region just 5’ of the branch site in pre-spliceosomes and spliceosomes
(Gozani et al., 1996). SF3b155 also binds to a region 5 nucleotides downstream of the
branch point (BP; Gozani et al., 1998). SF3b155 interacts with SF3b14a/p14, which
directly binds to the BP adenosine (Will et al., 2001). Additional known protein-
protein interactions between SF3a and SF3b subunits are between SF3b155 and
SF3b130 (Das et al., 1999), SF3b145 and SF3b49 (Champion-Arnaud and Reed,
1994), SF3a120 and SF3a60 (Chiara et al., 1994), and SF3a120 and SF3a66 (Krämer
et al., 1999).
SF3b155 also interacts with U2AF65 and this interaction replaces the
U2AF65-SF1 interaction and contributes to the recruitment of the U2 snRNP to the
BP (Gozani et al., 1998). The C-terminus of SF3b155 contains 22 nonidentical,
tandem repeats, which are similar to those found in the regulatory subunit A of the
phosphatase PP2A. However, no phosphatase activity has been reported for SF3b155
so far. Interestingly, the repeats must serve an important function given that the S.
cerevisiae homologue of SF3b155 consists almost entirely of them. The N-terminus is
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less well conserved and contains multiple TPGH motifs and several RWDETP motifs
(Wang et al., 1998). SF3b155 is phosphorylated during or just after step 1 but before
step 2 of the splicing reaction. And this phosphorylation might be important for
activity of the spliceosome (Wang et al., 1998). Cyclin E-cdk2 was shown to
phosphorylate SF3b155 and antibodies directed against cyclin E immunoprecipitated
the U2 snRNA and subunits of SF3b. Cyclin E-cdk2 is a critical regulator of cell
cycle progression from G1 into S phase in mammalian cells. These results suggested
that pre-mRNA splicing might be linked to the cell cycle machinery through
phosphorylation of SF3b155 (Seghezzi et al., 1998).
SF3b130 was identified as component of SF3b (Das et al., 1999). However,
very little is known about the function of the protein. The yeast homologues of
SF3b155 and SF3b130 were shown to be essential proteins (Das et al., 1999),
indicating that both proteins play an important role in mammals also. Interestingly,
SF3b130 shows sequence homology with CPSF160 (Das et al., 1999). A domain
assigned to bind RNA in CPSF160 is conserved in SF3b130, suggesting a role of the
protein in nucleic acid binding (Dichtl et al., 2002b). However, so far SF3b130 has
not been shown to interact with RNA.
CPSF100 shares homology with CPSF73 (Jenny et al., 1996). Like CPSF73
the 100 kDa subunits is a member of the metallo-β-lactamase / β-CASP family but
unlike CPSF73, CPSF100 is not believed to posses endonuclease activity as it lacks
part of all the conserved amino acids that are thought to be involved in the enzymatic
function (Callebaut et al., 2002). The function of CPSF100 is largely unknown. It can
be UV cross-linked to RNA (Edwalds-Gilbert and Milcarek, 1995), however RNA-
binding experiments did not confirm a function in RNA binding (Bernhard Dichtl
unpublished data).
Homologues of CPSF100 and CPSF73 have recently been identified in
mammalian cells.  The N-terminus of RC-74 is about 20% identical to CPSF100. Like
CPSF100 the protein contains mutations in the amino acids thought to be involved in
endonuclase activity. RC-68 is 40% identical to CPSF73 throughout the first 450
amino acids. It contains the metallo-β-lactamase / β-CASP motifs which have an
intact active site. RC-68 localizes to the cytoplasm and the nucleus whereas RC-74 is
found exclusively in the nucleus. RC-74 interacts with RC-68 but not with CPSF73
and none of the proteins was found to interact with CPSF160. Depletion of RC-68 by
RNAi arrested HeLa cells eary in G1 phase, but surprisingly the arrested cells
continued to grow and reached the size typical for G2 cells (Dominski et al., 2005b).
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We were able to show in vitro that the U2 snRNP and CPSF couple splicing
and 3’ end processing and wanted to test whether we can detect this effect in vivo
also. Therefore, we depleted SF3b155, SF3b130 and CPSF100 by RNAi in HeLa
cells and tested for deficiency in splicing and 3’ end processing in these cells. We
were able to show that both SF3b subunits are required for splicing in vivo. However,
neither SF3b155, SF3b130 nor CPSF100 knock down resulted in an observable
influence on 3’ end processing. This lack of effect can be explained by different
scenarios as described in the discussion of this chapter.
Interestingly, knock down of both SF3b subunits resulted in decrease of cell
viability whereas depletion of CPSF100 did not significantly affect cell viability. This
could indicate that CPSF100 shares redundant functions with another protein in the
cell.
3.2 Results
3.2.1 Growth analysis of HeLa cells after knock down of CPSF100,
SF3b130 and SF3b155
In order to test if CPSF100, SF3b130 and SF3b155 are essential proteins and to
investigate their roles in pre-mRNA processing we took advantage of the RNAi
method. We treated HeLa cells independently with two different siRNAs
complementary to the mRNAs of CPSF100, SF3b130 and SF3b155.
We determined the percentage of dead cells caused by the treatment with the
siRNAs by staining the cells with trypan blue. Figure 3.1 shows the percentage of
dead cells two and three days after transfection of the individual siRNAs as indicated
at the bottom. Knock down of CPSF100 with the siRNA CPSF100-1 resulted in cell
death of only 33% with a standard deviation (SD) of 6 three days after transfection.
Knock down of the same protein with the CPSF100-2 siRNA reslted in a cell death of
29% (SD=2) three days after transfection. In comparison, knock down of the
unessential gene lamin resulted in 20% (SD=5) cell death. Treatment of HeLa cells
with siRNAs directed against SF3b130 resulted in cell death of 44% (SD=9) with the
siRNA SF3b130-1 and 41% (SD=6) with the SF3b130-2 oligo. Knock down of
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SF3b155 lead to 49% (SD=5) cell death three days after tranfection with the siRNA
SF3b155-1 and 45% (SD=8) with the SF3b155-2 RNA oligo.
Figure 3.1 Percentage of dead cells after knock down of CPSF100, SF3b130 and SF3b155
The graph represents the percentage of dead cells 2 and 3 days after treatment with the individual





















































3.2.2 Western blot of total protein extracted from siRNA treated cells
Figure 3.2 Western blot analysis of the siRNA treated cells
Total proteins were extracted from cells harvested 2 or 3 days (indicated at the bottom) after
transfection with the siRNAs indicated at the top. Equal amounts of totoal proteins were loaded in each
lane. Lanes with a (–) represent total proteins extracted from cells that were mock transfected. The


















































Cells treated with siRNAs directed against CPSF100 showed significantly lower
amounts of CPSF100 already two days after transfection with both siRNAs used
(Figure 3.2). The protein level of CPSF160 was reduced in these cells but not the
protein levels of CPSF73, CF Im68, SF3b155, SF3b130, SF3a120, SF3a66 and of
lamin. Treatment of HeLa cells with siRNAs directed against SF3b130 or SF3b155
resulted in decrease of the targeted proteins as well as reduced levels of CPSF160,
CF Im68, SF3b155 repectively SF3b130, SF3a120 and SF3a66. CPSF100, CPSF73
and lamin protein levels were not affected.
3.2.3 The siRNA treatment lead to reduction of the targeted mRNAs
In order to test if the targeted mRNAs were indeed degraded in the siRNA transfected
cells, we performed RT PCR experiments. The reverse transcription was performed
with random primers in order to obtain the polyadenylated and non-polyadenylated
RNA species or with oligo dT primers which lead to reverse transcription of the
polyadenylated RNAs only. We did quantitative PCR on such produced DNA with
primers complementary to the mRNAs of the targeted proteins. In all three cases,
transfection of the HeLa cells with the respective siRNAs resulted in specific
degradation of the targeted mRNA (Figure 3.3). As loading control served the intron-
less H3F1 RNA. We obtained the same result for DNA produced with the random or
with the oligo dT primers.




































Total RNA was isolated from HeLa cells after 2 and 3 days incubation with the individual siRNAs
(indicated on top). (-) represents reactions that were performed with RNA isolated from mock
transfected cells. As control that no endogenous DNA was present in our preparations we used RNA
isolated from HeLa cells on which no reverse transcription had been performed (no RT). The RNA was
reverse transcribed with random primers and quantitative PCR was performed with primers
complementary to the mRNAs indicated at the left. The PCR was carried out with 32 cycles. H3F1
served as an internal loading control.
3.2.4 Knock down of SF3b subunits affected splicing in vivo
To test whether the knocked down proteins are involved in splicing in vivo we did
quantitative PCR on DNA obtained from reverse transcription with the oligo dT or the
random primers, and primers complementary to two neighbouring exons (Figure 3.4).
The last and an internal intron of the CPSF160 pre-mRNA and an internal intron of
SF3a120 were  not spliced out efficiently in SF3b130 and SF3b155 depleted cells,
given that we detected the unspliced pre-mRNA species in these cells. We sequenced
the PCR products and found that in the case of both CPSF160 introns the intron was
not spliced out at all. The upper product of the SF3a120 PCR reaction was identified
as partially spliced pre-mRNA that contained both exon borders and part of the intron.
We were not able to detect unspliced pre-mRNA in CPSF100 knock down cells.
These data show that both SF3b subunits are required for splicing in vivo.
Figure 3.4 SF3b130 and SF3b155 are essential for splicing in vivo
Total RNA was isolated from HeLa cells after 2 and 3 days incubation with the individual siRNAs











































transfected cells. As control that no endogenous DNA was present in our preparations we used RNA
isolated from HeLa cells on which no reverse transcription had been performed (no RT). The RNA was
reverse transcribed with random primers and quantitative PCR was performed with primers
complementary to adjacent exons of the pre-mRNA as indicated at the left. The PCR was carried out
with 35 cycles.
3.2.5 Kock down of CPSF100, SF3b130 and SF3b155 had no
detectable effect on 3’ end processing
Deficiency in 3’ end processing should likely lead to decreased levels of
polyadenalytated mRNA. In order to test whether depletion of CPSF100, SF3b130 or
SF3b155 resulted in deficient 3’ end processing, we reverse transcribed the RNAs
isolated from the siRNA treated cells with oligo dT primers. We did quantitative PCR
on this DNA with primers annealing to the mRNAs of SF3b14 and CPSF73. In both
cases we detected equal levels of mRNA in all cells (Figure3.5), indicating that knock
down of CPSF100, SF3b130 or SF3b155 had no effect on the levels of
polyadenylated mRNA. When we used 1/5 of the amount of DNA used in the PCR
reactions we found that the PCR product was clearly reduced, indicating that the
reaction was in linear range.
Figure 3.5 Depletion of CPSF100, SF3b130 and SF3b155 did not result in lower levels of
polyadenylated mRNAs
Total RNA was isolated from HeLa cells after 2 and 3 days incubation with the individual siRNAs
(indicated on top). (-) represents reactions that were performed with RNA isolated from mock
transfected cells. As control that no endogenous DNA was present in our preparations we used RNA
isolated from HeLa cells on which no reverse transcription had been performed (no RT).  The RNA







































complementary to adjacent exons of the pre-mRNA as indicated at the left. The PCR was carried out
with 30 cycles..
3.3 Discussion
We have found that only approximately 30% of all cells died upon knock down of
CPSF100. Depletion of the nonessential protein lamin resulted in cell death of 20%
also, indicating that the transfection procedure caused a certain percentage of cell
death independently of the siRNAs. We were surprised to find that knock down of
CPSF100 did not result in a higher lethality given that Ydh1p (the yeast homologue of
CPSF100) is an essential protein and 3’ end formation is generally regarded as a vital
process. One explanation for this observation could be that even though we knocked
down CPSF100 quite efficiently as determined by Western blotting, the remaining
levels of the protein could have been sufficient to allow survival of most cells. On the
other hand it is possible that a protein exists within the cells, which shares redundant
functions with CPSF100. Recently, RC-74 a homologue of CPSF100 has been
identified. The function of this protein is so far unknown but it was shown to interact
with the CPSF73 homologue RC-68 (Dominski et al., 2005b). It would be very
interesting in the future to determine whether a double knock out of CPSF100 and
RC-74 would cause lethality of the cells. However, we cannot exclude either that the
function which CPSF100 carries out in a cell is indeed not very crucial for survival.
Kock down of SF3b130 and SF3b155 lead to cell death of 40% respectively 45%
three days after transfection with the individual siRNAs, clearly above the lethality
level of the cells treated with the siRNAs directed against lamin. We therefore believe
that both SF3b130 and SF3b155 are essential genes. The levels of the targeted
proteins were clearly reduced as determined by Western blotting. However, a certain
amount of the proteins could still have remained in the cells, allowing for the survival
of a percentage of the cell population. Furthermore, not every single cell takes up
siRNAs upon transfection. Therefore, there is always a pool of un-depleted cells
present within the siRNA transfected cells.
The protein levels of CPSF160 were reduced in the CPSF100 depleted cells. Possibly
this could mean that CPSF100 is involved of the processing of the CPSF160 pre-
mRNA (or in its transcription/translation). However, given that we did not detect any
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splicing or 3’ end processing deficiency in these cells we think that this is rather
unlikely. The low levels of CPSF100 present in the cells could however result in
incompletely assembled and perhaps less stable CPSF complexes. This in turn could
make the CPSF subunits more accessible to proteases. The yeast homologues of
CPSF100 and CPSF160 have been shown to interact with each other. Maybe this
interaction takes place in mammalian cells also and could be crucial for recruitment of
CPSF160 to CPSF and therefore indirectly for the stability of the protein.
We have found that depletion of SF3b130 and SF3b155 resulted in deficient
splicing. To our knowledge, this is the first time that it was shown in vivo that the two
proteins are indeed involved in splicing. We wanted to test, if there are indications
that CPSF and the U2 snRNP couple splicing and 3 end formation in vivo. If this was
the case knock down of either CPSF or U2 snRNP subunits should result in inhibition
of splicing as well as 3’ end processing. However, depletion of CPSF100 did not
result in deficient splicing. This could indicate that CPSF100 is not involved in
splicing. However, it is also possible that knock down of CPSF100 was not efficient
enough to cause a detectable defect in splicing. This would explain also, why a very
low number of cells died upon depletion of CPSF100. On the other hand, it is possible
that CPSF100 shares redundant functions with another protein, which could take over
the role of CPSF100 in coupling splicing and 3’ end processing when CPSF100 is
depleted.
Depletion of neither CPSF100, SF3b130 nor SF3b155 resulted in an
observable decrease of polyadenylated mRNA levels. As for CPSF100 this could be
explained by the reasons mentioned above. It is possible that SF3b130 and SF3b155
are not involved in the 3’ end processing of pre-mRNAs in vivo. On the other hand
their effect could be to weak as to be detected by the method we used. It is also
possible that the coupling of 3’ end formation and splicing mediated by CPSF and the
U2 snRNP is gene specific.
Taken together we were not able to show that the coupling between 3’ end
processing and splicing mediated by CPSF and the U2 snRNP takes place in vivo also.
However, there are many reasons that could explain this lack of an effect. To address
this question in the future, it would be necessary to look at the phenotypes caused by
depletion of other subunits of CPSF and of U2 snRNP. It would also be advisable to
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HeLa cells were seeded in 6-well plates at a concentration of 2.5*10^4 cells per well
in MEM +Earls +GlutamMAXTMI, 10% foetal bovine serum (all Gibco). The next day
they were transfected with 225 pmol chemically synthesized, annealed siRNA
(Dharmacon) in the presence of oligofectamine (Invitrogen) according to the
manufacturers manual. The next day the medium was changed and the attached and
detached cells harvested two and three days after transfection. For harvesting the
following procedure was used: the medium was taken off and collected, the cells were
washed with 1 ml of PBS and the wash was discarded. To detach the surviving cells
from the plates they were incubated for 5 min. with 250 µl Trypsin and the cells
combined with the medium from the first step. 50 µl of this cell suspension was given
into a separate tube to determine the cell density. The rest of the suspension was
centrifuged for 10 min. at 4°C and 3000 rpm. the supernatant was removed and the
cells washed once in 1 ml cold PBS. The cell pellet was frozen in liquid nitrogen and
stored at -80°C.
The cell viability was determined by staining the cells with trypan blue.
The sense sequences of the siRNA used in this study were as follows:








3.4.2 Isolation of RNA and RT-PCR
The RNA was isolated 2 and 3 days after transfection of the siRNAs with the RNeasy
Mini kit (Qiagen). The DNA was digested on the column (Qiagen) following the
manufacturers protocol.
Reverse transcription was performed with 0.2 µg total RNA, 200 ng random primer
(Promega) or 5.6 µM oligo dT with the Super Script II reverse transcriptase
(Invitrogen) in the presence of 20 U RNaseOUT (Invitrogen) at 42°C following the
manufacturers protocol.
PCR reactions were carried out with the Expand high-fidelity PCR system (Roche).
We used 1 µl of a 1:30 dilution of the DNA obtained in the reverse transcription. 10
µl [10 mM] dNTPs, 30 µl [10 mM]  primer 1, 30 µL [10 mM] primer 2, 490 µl H2O,
100 µl Buffer 3, 10 µl Enzyme and 60 µl [25 mM] MgCl2 was combined and 24 µl
added to the DNA. The PCR was carried out with the following program:
Step1: 95°C, 2 min.
Step 2: 95°C, 40 sec.
Step 3: 50°C, 1 min.
Step 4: 68°C, 4 min.
Step 5: 68°C, 10 min
For how many times the steps 2 to 4 were repeated is indicated in the legends to the
different figures.
The primer pairs we used in this study were:
CPSF160-ex9 / CPSF160-ex10: aagctcgagcttgctgcc / agctcaggctcctcaaag
CPSF160-ex60 / CPSF160-ex61: acctgtacctgagcacca / gttttgtacaaaaagggggtg
CPSF100-ex24 / CPSF100-ex25: cctggacatcagtcagtttt / gtaagtttttctggcagattc
CPSF73-ex52 / CPSF73-ex55: catatttggagaagactgtg / ggtaacaaaagtagagtcaag
H3F1-primer1 / H3F1-primer2: gtgaaatccgccgctatcag / gtttaagttggcgcacaccc
SF3a120-ex16 / SF3a120-ex18: cttgattccacccaaaggtt / cattgggttggaagtccact
SF3b155-ex49 / SF3b155-ex51: cccaatgtatttgagacatc / gtcactactggcatttactg
SFb130-ex53 / SF3b130-ex55: gtgatcatgaactaccatgt / gtaggagcgaaagctgaggt
SF3b14-ex10 / SF3b14-ex13: gaacacacctgaaactagag / gtttcaagcaggtcattttg
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3.4.3 Western blot analysis
The frozen cell pellets were thawed on ice and resuspended in 50 µl RIPA buffer (50
mM Tris-HCl pH8.0, 150 mM NaCl, 1% NP40, 0.5% sodiumdeoxycholate, 0.1%
SDS, 0.2 mM Na3VO4, 10 mM NaF, 0.4 mM EDTA, 10% glycerol, before use the
following solutions were add to a final concentration of 0.2 mM Vanadate, 0.5 mM
DTT, 0.5 mM PMSF, 2 µg/ml Pepstatin, 2 µg/ml Leupeptin. The cells were vortexed
quickly and put on a shaker at room temperature for 5 to 10 min. The suspension was
centrifuged for 5 min at 4°C and 2000 rpm and the supernatant transferred to a fresh
tube. For Western blot analysis 3x104 cells were run on an 8% SDS-gel.
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4.1 Introduction
In yeast only very few genes contain introns and most of the times they are located
close to the 5’ end of the pre-mRNA. Therefore, there has been almost no research
done on the coupling between splicing and 3’ end processing in yeast. However, most
proteins of the 3’ end processing machinery and the U2 snRNP are conserved from
mammalians to yeast and we wanted to investigate whether the coupling mechanism
mediated by CPSF and the U2 snRNP we observed in humans takes place in S.
cerevisiae also.
Below is a table of the mammalin U2 snRNP subunits and their homologues in yeast.




















Table 4.1 Mammalin subunits of the U2 snRNP and their yeast homologues
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To address the question if  the U2 snRNP and CPF couple 3’ end formation and
splicing, we characterized the temperature sensitive rse1-1 yeast strain. Rse1p (named
for RNA splicing and ER-toGolgi transport) was originally identified in a screen for
mutants deficient in ER-to-Golgi transport (Chen et al., 1998). The secretion defect of
the rse1-1 mutant strain could be suppressed by either increasing the amount of SRA1
or deleting the intron from the chromosomal SAR1 locus. Sar1p is a small GTP-
binding protein required for transport from the endoplasmic reticulum to the Golgi
apparatus (Nakano and Muramatsu, 1989). This suggested that the secretion
deficiency of the Rse1p mutant strain was an indirect effect. In agreement with this,
Rse1p was shown to be required for splicing and for spliceosome assembly and to be
part of the U2 snRNP (Chen et al., 1998; Caspary et al., 1999). It interacts only
transiently or weakly with the U2 snRNA. Like its mammalian homologue SF3b130,
its sequence is similar to CPSF160 and XPE proteins (Caspary et al., 1999). Rse1p
interacted in a two-hybrid screen with Prp9 (Fromont-Racine et al., 1997).
We found that the rse1-1 mutant strain was sensitive to cordycepin. In
addition rse1-1 genetically interacted with different subunits of CPF and Northern
blot experiments indicated that some double mutants had increased levels of un-
spliced pre-mRNA at restrictive temperature compared to the single mutants. This
suggested that the coupling between splicing and 3’ end processing takes place in
yeast also and that this coupling might be mediated by the U2 snRNP and CPF.
4.2 Results
4.2.1 Does Rse1p directly interact with subunits of CPF?
Given that many proteins involved in 3’ end processing and splicing are conserved in
mammals and yeast we decided to test whether the coupling mechanism of the two
processes mediated by CPSF and the U2 snRNP takes place in yeast as well.
Rse1p is the yeast homologue of SF3b130 which we found to interact with
CPSF160, CPSF100 and CPSF30. To test whether Rse1p interacts with subunits of
the yeast 3’ end processing machinery, we expressed the C- and N-terminal half of the
protein in E. coli (it was not possible to obtain full length recombinant protein). GST-
pull down experiments were performed with numerous subunits of the 3’ end
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processing machinery; however, both recombinant fragments of Rse1p bound to all
tested proteins (results not shown). Given that it is highly unlikely that Rse1p binds to
such a large number of polypeptides, we believe that both recombinant proteins are
sticky and bind to any partner protein in GST-pull down experiments.
4.2.2 The rse1-1 strain is sensitive to cordecypin
The rse1-1 strain is temperature sensitive (Chen et al., 1998) and grows slowly at
30°C. The mutation is lethal at 33°C (Figure 4.1).
Figure 4.1 The rse1-1 strain is temperature sensitive
Ten-fold serial dilutions of the yeast strains indicated at the left were put on SD-complete medium
plates and incubated at the temperatures indicated at the top.
We tested the rse1-1 temperature sensitive mutant strain for its sensitivity to
cordycepin. Figure 4.2 shows that the rse1-1 strain grew slower on cordycepin-
containing medium than the wild-type strain at 30°C. Cordycepin is a drug that
prevents the addition of poly(A) tails (Zeevi et al., 1982). Sensitivity to cordycepin is





Figure 4.2 The rse1-1 mutant is sensitive to cordycepin
Ten-fold serial dilutions of the yeast strains indicated at the left were put on SD-complete medium with
or with out cordycepin as indicated at the top and incubated at 30°C.
4.2.3 The rse1-1 strain is not deficient in 3’ end cleavage in vitro
We analyzed whether the mutation in Rse1p affected cleavage and polyadenylation in
vitro and tested extracts from wild-type and rse1-1 cells for their ability to cleave a
synthetic CYC1 pre-mRNA (Figure 4.3). Extracts from isogenic wild-type cells (lanes
2 and 4) and rse1-1 cells (lanes 3 and 5) efficiently cleaved the RNA precursor at










Figure 4.3 The rse1-1 strain is not deficient in 3’ end cleavage in vitro
3’ end cleavage assay with extract obtained from the rse1-1 and its isogenig wild-type strain. Input
represent mock treated reactions. Equal amounts of total proteins were used in each lane. As substrate
served the CYC1 pre-mRNA. The migration position of the full length RNA and its 3’ end cleavage
(3’) and 5’ end cleavage product (5’) are indicated at the left. The assay was performed at 30°C and at
34°C as indicated at the top.
We also tested the extracts for their polyadenylation activity with pre-cleaved CYC1
RNA precursor, but the extracts from wild-type and rse1-1 cells were both inactive in
polyadenylation (results not shown). We generated numerous extracts but were in no
case successful to obtain extract that was active in polyadenylation with the above
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this specific genetic background requires as different protocol than the one generally
used.
4.2.4 The mRNA levels of intron-containing genes are lowered in the
rse1-1 mutant strain at restrictive temperature but not the levels of
pre-mRNAs without introns
Figure 4.4 shows a growth curve of the rse1-1 and its isogenic wild-type strain
following shift from 25°C to 37°C. The rse1-1 cells started to grow significantly more
slowly than the wild-type cells after two to three hours incubation at 37°C.
Figure 4.4 Growth analysis of the rse1-1 mutant strain at 37°C
The graph represents the growth behavior of the rse1-1 and its isogenic wild-type strain after shift to
37°C. The strains were grown to exponential growth at 25°C and then shifted to a 37°C water bath. The
OD was measured after every hour and the growth determined as the log(ODt/ODt0).
Low levels of mRNAs can serve as an indication that a mutant strain might be
deficient in pre-mRNA splicing or in 3’ end formation. We carried out Nothern blot
analysis of the rse1-1 and isogenic wild-type strains. We found that the rse1-1 cells
contained lower levels of the CYH2 and ASC1 mRNAs after three hours shift to 37°C


















restrictive temperature. Unspliced CYH2 pre-mRNA is present in the wild-type and
the rse1-1 cells; interestingly, the levels of unspliced CYH2 pre-mRNA were not
elevated in the rse1-1 cells compared to the wild-type cells. In contrast a faint band of
probably unspliced ASC1 pre-mRNA is visible only in the rse1-1 but not in the wild-
type strain after three hours incubation at restrictive temperature, indicating that
Rse1p is required for efficient splicing of this substrate. The levels of the ACT1
mRNA were marginally lower compared to wild-type cells after six hours shift to
restrictive temperature. The levels of the ADH1 and NRD1 pre-mRNA were not
significantly affected by the rse1-1 mutation; 18S rRNA served as loading control.
CYH2, ASC1 and ACT1 pre-mRNAs contain introns, whereas the other pre-mRNAs
tested do not. These results indicate that Rse1p is required for the processing of
intron-containing pre-mRNAs but not for the processing of intronless pre-mRNAs. At
present we do not know whether the low levels of mRNAs from intron-containing
genes were due solely to a splicing deficiency of the rse1-1 strain or if these pre-
mRNAs were also 3’ end processed with lower effciency.
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Figure 4.5 The mRNA levels of intron-containing genes are reduced in the rse1-1 strain upon
shift to restrictive temperature
Northern analysis of total RNA extracted form wild-type and mutant rse1-1 cells grown at 25°C, or
after shift to 37°C for 3 and 6 hours as indicated on the top of each lane. The filters were developed
with random-primed labeled probes directed against the RNA species indicated at the left of each
panel.
4.2.5 Poly(A) tails shorten in the rse1-1 strain after six hours at 37°C
Next, we analyzed the poly(A) tail length distribution of the rse1-1 mutant strain
before and after shift to restrictive temperature. Up to three hours after shift to 37°C
the poly(A) tail length distribution of the rse1-1 cells were comparable to wild-type
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Given that the rse1-1 strain ceased growth significantly after three hours at 37°C but
showed a normal distribution of poly(A) tail length at this time it is likely that the
effect we observed after six hours shift could be due to secondary effects caused by
the rse1-1 mutant protein and not due to a direct effect of the mutant protein.
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Poly(A) tail length distribution assay of rse1-1 and its isogenic wild-type strain after growth at 25°C, or
following shift to 37°C for 1, 2, 3 and 6 hours. The position and size (in number of nucleotides) of the
marker bands are indicated on the left.
4.2.6 RSE1  genetically interacts with subunits of the 3’ end
processing machinery
We showed here that CPSF100 interacts with SF3b130. Therefore, we tested if Rse1p
interacts genetically with Ydh1p, the yeast homologue of CPSF100. The mutant
strains ydh1-1 and ydh1-3 but not ydh1-2 were deficient in 3’ end cleavage. ydh1-1
was also shown to be deficient in the polyadenylation step of the 3’ end processing
reaction. All three mutant strains did not recognize the ACT1 poly(A) site efficiently
(Chapter 6; Kyburz et al., 2003). Figure 4.7 shows that the ydh1-1 mutation was
synergistically lethal in combination with the rse1-1 mutation at 30°C on YPD but not
on SD-complete medium. Furthermore, the cells carrying both mutations were less
sensitive to corycepin than the rse1-1 single mutant cells (Figure 4.7). rse1-1/ydh1-2
and rse1-1/ydh1-3 double mutants both grew better on SD-complete medium with or

















Figure 4.7 rse1-1 and ydh1-1 are synergistically lethal at 30°C on YPD-medium
Ten-fold serial dilutions of the yeast strains indicated at the left were put on YPD and SD-complete
plates or SD-complete plates containing 20 µg/ml or 40 µg/ml cordycepin as indicated at the top.
W303 is the isogenic wild-type strain of ydh1-1 and wt stands for the isogenic wild-type strain of
rse1–1.
SF3b130 interacted directly in GST-pull downs with CPSF160 (the homologue of
Yhh1). Furthermore, SF3b130, CPSF160 and Yhh1p share homology (Dichtl et al.,
2002b). Therefore, we generated rse1-1/yhh1-3 and rse1-1/yhh1-6 double mutants.
The mutant strains yhh1-3 and yhh1-6 are both deficient in the poly(A) addition step
of the 3’ end processing reaction. Both strains were also shown to negatively affect
poly(A) site selection and transcription termination. Yhh1-3 but not yhh1-6 was
shown to be deficient in 3’ end cleavage in vitro (Dichtl et al., 2002b). The rse1-
1/yhh1-6 strain grew as slowly on YPD at 30°C as the rse1-1 single mutant but the
double mutant grew better than the single mutant on SD-complete medium with or
without cordycepin (Figure 4.8). The rse1-1/yhh1-3 did also grow better on SD-
complete medium with or without cordycepin than the rse1-1 single mutant (results
not shown). We do not know why the double mutants of rse1-1/ydh1-1 and rse1-
1/yhh1-6 grow better on SD-complete than on YPD medium.
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Figure 4.8 rse1-1 and yhh1-6 genetically interact
Ten-fold serial dilutions of the yeast strains indicated at the left were put on YPD and SD-complete
plates or SD-complete plates containing 20 µg/ml or 40 µg/ml cordycepin as indicated at the top.
W303 is the isogenic wild-type strain of yhh1-6 and wt stands for the isogenic wild-type strain of
rse1–1.
The cordycein sensitivity of rse1-1 indicated that this strain might be deficient in
polyadenylation. Therefore, we generated double mutants of rse1-1 and mutants in
PAP. pap1-3 was shown to be deficient in polyadenylation but not in 3’ end cleavage
(Minvielle-Sebastia et al., 1994; P. Preker and W. Keller unpublished results). Indeed
the double mutant with rse1-1 showed synergistic lethatlity at 30°C on YPD and SD-
complete medium. The double mutant was as sensitive to cordycepin as the rse1-1


















Figure 4.9.rse1-1 and pap1-3 are synergistically lethal at 30°C
Ten-fold serial dilutions of the yeast strains indicated at the left were put on YPD and SD-complete
plates or SD-complete plates containing 20 µg/ml or 40 µg/ml cordycepin as indicated at the top.
W303 is the isogenic wild-type strain of pap1-3 and wt stands for the isogenic wild-type strain of
rse1–1.
 Furthermore we generated rse1-1 / pap1-9 double mutants. Pap1-9 is deficient in
polyadenylation (P. Preker and W. Keller unpublished data). This double mutant
showed the same growth on YPD, SD-complete or cordycepin containing medium as
the rse1-1 single mutant. Taken together these results show that Rse1p genetically
interacts with Ydh1p, Yhh1p and PAP.
4.2.7 Northern analysis of the single and double mutant strains
We measured the growth curves of the single and double mutants following shift from
25°C to 30°C or 33°C in YPD medium. At 30°C the rse1-1 and ydh1-1 single mutant
strains grew as well as the wild-type strains. The rse1-1/ydh1-1 double mutant grew
slower than the single mutant strains but did not cease growth. At 33°C the rse1-1 and
ydh1-1 single mutants started to grow slower than the wild-type cells after four
respectively three hours. The rse1-1/ydh1-1 double mutant cells ceased growth after


















Figure 4.10 Growth analysis of the single and double mutant strains after shift to 30°C and 33°C
The graph represents the growth behavior of the single and double mutant strains and their isogenic
wild-type strains after shift to 30°C or 33°C as indicated at the top. W303 is the isogenic wild-type
strain of ydh1-1 and wt is the isogenic wild-type strain of rse1-1. The strains were grown to
exponential growth at 25°C and then shifted to a water bath with the higher temperature. The OD was


















































The yhh1-6 single mutant grew as well as the wild-type cells at 30°C and 33°C and
the rse1-1/yhh1-6 double mutant strain grew marginally less well than the respective
single mutants at both temperatures (Figure 4.11).
Figure 4.11 Growth analysis of the single and double mutant strains after shift to 30°C and 33°C
The graph represents the growth behavior of the single and double mutant strains and their isogenic
wild-type strains after shift to 30°C or 33°C as indicated at the top. W303 is the isogenic wild-type



















































exponential growth at 25°C and then shifted to a water bath with the higher temperature. The OD was
measured after every hour and the growth determined as the log(ODt/ODt0).
The pap1-3 single mutant strain grew more slowly than the wild-type strain after one
hour shift to 30°C and the rse1-1/pap1-3 double mutant cells ceased growth after
approximately one hour at 30°C. The pap1-3 and rse1-1/pap1-3 strains both ceased to
grow one hour after shift to 33°C (Figure 4.12).
Figure 4.12 Growth analysis of the single and double mutant strains after shift to 30°C and 33°C
The graph represents the growth behavior of the single and double mutant strains and their isogenic
wild-type strains after shift to 30°C or 33°C as indicated at the top. W303 is the isogenic wild-type
strain of pap1-3 and wt is the isogenic wild-type strain of rse1-1. The strains were grown to
exponential growth at 25°C and then shifted to a water bath with the higher temperature. The OD was


















































We did Northern analyzes of the single and double mutants after shift to 30°C and
33°C (Figure 4.13.). The levels of the CYH2 and ASC1 mRNAs were significantly
reduced compared to the wild-type cells after 5 hours shift to 30°C and 33°C in the
rse1-1 cells. The unspliced CYH2 pre-mRNA was visible in the Northern blot with
the same intensity in the wild-type as in the rse1-1 strain. The unspliced form of the
ASC1 pre-mRNA was visible after 5 hours shift to 30°C and 33°C in the rse1-1 cells
but not in the wild-type cells. The mRNA levels of ACT1, ADH1, NRD1 and 18S
were not affected by the rse1-1 mutation. The ydh1-1 mutant cells showed reduced
levels of the CYH2, ASC1, ACT1 and ADH1 mRNA after 5 hours growth at 30°C and
33°C, the NRD1 mRNA levels did not change significantly upon shift to the higher
temperatures. The same low levels of mRNA and elevated levels of pre-mRNA of the
single mutants were found in the double mutant strain rse1-1/ydh1-1.
The levels of the CYH2, ASC1 and ADH1 mRNAs were reduced in the yhh1-6
cells only after 5 hours shift to 33°C. ACT1 mRNA levels did not seam to be effected
and the NRD1 mRNA levels were increased five hours after shift to 30°C and 33°C.
The mRNA levels of the rse1-1/yhh1-6 double mutant cells were comparable to the
yhh1-6 single mutant with the exception that the NRD1 mRNA levels were not
increased. Interestingly this double mutant had higher levels of unspliced CYH2 pre-
mRNA compared to the single mutants. The unspliced ASC1 pre-mRNA was also
found in higher levels compared to the rse1-1 or yhh1-6 single mutants even before
shift to restrictive temperature. In the rse1-1 mutant this pre-mRNA is only visible
after five hours shift to the restrictive temperature and not at all in the yhh1-6 mutant
cells. However, in the double mutant cells unspliced ASC1 pre-mRNA is present even
before shift to restrictive temperature.
The pap1-3 cells contained lower levels of the CYH2, ASC1 and ACT1
mRNAs after two and five hours shift to 30°C and 33°C. The ADH1 mRNA levels
diminished only at 33°C after two and five hours shift. The NRD1 mRNA levels were
increased five hours after shift to 33°C. Interestingly, cells carrying the pap1-3
mutation contained unspliced ASC1 pre-mRNA after five hours shift to 30°C and
33°C. The mRNA levels of the rse1-1/pap1-3 double mutant strain were comparable
to the pap1-3 single mutant cells. The amounts of unspliced ASC1 pre-mRNA were
however significantly higher in the double mutant compared to the single mutants.
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4.2.8 Poly(A) site selection assay
Given that the U2 snRNP plays a vital role in splice site selection, we decided to test
if Rse1p influences poly(A) site selection. We analyzed poly(A) site usage of the
ACT1 pre-mRNA in wild-type and mutant cells. The ACT1 3’ untranslated region
(UTR) contains at least four polyadenylation sites, of which the most proximal one
(site I) is used with highest frequency in wild-type cells. We found that the rse1-1
cells cleaved site I over site IV with the same ration as the wild-type cells even after 5
hours shift to restrictive temperature (Figure 4.14). As has been shown before for
ydh1-1 (Kyburz et al., 2003) and yhh1-6 (Dichtl et al., 2002b) the ratio of site I over
site IV was significantly lower in the ydh1-1and yhh1-6 strains before and after five
hours shift to restrictive temperature the same was the case for the respective double
mutants. Also pap1-3 single mutant and the rse1-1/pap1-3 double mutant strains were
deficient in ACT1 poly(A) site selection after shift to 33°C.
Figure 4.14 ACT1 poly(A) site selection assay
The graph represent the evaluation of three independent experiments of ACT1 poly(A) site selection of
single and double mutant strains before and after 5 respectively 2 hours shift to 33°C. All strains were
analyzed 5 hours after shift to 37°C except pap1-3 and rse1-1/pap1-3 which were analyzed after 2





















































The coupling between splicing and 3’ end processing in mammalians is quite well
established. However, there is very little information concerning the question whether
this coupling is found in yeast as well. We showed here that the U2 snRNP and CPSF
are involved in coupling the two processes in mammalian cells and wanted to find out
whether this mechanism is conserved in yeast.
If the yeast U2 snRNP is indeed involved in coupling splicing and 3’ end
processing one would expect that mutation in its subunits would not only affect
splicing but 3’ end processing as well. Therefore, we investigated if Rse1p, a subunit
of the U2 snRNP, is involved in 3’ end formation. We found that the rse1-1 strain is
not deficient in 3’ end cleavage in vitro or in poly(A) site selection in vivo. The length
of the poly(A) tails were reduced in this strain after six hours shift to restrictive
temperature, which could be the result of a direct involvement of Rse1p in poly(A)
tail synthesis. However, this phenotype only appeared after six hours shift to
restrictive temperature, whereas the cells ceased to grow already after three hours.
Therefore, it is more likely that this was not a direct but rather an indirect effect of the
rse1-1 mutation. Furthermore, Northern analysis showed that mRNA levels of genes
that do not contain an intron were not reduced in the rse1-1 strain upon shift to
restrictive temperature. Given that un-polyadenylated mRNAs are prone to rapid
degradation, this indicated that the pre-mRNAs of intron-less genes were efficiently
3’ end processed. The combined results suggest that Rse1p is not involved in the
3’ end processing reaction of intron-less pre-mRNAs. Given that the coupling of
splicing and 3’ end processing can only take place on intron-containing mRNA this
finding is not surprising. Interestingly, Northern analysis showed that the levels of
intron-containing pre-mRNAs are reduced in this strain upon shift to restrictive
temperature. We do not know at present whether this effect is due solely to the
splicing deficiency of the rse1-1 mutant or to an additional 3’ end processing
deficiency.
However, we showed that rse1-1 is sensitive to cordycepin, a drug which
prevents the addition of poly(A) tails. In addition, the rse1-1 mutation genetically
interacted with mutations in CPF subunits. Northern Blot analysis of the different
single and double mutants indicated that the rse1-1/yhh1-6 and rse1-1/pap1-3 double
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mutants had higher levels of unspliced pre-mRNAs than the single mutants. Given the
genetic interaction and the observation that double mutants in Rse1p and CPF
subunits showed an increased splicing deficiency indicated that splicing and 3’ end
processing are coupled in yeast and that the coupling mechanism mediated by CPSF
and the U2 snRNP we observed in mammals could take place also in yeast cells.
Furthermore, the single mutant pap1-3 had elevated levels of unspliced ASC1
pre-mRNA after five hours shift to 30°C and 33°C. This indicated that this mutation
might disturb the coupling of splicing and 3’ end processing. On the other hand, Pap
could be even more directly involved in the splicing mechanism than only through the
coupling mechanism. However, given that we observe this effect only after five hours
shift to the non-permissive temperature one would have to look at earlier time points,
in order to be able to rule out that this was merely a secondary effect. Interestingly,
Ysh1p the putative endonuclease was originally identified as a splicing factor (Noble
and Guthrie, 1996). In this case, it is not clear yet either if the protein is directly
involved in the splicing mechanism or enables the coupling between 3’ end
processing and splicing. It will be very interesting in the future to further investigate
the role that the 3’ end processing factors play in splicing.
The levels of the Nrd1 transcript were higher in the yhh1-6 but not in the rse1-
1/yhh1-6 double mutant cells compared to the wild-type strains. Nrd1 was shown to
be involved in the transcription termination of snoRNAs. Elevated levels of this
transcript could be an indication for a deficiency in this pathway (Steinmetz et al.,
2001). To our knowledge, Yhh1p has so far not been implied to play a role in
snoRNA termination and it would be interesting to investigate this possibility in the
future. Furthermore, it is intriguing that the double mutant does not show higher
levels of the NRD1 message. This suggests that the rse1-1 mutation could potentially
counteract the effect of yhh1-6 on snoRNA termination or NRD1 transcription
regulation.
The rse1-1/pap1-3 double mutant caused synergistic lethality on YPD and on
SD-complete medium. Interestingly, we found that the rse1-1/ydh1-1 and rse1-
1/yhh1-6 double mutants grew better on SD-complete than on YPD containing
medium. In both cases the double mutant cells grew better than the rse1-1 single
mutant strain on the SD-complete medium. At present we do not know what caused
this peculiar growing behavior. One possible explanation could be the following:
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Cells generally grow slower on SD-complete compared to YPD medium, given that
the YPD is a richer medium than the SD-complete medium. Assuming that the double
mutants are deficient in pre-mRNA processing, this would lead to unprocessed and
maybe incorrectly processed mRNAs. When the cells are growing quickly, a large
pool of deficient mRNAs would be generated in the cells. However, when the cells
grow slower, it is possible that they have enough time to repair the deficient mRNAs
and therefore be able to survive.
We found that the rse1-1/ydh1-1 and rse1-1/yhh1-6 double mutants grew
better on cordycepin-containing medium than the rse1-1 single mutant. This could
indicate that the effect of mutations in Ydh1p and Yhh1p counteract the effect of the
rse1-1 mutation, which causes sensitivity to cordycepin. However, the double mutants
generally grew better than the rse1-1 strain on SD-complete medium plates also –
therefore, the observation that the rse1-1/ydh1-1 and rse1-1/yhh1-6 double mutants
grew better on cordycepin-containing medium than the rse1-1 single mutant does not
necessarily need to be an indication of opposite effects of the single mutants on the
cordycepin sensitivitiy but could also be explained by different growth behavior of
the strains on the SD-medium.
In summary the combined results suggest that the coupling between splicing
and 3’ end formation is indeed taking place in S. cerevisiae as well. The genetic
interactions indicate that this coupling could be mediated by subunits of CPF and the
U2 snRNP. However, proof that the two complexes indeed physically interact is still
missing. Future work should investigate the interaction network of the 3’ end
processing machinery and proteins of the spliceosome. Furthermore, it would be





The strains were grown over night and diluted to an OD600 of 0.1, 0.01, 0.001, 0.0001,
0.00001. 5 µl of each dilution were spotted on three different YPD plates and
incubated at 15, 23 and 37˚C.
4.4.2 Growth curve
The yeast strains were incubated at 25˚C over night diluted in the morning to an OD600
of 0.1 (100 ml cultures) and incubated again at 25˚C until they reached an OD600 of
0.2 - 0.4. The strains were transferred to a water bath at 37˚C (t0); the OD600 was
measured every hour and the cells were diluted with pre-warmed medium when they
reached an OD600 higher than 0.8.  After 0, 2, 4, 6 and 8 hours 40 ml of the cultures
were harvested. Approximately 10 ml ice were added and centrifuged at 4˚C for 5 min
at 5 k. The cells were washed with cold water and centrifuged again. The pellets were
frozen in liquid Nitrogen and stored at –70˚C.
4.4.3 RNA analyses
Northern analysis and Rnase H experiments were carried out as described in (Dichtl et
al., 2002b).
4.4.4 Protein-protein interactions
GST-pull down experiments were performed as described in chapter 2.5.5. We
increased the salt concentration of the binding and the washing buffers in order to get
rid of the unspecific binding but without success.
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4.4.5 Extract preparation and in vitro cleavage and polyadenylation
assays
The experiments were performed as described in 6.5.5.
4.4.6 3’-end labeling of total RNA
Procedure: To 2 µg total RNA, was dissolved in a total volume of 162 µl 5 mM Tris
HCl, pH 7.0, 12.5 mM KCl, 175 µM MnCl2, 2.5% glycerol, 50 mg BSA, 1 µl
poly(A) polymerase (yeast) and 1 µl cordycepintriphosphate was added and the
mixture incubated at 37˚C for 30 min. The poly(A) polymerase was deactivated at
95˚C for 3 min and 188 µl H2O added to the solution. The radioactivity of two times
10 µl of each sample was measured in the scintillation counter.
The amount of solution equivalent to 1200000 cpm was digested by addition
of 80 µl the digestion-mix (10 mM Tris HCl, pH 8.0, 300 mM NaCl, 1 µg RNase A,
25 U RNase T1). The reaction was carried out at 37˚C for two hours, stopped by
addition of 20 µl stop-mix (50 mM EDTA, 5% SDS, 20 µg Glykogen, 1 µg
Proteinase K) and incubation for 30 min at 42˚C. 2.5 M NaOAc (f.c. 0.08 M) and 300
µl ethanol were added and the RNA precipitated over night at –20˚C. The mixture
was centrifuged at 14 k, 4˚C for 15 min and the pellet washed with 70% ethanol, dried
in the speedvac for 5 min at low temperature and resuspended in 9 µl FA (95%
formamide, 20 mM EDTA, 0.05% bromphenolblue, 0.05% xylenecyanol).
The poly(A) tails were separated on a 10% denaturing sequencing
polyacrylamide gel. 1x TBE served as running buffer and the gel was run at 1200 V
until the bromphenolblue reached the bottom of the gel.
4.4.7 Plasmids and primers
The sequence of Rse1 was PCR amplified from genomic DNA with the primers: 3’-
Rse1H6-EagI
(CCATCATCGGCCGCTAGTGATGGTGATGGTGATGCATGTAATTTGTTCTG
A C T T C G T )  a n d  5 ’ - R s e 1 - X m a I :
(ATGGTTAGCCCCGGGGATGTGGGGAGGTGGCAAAATGGC-3’). The PCR
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product was ligated into the GDV vector. The N-terminal part of the protein was PCR
a m p l i f i e d  w i t h  t h e  p r i m e r s  R s e 1 - N o t 1 - s h o r t :
(ATCAAGCTGCGGCGCTTAGTGATGGTGATGGTAGCGAGGACGTGGCACA
T A C A A T A C G A A T T C )  a n d  5 ’ - R s e 1 - X m a I :
(ATGGTTAGCCCCGGGGATGTGGGGAGGTGGCAAAATGGC-3’). The C-




GCCGCAGCTTGAT). The N- and C-terminal fragments were both cloned into the
GDV vector.
4.4.8 Yeast strains
Genotypes of yeast strains used in this study were: CYK568: MATa; rse1-1; ura3-52;
leu2-3,112; CKY294: MATa; ura3-52; leu2-3,112; YPP106: MATα; ura3-1; ade2-1;
leu2-3,112; his3-11,15;trp1Δ; ydh1::TRP1[pIA115; CEN4-URA3-YDH1]; YBD40:
MATα; urs3-1; ade2-1; leu2-3,112; his3-11.15; ;trp1Δ; yhh::TRP1 [pBD57; CEN4-
URA3-YHH]. PJP14: MATα; ura3-1; trp1-1; ade2-1; leu2-3,112; his3-11.15;
pap::LEU2 [pHCp50; CEN4-URA3-PAP];
To generated the double mutants the CYK568 strain was crossed with the
YPP106, PJP14 or the YPD40 strain. The spores were dissected and the resulting
strains tested for temperature sensitivity at 37°C. The sensitive strains were
transformed with plamids carrying the mutant 3’ end processing subunits. pAK21
(CEN-LEU2-ydh1-1), pAK22 (CEN-LEU2-ydh1-2)and pAK22 (CEN-LEU2-ydh1-3)
were transformed into the double mutants generated with the YPP106 strain. The
double mutants produced with the strain YBD40 were transformed with the plasmide:
pBD243 (CEN-LEU2-yhh1-3) or pBD244 (CEN-LEU2-yhh1-6). The double mutants
generated with the strains PJP14 were transformed with pBD13 (CEN-LEU2-pap1-3)
or pBD14 (CEN-LEU2-pap1-9). The yeast strains were plated onto 5’FOA plates in
order to shuffle out the wild-type plasmid. The genotypes of the double mutants were
verified by PCR and sequencing.
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5.1 Introduction
Only recently, the homologues of the yeast tRNA splicing endonuclease in humans
have been identified by searching of the data bases for the mammalian homologues
and isolation of the cDNA of the putative hSEN2 and hSEN34 genes (Paushkin et al.,
2004). Two different splice variants of the hSEN2 gene were isolated, one of them
lacking the entire exon 8 (hSen2∆Ex8). The authors generated HEK293 cell lines
stably expressing His-Flag-tagged hSen2, hSen34 as well as hSen2∆Ex8. Purification
of the complexes revealed that hSen2 and hSen34 were active in tRNA splicing.
However, complexes purified with His-Flag-tagged hSen2∆Ex8 retained the ability to
cleave precursor tRNA but the fidelity and accuracy of cleavage was severely
reduced. Mass spectrometry analysis of the different complexes revealed that the
homologue of the yeast Sen54p protein was present in all three complexes, but the
homologue of the yeast Sen15p was not found in the complex isolated with His-Flag-
hSen∆Ex8.
Interestingly, mass spectrometry analysis of a band running at approximately
45 kDa identified hClp1, a subunit of Cleavage Factor IIm, in all the different
complexes. This finding was very surprising given that no link between tRNA
splicing and 3’ end formation had previously been observed. Furthermore, the
presence of the 3’ end processing subunits symplekin and CstF64 were probed and
they were seen in all the differently purified complexes. Therefore stable cell lines
expressing His-Flag-hClp1 were generated and the complex was isolated (Paushkin et
al., 2004). The purified complex displayed a protein pattern that was almost identical
to that of complexes purified by the tagged versions of hSen2, hSen34 and hSen15.
Furthermore, it posessed tRNA endonuclease activity. These results suggested that the
tRNA endonuclease complex is tightly associated with 3’ end processing factors.
Paushkin and coauthors wanted to test the hypothesis that the tRNA
endonuclease subunits hSen2 is involved in 3’ end processing. Therefore the levels of
the hSen2 protein were depleted by RNAi. As expected this depletion resulted in
increased levels or pre-tRNA consistent with a role of the protein in tRNA splicing.
Furthermore, it was shown that depletion of the hSen2 protein also resulted in
increased levels of pre-mRNA, which had not been cleaved at the 3’ end. This
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suggested that the tRNA splicing endonulease complex could be involved in 3’ end
formation.
We wanted to further clarify the role of the tRNA endonuclease subunits in
3’ end processing. We therefore performed 3’ end cleavage experiments with nuclear
extract depleted of hPcf11 or hClp1 and tried to reconstitute the activity with the
different complexes that had been purified by Paushkin and collaborators (2004).
However, only addition of the complex purified with the His-Flag-hClp1 protein was
able to reconstitute cleavage activity. Furthermore Western Blot analysis showed that
hPcf11 was present only in the His-Flag-hClp purified complex but not in the
complexes purified with any of the hSen proteins.
S. Paushkin and C. Trotta assayed different fractions of purified CPSF, CstF,
CF Im and CF IIm for tRNA endonuclease activity. They found that all CF IIm fractions
were active.
Taken together these results suggest that hClp1 is a subunit of the tRNA endonuclease
complex as well as a subunit of CF IIm. However, we do not believe that the tRNA




Given that CF IIm has never been purified to homogenity, we wanted to try to obtain
pure factor. We therefore looked in our CPSF purification on which column CPSF
and CF IIm subunits separated from each other. Western blot experiments revealed
that subunits of CF IIm separated form CPSF subunits on the Mono Q column (results
not shown). We pooled the fractions of the MQ column that contained CF IIm and
further purified the factor over Mono S followed by Resource Q and a Superose S200
gel filtration column (Figure 5.1).
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Figure 5.1 Purification scheme of CPSF and CF IIm
hClp1 and hPcf11 eluted on the gel filtration column mainly between the fractions 55
to 58 as determined by Western blotting (Figure 5.2 left panel). These fractions also
contained the 59, 68 and 72 kDa subunits of CF Im. The polypeptide composition of
the gel filtration column fractions is shown in Figure 5.2, right panel. Unfortunately,














Figure 5.2 Protein composition of CF IIm after purification on a gel-filtration column
The left panel shows a Western blot of the gel-filtration fractions (indicated at the top) with antibodies
directed against the polypeptides indicated at the left. The right panel shows a silver stained gel of the
gel-filtration fractions 54-61. The migration position of the molecular weight marker is indicated at the
left. The approximate migration position of hPcf11, CF Im 72 kDa, CF Im 68 kDa, CF Im 59 kDa and
hClp1 is indicated at the right.
5.2.2 tRNA splicing activity co-elutes with CF IIm
In order to test if the pre-tRNA endonuclease activity is associated with the different
3’ end processing factors, S. Paushkin and C. Trotta assayed purified CPSF, CstF,
CF Im and CF IIm in tRNA splicing assays. As can be seen in Figure 5.3 neither pure
CstF (lane 7), different purification grades of CPSF (lanes 10 and 12) nor CF Im (lane
11) were active in tRNA splicing. In contrast, all the protein fractions that contained
















Figure 5.3 pre-tRNA splicing assay (performed by  S. Paushkin and C. Trotta)
The purified fractions indicated at the top were assayed for their ability to cleave the pre-tRNA
Phenylalaline (upper panel) or the pre-tRNA Tyrosin (lower panel). The migration position of the free
3’ and 5’ exons and the intron are indicated at the right. Buffer A was the buffer used to purify the
human and yeast tRNA endonuclease complexes (Human / Yeast tRNA Endo). Dialysis Buffer
indicates reactions that were only incubated with buffer that was used for the dialysis of the different
fractions used in the lanes 6 – 15. The lane labeled with M1 24 contained partially purified CPSF that
contained CF Im and CF IIm. Lane 7 contained highly purified CstF. The reaction in lane 8 was
performed with partially purified CF IIm after purification on a Resource Q (H. deVries). The lane
labeled with CF IIm MS23 contained proteins obtained after purification on the MonoS column fraction
23. CPSF GF64 was highly purified CPSF that was run over a gelfiltration column. Lane 11 contained
highly pure CF Im (U. Rüegsegger) and lane 12 pure CPSF obtained after the poly(A) sepharose
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column.  CF IIm RQ20 stands for the fraction 20 of the Resource Q column described in this capter.
Lane 14 contained CF IIm that was purified over a gelfiltration column. Lane 15 contained CF IIm that
was purified by H. deVries over a Mono S column, fraction 8 of this column was used.
5.2.3 Purified CF IIm is active in tRNA splicing
In order to confirm the hypothesis that CF IIm and the tRNA endonuclease proteins
form a single complex T. Trotta and S. Paushkin carried out tRNA splicing assays
with different fractions of purified CF IIm. The fractions 16 to 26 of the Resource Q
column were active in splicing tRNA (Figure 5.4A) in accordance with the elution






Figure 5.4 tRNA endonuclease activity co-purifies with CF II on the Resource Q column
A)  Upper panel shows a tRNA endonuclease assay (performed by S. Paushkin and C. Trotta) with
fractions of the Resource Q column indicated at the top. FT1-3 stands for reactions incubated with the
flow-through fractions number 1-3 of the RQ column. The migration positions of the free 5’ and 3’
exons, the intron and pre-tRNA are indicated at the left. The lower panel shows the quantitative
evaluation of the cleavage activity of the Resource Q fractions.
B) Western blot analysis of Resource Q column fractions. The numbers of the fractions are indicated at
the top. FT1-3 stands for the flow through fractions of the column. The antibodies used are indicted at
the left.
The gel filtaration fractions number 54 to 64 were also active in tRNA splicing
(Figure 5.5). hClp1 and hPcf11 eluted on this column mainly between the fractions 55
to 58 (Figure 5.2). Therefore, the elution profile of CF IIm subunits and the tRNA
endonuclase activity did not fully overlap suggesting that the two complexes might
not form a single complex. On the other hand, some tRNA endonuclease complexes
might contain CF IIm whereas others might not. This could explain why CF IIm and


















Figure 5.5 tRNA endonuclease activity co-purifies with CF II on the gel filtration column
(performed by S. Paushkin and C. Trotta)
The upper panel shows a tRNA endonuclease assay with fractions of the gel filtration column indicated
at the top. The free 5’ and 3’ exons, the intron and pre-tRNA are indicated at the left. The lower panel
shows the quantitative evaluation of the cleavage activity of the gel filtration column.
As expected, Western blot assays with antibodies directed against hSen2 confirmed,







Figure 5.6 hSen2 protein is present in purified CF II (performed by S. Pauskin and C. Trotta)
Western blot of different fractions of purified CF II after a Resource Q or following a gel filtration
column as indicated on top. The numbers represent the different fraction of the corresponding column.
An antibody directed against hSen2 was used.
5.2.4. His-Flag-hClp1-purified complexes but not His-Flag-hSen
purified complexes are active in pre-mRNA 3’ end cleavage
If the model that tRNA splicing endonuclease proteins and CF IIm are present in a
common complex, then complexes purified with the His-Flag-tagged tRNA
endonuclease subunits should be active in 3’ end cleavage. To test this hypothesis, we
depleted nuclear extract of hPcf11 and tried to reconstitute the cleavage activity with
complexes purified with His-Flag-hClp1 or complexes purified with His-Flag-hSen2
that lacked exon 8 (His-Flag-hSen2∆8), His-Flag-hSen2, or a mutant hSen2 protein
that contained a mutation in the active site, His-Flag-hSen34 or a mutant hSen34
protein that contained a mutation in the active site of the protein or His-Flag-hSen54
(Figure 5.7). However, only the addition of the His-Flag-hClp1-purified complex
could reconstitute the cleavage activity but not the addition of the other complexes.
Mock purifications of HEK293 cells which did not contain any tagged proteins served
as negative controls. We performed the reconstitution assay also with hClp1-depleted
HeLa nuclear extract and got the same results as with the extract depleted of hPcf11
(results not shown).
hSen2
18     19    42    42    57    58
Resource-Q Gel filtration
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Figure 5.7 Complexes purified with His-Flag-tagged hClp1 but not other purified tRNA
endonuclease complexes can reconstitute 3’ end cleavage activity.
3’ end cleavage assay with hPcf11 depleted HeLa nuclear extract and the differently purified
complexes (indicated on top). In the lane labeled with NXT undepleted extract was used in the assay.
ProteinA-S stands for nuclear extract that was mock depleted, and pre-Serum for extract that was
depleted with pre-immune serum. The migration position of the unprocessed pre-mRNA (pre-mRNA)
or the 3’ end cleavage product (3’) is indicated at the left.
Furthermore, Western blot analysis showed that the complexes purified with His-
Flag-hClp1 but not with the His-Flag-hSen proteins contained hPcf11 (Figure 5.8,
upper panel) even though all of them contained hClp1 (Figure 5.8, lower panel). We
did not detect CF Im 68 kDa, CF Im 59kDa, CPSF160, CPSF73 nor CPSF100 in any of
























































































Figure 5.8. His-Flag-hClp-purified complex contains hPcf11
Western Blotting with the differently purified complexes as indicated at the top with antibodies
directed against hPcf11 (upper panel) or hClp1 (lower panel; performed by S. Paushkin and C. Trotta).
293Co and 293M2 correspond to purifications performed with HEK cells that did not contain any
tagged proteins.
In summary, the results indicate that the tRNA endonuclease complex and CF IIm are
not one but rather two distinct complexes. However, it appears that hClp1 is a genuine















































































Paushkin and coworkers proposed a model, suggesting that tRNA splicing and pre-
mRNA 3’ end formation are catalyzed by the same components of an endonuclease
complex in mammalian cells (Pauskin et al., 2004). These authors hypothesized that
this endonuclease complex functions in the formation of mRNA, tRNA and
potentially other RNA substrates. They based this model on the finding that hClp1,
CstF64 and symplekin co-purified with the tRNA splicing complex. Furthermore,
tagged hClp1 pulled down the proteins involved in tRNA splicing and knock down of
hSen2, a subunit of the tRNA endonuclease complex resulted in decrease of tRNA
splicing as well as 3’ end processing activity.
We found that tRNA splicing activity is associated with purified CF IIm but
not with CstF, CPSF or PAP. This is in agreement with the finding that tRNA splicing
proteins were pulled down with tagged hClp1. Furthermore, the elution profile of
hClp1 and hPcf11 after purification of CF IIm on Resource Q overlapped with tRNA
endonuclease acitvity. However, the elution profile of the CF IIm subunits on the gel
filtration column did not fully overlap with the tRNA endonuclease activity. The
proteins started to elute in the same fractions but the endonuclease activity eluted over
more fractions than hClp1 or hPcf11. Given that gel filtration columns separate
complexes according to their size, this could indicate that only a part of the
endonuclease complexes present in a cell are associated with CF IIm. On the other
hand this could also mean that CF IIm and the tRNA endonuclease complex are two
independent complexes of similar sizes. In agreement with the second possibility,
Western blot analysis showed that hPcf11, the second subunit of CF IIm, was only
present in complexes purified with His-Flag-tagged hClp1 but not in the complexes
purified with tagged hSen proteins.
To test if the tRNA endonuclease complexes are active in 3’ end formation we
tested differently purified complexes for their ability to reconstitute CF IIm activity.
Only the complex that was purified with tagged hClp1 but not the complexes purified
with tagged hSen proteins were active in 3’ end cleavage. Taken together, these
results do not support the model in which tRNA splicing endonuclease subunits and
proteins involved in 3’ end processing form a single complex capable of different
processing reactions. However, the data support the model that hClp1 is part of the
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3’ end processing complex as well as a subunit of the tRNA endonuclease complex.
hClp1 contains the Walker A and B motifs, which have been implicated in ATP/GTP
binding (Walker et al., 1982; Saraste et al., 1990). Unpublished UV cross-linking
experiments by Henk deVries suggested that hClp1 indeed binds GTP. It is possible
that hClp1 plays similar roles in the 3’ end formation as well as in the tRNA splicing
complex. Given that both complexes are involved in RNA processing, it is likely that
they could share a subunit that carries out a similar function in both complexes –
potentially its role could be the binding of GTP. This would not be the first example
of a subunit of the 3’ end processing machninery that is found in a different complex
as well. Swd2p was shown to be part of CPF and is also a subunit of the SET-
complex (Dichtl et al., RNA 2004).
CstF64 and symplekin were found to be associated with the tRNA
enodnuclease complex (Paushkin et al., 2004). We did not detect other CPSF or CF Im
subunits in these complexes. At present it is not known whether CstF64 and
symplekin are integral parts of the endonuclease complex or if they are only losely
associated. This question could be addressed by His-Flag tagging and purification of
the two protein.
It was also shown that knock down of hSen2 caused defects in tRNA splicing
and 3’ end processing, implicating that this protein is involved in 3’ end formation
(Paushkin et al., 2004). It is possible that the deficient 3’ end processing observed
upon hSen2 depletion could in fact be caused by a secondary effect. Depletion of
hSen2 did not cause lethality of the cells and therefore stable cell lines in which
hSen2 was permanently knocked down were generated. The effect of this knock down
was analyzed thirty days after initial silencing of the gene – therefore after a relatively
long period of time, during which many secondary effects of the knock down could
have accumulated. Furthermore, the 50% knock down of the hSen2 protein was not
lethal. Given that 3’ end processing in yeast is essential one would expect that knock
down of a protein involved in 3’ end formation in human cells would also lead to cell
death. It is a possibility that 50% of the hSen2 protein level normally found in cells
could be sufficient for survival. However, taking all the results into consideration we
think that it is unlikely that hSen2 is directly involved in 3’ end processing.
We suggest that hClp1 is part of the tRNA splicing endonuclease complex as
well as a subunit of CF IIm. We cannot exclude the possibility that the tRNA
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endonuclease complex functions in the formation of mRNA but we think the results
supporting this hypothesis are rather weak.
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5.4 Experimental procedures
5.4.1 Purification of CF IIm
The CF IIm containing fractions of the Mono Q column were pooled and dialyzed
against Buffer A containing: 25 mM (NH4)2SO4, 20 mM Hepes-KOH pH. 7.9, 0.4
mM EDTA pH. 8.0, 0.02% NP40, 10% Glycerol, 3 mM MgCl2, 0,5 mM DTT, 1 mM
PMSF, 2 µg/ml Pepestatin, 2 µg/ml Leupeptin. A 8 ml Mono S HP10/10 column was
washed with 2 M KCl, Buffer B (same as Buffer A but containing 380 mM
(NH4)2SO4) followed by Buffer A. The pooled fractions were loaded, the column
washed with 40 ml Buffer A and the proteins eluted by a gradient that started with
Buffer A and ended after 160 ml with Buffer B. The fractions containing CF IIm were
identified by western blotting, pooled and dialysed against Buffer C containing: 20
mM (NH4)2SO4, 50 mM Tris-HCl pH 7.9, 10% Glycerol, 0.02% NP40, 0.5 mM
EDTA, 3 mM Mg, 0.5 mM DTT, 1 mM PMSF, 2 µg/ml Pepestatin, 2 µg/ml
Leupeptin.
A 6 ml Resource Q column (Pharmacia) was washed with 12 mM Buffer C,
followed by 12 ml Buffer D containing the same ingredients as Buffer C but 300 mM
(NH4)2SO4 instead of 20 mM (NH4)2SO4, and finally the column was washed with 30
ml Buffer C again. The pooled and dialysed Mono S fractions were loaded, the
column washed with 30 mM Buffer C and the proteins eluted with a gradient of 120
ml ranging from Buffer C to Buffer D.
A Superdex 200 16/60 (Pharmacia) was washed with 2 ml 2 M KCl followed
by overnight washing with Buffer A containing 30 mM (NH4)2SO4 instead of 25 mM
(NH4)2SO4. 1 ml of fracition 19 of the Resource Q column was loaded onto the gel
filtration column and 50 µl fractions collected.
5.4.2 3’ end cleavage reaction
15 fmol RNA substrate was incubated with 3 µl HeLa cell nuclear extract, and in case
of the reconstitution reactions with 6 µl of the different complexes, in a final
concentration of: 2 mM DTT, 0.2 U RNA guard,  2.6% Polyvinylalcohol, 0.01%
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NP40, 0.01 µg/µl Cratin Kinase, 20 mM Creatin Phosphate, 0.5 mM cordycepin, 1
mM MgCl2 and 0.1 µg/µ l tRNA in a final volume of 25 µl. The reaction was
incubated at 30°C for one hour. 1,5 ml Proteinase K buffer (200 mM Tris HCl pH 7.9,
300 mM NaCl, 25 mM EDTA pH 8.0, 2 % SDS), 60 µl Proteinase K (10 mg/ml), 7.5
µl Glykogen (20 mg/ml; Boehringer) and 682.5 µl H2O was combined and 75 µl
given to the reaction. The mixture was incubated at 42°C in order to digest the
proteins. The RNA was precipitated by addition of 250 µl 100% ethanol and
zetrifugation at 14 k for 30 min. The RNA was washed with 70% ethanol, dried,
resuspended in 6 µl RNA lading dye (FA; 95% formamide, 20 mM EDTA, 0.05%
bromphenolblue, 0.05%xylencyanol) and run on a 10% polyacrylamide / 8.3 M urea
gel.
5.4.3 Purification of tRNA endonuclease complexes and tRNA
endonuclease assay
Purification of the tRNA enodonuclease complexes and the tRNA endonuclease
assays were performed as described in (Paushkin et al., 2004).
5.4.4 Western blot analysis
25 µl of the different complexes were run on a 10% SDS gel, the proteins transferred
to nitrocellulose and analyzed by the antibodies indicated in each figure.
134
Chapter 6: The role of the yeast cleavage and polyadenylation factor
subunit Ydh1p/Cft2p in pre-mRNA 3’ end formation




6.3.1 Ydh1p is required for cleavage and polyadenylation in vitro 138
6.3.2 mRNAs are unstable in ydh1  mutant strains at restrictive
temperature 142
6.3.3 Ydh1p is required for poly(A) site selection of ACT1 pre-mRNA 142
6.3.4 Ydh1p interacts with the C-terminal domain of RNA polymerase II 145
6.3.5 Ydh1p interacts with other subunits of CPF and with Pcf11p, a
subunit of CF IA 147
6.4 Discussion 149
6.5 Experimental procedures 152
6.5.1 Yeast strains 152
6.5.2 Plasmids and primers 153
6.5.3 Expression of recombinant proteins in E. coli 154
6.5.4 Protein-protein interactions 154
6.5.5 Extract preparation and in vitro cleavage and polyadenylation
assays 155
6.5.6 RNA analyses 155
6.5.7 Protein extraction for Western blotting 155
135
6.1 Abstract
Cleavage and polyadenylation factor (CPF) is a multi-protein complex that functions
in pre-mRNA 3’ end formation and in the RNA polymerase II (RNAP II)
transcription cycle. Ydh1p/Cft2p is an essential component of CPF but its precise role
in 3’ end processing remained unclear. We found that mutations in YDH1 inhibited
both the cleavage and the polyadenylation steps of the 3’ end formation reaction in
vitro. Recently, we demonstrated that an important function of CPF lies in the
recognition of poly(A) site sequences and RNA binding analyses suggested that
Ydh1p/Cft2p interacts with the poly(A) site region. Here we show that mutant ydh1
strains are deficient in the recognition of the ACT1 cleavage site in vivo. The C-
terminal domain (CTD) of RNAP II plays a major role in coupling 3’ end processing
and transcription. We provide evidence that Ydh1p/Cft2p interacts with the CTD of
RNAP II, several other subunits of CPF and with Pcf11p, a component of CF IA. We
propose that Ydh1p/Cft2p contributes to the formation of important interaction
surfaces that mediate the dynamic association of CPF with RNAP II, the recognition
of poly(A) site sequences and the assembly of the polyadenylation machinery on the
RNA substrate.
6.2 Introduction
All eukaryotic mRNA precursors (pre-mRNA) are extensively modified before they
can serve as templates for protein synthesis. Pre-mRNA 3’ end processing is initiated
by endonucleolytic cleavage at the poly(A) site. Subsequently, the upstream cleavage
product is polyadenylated whereas the downstream fragment is rapidly degraded (for
review see (Zhao et al., 1999a). The yeast 3’ end processing reaction can be
reconstituted in vitro with the cleavage and polyadenylation factor IA (CF IA),
cleavage and polyadenylation factor IB (CF IB), cleavage and polyadenylation factor
(CPF) and the poly(A) binding protein (Pab1p; Chen and Moore, 1992; Ohnacker et
al., 2000). Interactions between their subunits allow bridging of the different factors
and ensure their coordinated action on the substrate. So far the CPF components
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Fip1p and Pfs2p were shown to bridge CPF with CF IA by interacting with Rna14p, a
subunit of CF IA ( Preker et al., 1995; Ohnacker et al., 2000). A table of the factors
involved in 3’ end processing and their subunits is provided as supplementary
material.
The polyadenylation signals that guide the processing machinery in yeast are
redundant and more degenerate compared to the well-conserved sequences in higher
eukaryotes. Still, conserved elements can be found, which are the efficiency element
(EE), the positioning element (PE), the poly(A) site and U-rich sequences. The EE is
located at variable distances upstream of the cleavage site (Graber et al., 1999). The
PE is often found approximately 20 nucleotides upstream of the cleavage site and
consists of an A-rich sequence (Russo et al., 1991). U-rich regions, located directly
upstream and downstream of the cleavage site, and the poly(A) site itself act in
concert to produce multiple recognition sites (Guo and Sherman, 1996; Graber et al.,
1999; van Helden et al., 2000; Dichtl and Keller, 2001).
RNase H protection mapping experiments with a CYC1 pre-mRNA suggested
that CPF is involved in the recognition of the poly(A) site by specific interactions of
its subunits Yhh1p/Cft1p, Ydh1p/Cft2p and Yth1p with sequences surrounding the
poly(A) site (Barabino et al., 2000; Dichtl and Keller, 2001). Nab4p/Hrp1p (CF IB)
binds to the EE ( Kessler et al., 1997; Chen et al., 1998) and through interaction with
Rna14p, possibly enables CF IA to bind to the PE (Gross and Moore, 2001b).
However, it was also reported that Nab4p/Hrp1p (Minvielle-Sebastia et al., 1998) as
well as the PE and EE (Dichtl and Keller, 2001) are not essential for cleavage in vitro,
underscoring the importance of the poly(A) site region itself.
The yeast and mammalian 3’ end processing factors are highly homologous
(reviewed in Shatkin and Manley, 2000). In mammals cleavage and polyadenylation
specificity factor (CPSF) contributes to poly(A) site selection by binding to the well
conserved AAUAAA element upstream of the cleavage site (Keller et al., 1991);
CPSF 160 and possibly additional CPSF subunits are thought to mediate specific
interactions to the RNA (Murthy and Manley, 1995). The binding of purified CPSF is
weak, but is strongly enhanced by a cooperative interaction with cleavage stimulation
factor (CstF) bound to the downstream elements (Wilusz and Shenk, 1990; Gilmartin
and Nevins, 1991; MacDonald et al., 1994).
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Transcription by RNA polymerase II (RNAP II) and pre-mRNA processing
reactions are coupled events (reviewed in (Bentley, 2002; Proudfoot et al., 2002;
Howe, 2002; Proudfoot and O'Sullivan, 2002). The C-terminal domain (CTD) of
RNAP II plays a central role in linking the processing reactions to transcription.
Current models suggest that the CTD is hypo-phosphorylated during transcription
initiation and that escape of RNAP II into the elongation phase is accompanied by
phosphorylation of the CTD. It has been proposed that the change in charge upon
phosphorylation enables proteins involved in pre-mRNA processing to bind to the
CTD (Komarnitsky et al., 2000; Cho, 2001; Licatalosi et al., 2002). This includes
proteins involved in capping (McCracken et al., 1997; Cho et al., 1997; Ho et al.,
1998), splicing (Yuryev et al., 1996) and 3’end formation (McCracken et al., 1997;
Rodriguez et al., 2000; Barilla et al., 2001; Fong and Bentley, 2001; Dichtl et al.,
2002b; Licatalosi et al., 2002). It is assumed that the assembled proteins subsequently
travel with the elongating RNAP II during transcription and act on the nascent RNA
transcript.
In mammals the CTD was suggested to play a direct role in 3’end cleavage in
vivo (McCracken et al., 1997) and in vitro (Hirose and Manley, 1998; Ryan et al.,
2002). Experiments in yeast provided evidence that transcription in the absence of the
CTD was accompanied by a reduction of cleavage efficiency and the resulting
mRNAs had shorter poly(A) tails (Licatalosi et al., 2002; McNeil et al., 1998).
Correct transcription termination requires a functional poly(A) signal in all organisms
(Tran et al., 2001; Orozco et al., 2002), reviewed in (Proudfoot, 1989) and yeast
strains carrying mutations in CPF and CF IA were shown to be deficient in correct
transcription termination, indicating the coupling between 3’end processing and
transcription termination (Birse et al., 1998; Barilla et al., 2001; Dichtl et al., 2002a;
Dichtl et al., 2002b; Hammell et al., 2002; Sadowski et al., 2003). Furthermore,
correct transcriptional termination was found to require the transcription factors
Sub1p (Calvo and Manley, 2001) and Res2p (Aranda and Proudfoot, 2001) and
chromatin remodeling factors (Alen et al., 2002). The Nrd1p complex was shown to
be required for correct termination at snoRNA genes (Steinmetz et al., 2001).
Ydh1p/Cft2p (which will be referred to as Ydh1p in the remainder of this
paper) is the 105 kDa subunit of CPF. It shares 24.4% identity and 43% similarity
with the mammalian CPSF-100 protein. It is also significantly related to Ysh1p and to
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CPSF-73 (Jenny et al., 1996). Ydh1p is essential for cell viability (Preker et al., 1997)
and was shown to bind RNA (Zhao et al., 1997). RNase H protection experiments
suggested that the protein interacts with the poly(A) site region (Dichtl and Keller,
2001). Here, we show that Ydh1p is required for cleavage and polyadenylation in
vitro and for poly(A) site recognition in vivo. Furthermore, we provide evidence that
Ydh1p interacts with several subunits of CPF, with Pcf11p, a subunit of CF IA, and
with the CTD of RNAP II. The results suggest that Ydh1p is part of an interaction
surface that mediates important contacts with CF IA, the CTD of RNAP II and the
pre-mRNA substrate.
6.3 Results
6.3.1 Ydh1p is required for cleavage and polyadenylation in vitro
In order to investigate the role of Ydh1p in 3’end processing we generated
temperature sensitive ydh1 alleles (see Materials and Methods). Figure 6.1A shows
growth curves of ydh1 mutant and isogenic wild-type cells following shift from 25°C
to 37°C. The ydh1-1 strain displayed growth arrest at 37°C after 3 hours whereas the
strains ydh1-2 and ydh1-3 ceased growth after approximately 5 hours. A drop-test
revealed that the mutant strains did not form colonies at the restrictive temperature
(Figure 6.1B).
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Figure 6.1 YDH1 mutant strains display a temperature sensitive phenotype
A) Growth curves of wild-type and mutant ydh1 strains at 37°C.
B) Ten-fold serial dilution of cultures spotted on YPD plates followed by incubation at the indicated
temperature for two days.
Next, we analyzed whether mutations in YDH1 affect cleavage and polyadenylation in
vitro and tested extracts from wild-type, ydh1-1, ydh1-2 and ydh1-3 cells for their
ability to cleave a synthetic CYC1 pre-mRNA (Figure 6.2A). Extracts from wild-type
(lanes 2 and 6), ydh1-2 (lanes 4 and 8) and ydh1-3 cells (lanes 5 and 9) accurately
cleaved the substrate RNA at 30°C and 34°C. Notably, ydh1-3 extract (lane 9)
showed a reduced efficiency of cleavage at 34°C compared to wild-type (lane 6). In
contrast, extract of ydh1-1 cells was deficient in cleavage at either temperature (lanes
3 and 7).
To show that the deficiency in cleaving the RNA substrate is due to inactive
Ydh1p or CPF, respectively, we carried out reconstitution assays either with extract
which is mutant in a CF IA subunit (rna15-1) or with purified factors at 30°C (Figure























extract (lane 4) or purified CPF (lane 6) but not by addition of purified CF IA (lane
7). As expected, the rna15-1 extract on its own lacked cleavage activity (lane 5;
(Minvielle-Sebastia et al., 1994) and purified CPF and CF IA alone were not able to
cleave the substrate (lanes 8 and 9); cleavage occurred at specific and at cryptic sites
when both factors were added to the reaction (lane 10); site-specific cleavage was
obtained by including CF IB in the reaction (lane 11; Minvielle-Sebastia et al., 1998).
Next we analyzed whether mutations in YDH1 affect the polyadenylation reaction of
pre-cleaved CYC1 substrate (CYC1-Pre) in vitro (Figure 6.2.C). No polyadenylation
activity could be observed in ydh1-1 extract at 30°C and 34°C (lanes 3 and 7). In
contrast, the ydh1-2 and ydh1-3 extracts specifically and efficiently polyadenylated
the substrate at both temperatures (lanes 4, 5, 8 and 9) comparable to wild-type (lanes
2 and 6). Specific polyadenylation activity was restored in ydh1-1 extract by addition
of purified CPF (Figure 6.2D, lane 4) but not by addition of purified CF IA (lane 5).
As shown before, CPF by itself unspecifically polyadenylated the substrate (lane 6;
(Ohnacker et al., 2000), whereas CF IA alone displayed no polyadenylation activity
(lane 7). Specific polyadenylation activity was restored upon combination of CPF, CF
IA, CF IB and Pab1p (lane 8).
Notably, addition of 100 to 250 ng recombinantly expressed Ydh1p failed to
reconstitute the cleavage and polyadenylation activities in ydh1-1 extract, possibly
because the recombinant protein was not able to replace its mutant counterpart in the
CPF complex (results not shown).
The above results showed that the ydh1-1 extract was strongly reduced in
cleavage and polyadenylation activities in vitro and that both activities could be
reconstituted by addition of purified CPF. Furthermore, the cleavage activity of the
ydh1-3 mutant was lower at 34°C compared to 30°C. The results indicate that Ydh1p
is involved in both steps of the 3’ end processing reaction.
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Figure 6.2 Ydh1p is required for cleavage and polyadenylation in vitro.
In vitro analysis of cleavage (A and B) and polyadenylation activities (C and D) of ydh1 mutant
extracts. Input lanes (1) represent mock-treated reactions. The migration positions of the CYC1 and
CYC1-precleaved (CYC1-Pre) RNA substrate, specific (5’ and 3’) and cryptic (asterisks) cleavage
products and the polyadenylation products [Poly(A)] are indicated on the right of each panel. The
position and size (in number of nucleotides) of the marker bands are indicated on the left.
A) Extracts prepared from yeast strains as indicated on top were monitored for their ability to cleave
internally 32P-labelled CYC1 RNA substrate at 30°C and 34°C.
B) Reconstitution of cleavage activity in ydh1-1 extract at 30°C. As indicated on top, ydh1-1 extract
was combined with equal amounts of rna15-1 extract (lane 4), purified CPF (lane 6) or CF IA (lane 7).
C) Specific polyadenylation was analysed at 30° and 34°C with internally 32P-labelled precleaved
CYC1 RNA substrate that ends at the natural poly(A) site.
D) Reconstitution of specific polyadenylation activity in ydh1-1 extract at 30°C. ydh1-1 extract was



























































































































































































6.3.2 mRNAs are unstable in ydh1 mutant strains at restrictive
temperature
mRNAs without poly(A) tails are rapidly degraded in living cells. Yeast strains with a
3’ end processing deficiency are therefore expected to under-accumulate mRNAs
after shift to the restrictive temperature. For this reason, we performed Northern blot
analyses on total RNA extracted from strains grown at 25°C and after shift to 37°C
(Figure 6.3A). The amount of 18S rRNA served as control for the loading of the RNA
(panel VI). ADH1, ACT1, CYH2 and CYC1 mRNA levels diminished in the ydh1-1
mutant cells after two hours shift to 37°C (panels I-IV, lanes 3-6). The level of the
stable PGK1 mRNA (t1/2 = 45 min) dropped significantly only after the cells were
shifted to 37°C for 6 hours (panel V, lanes 3-6). In comparison the ADH1, ACT1,
CYH2 and CYC1 mRNA levels of the ydh1-2 mutant strain did only drop slightly after
4 hours and the PGK1 mRNA level remained stable even after shift to 37°C for 6
hours (panels I-V, lanes 7-10). The mutant strain ydh1-3 under-accumulated ACT1
mRNA already after 2 hours at 37°C; ADH1, CYH2 and CYC1 mRNA levels were
reduced after 4 hours (panels I-IV, lanes 11-14). The PGK1 mRNA level showed a
slight decrease after 4 hours and more so after 6 hours (panel V, lanes 11-14). The
RNA polymerase II transcribed U24, U14 and snR13 snoRNAs were stable in all
mutants tested, even after shift to 37°C for 6 hours (panels VII to IX), indicating that
snoRNA processing was not affected in ydh1 mutant strains. These results showed
that ydh1 mutant strains under-accumulated mRNAs at restrictive temperature. The
ydh1 mutant phenotypes are possibly due to a deficiency of the strains in poly(A) site
recognition (see below) which might impair the efficiency in 3’ end processing.
6.3.3 Ydh1p is required for poly(A) site selection of ACT1 pre-mRNA
The previous observation that Ydh1p binds RNA around the poly(A) site (Dichtl and
Keller, 2001), raised the possibility that the protein is required for poly(A) site
recognition. To test this, we analyzed poly(A) site usage of ACT1 pre-mRNA in wild-
type and mutant cells (Mandart and Parker, 1995). The ACT1 3’ untranslated region
(UTR) contains at least four polyadenylation sites, of which the most proximal one
(site I) is used with highest frequency in wild-type cells (Figure 6.3B; lanes 1 and 2).
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All tested ydh1 mutants used site I three times more often then site IV at 25°C (lanes
3, 5 and 7). At restrictive temperature, however, processing shifted from site I towards
site IV in a ratio of 1:1 in ydh1-1 and ydh1-3 cells (lanes 4 and 8); the ydh1-2 mutant
showed a ratio of 2:1 (lane 6). These results indicated that mutations in ydh1-1, ydh1-
2 and ydh1-3 impair poly(A) site recognition in vivo. To verify that the ACT1 mRNAs
were polyadenylated we incubated the reactions with RNase H and the oligos ACT1-
RnaseH and dT to digest the poly(A) tails. This resulted in a slight downward shift
and sharpening of the RNA bands. This showed that the ACT1 mRNAs were
polyadenylated (results not shown).
Western blot analyses were carried out to test whether the observed
phenotypes were the result of an under-accumulation of Ydh1p or other subunits of
the 3’ end processing machinery (Figure 6.3C). As control, purified CPF or CF IA
were analyzed in parallel (lane 1). In wild-type and ydh1-2 cells Ydh1p was stable
even after 6 hours at 37˚C (panel I, lane 2, 3, 7-9), whereas it was reduced in ydh1-1
and ydh1-3 cells after 3 hours at at 37˚C (lanes 5, 6, 11 and 12). Ysh1p/Brr5p, Pfs2p
and Ssu72p (panels II, IV and VII) under-accumulated in ydh1-1 and ydh1-3 cells
after 6 hours at 37˚C (lanes 6 and 12). The levels of Pap1p, Fip1p and Yth1p were
constant even after 6 hours at 37˚C (panels III, V, VI). In addition, mutations in YDH1
did not affect the levels of the CF IA subunits Rna14p and Rna15p (panels VIII, IX).
These results indicated that the defects observed in the ydh1 mutant strains
might be caused by a destabilization of the Ydh1p protein. Since the destabilization at
restrictive temperature of Ysh1p/Brr5p, Pfs2p and Ssu72p was detectable at later
time-points compared to the appearance of phenotypes (see Northern blot and ACT1
poly(A) site selection), we consider it unlikely that lower levels of factors other than
Ydh1p are responsible for the deficiencies of the ydh1 mutant cells.
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Figure 6.3 mRNAs are unstable in ydh1 mutant strains at restrictive temperature and the mutant
strains are deficient in the recognition of ACT1 poly(A) site in vivo
A) Northern analysis of total RNA extracted from wild-type and mutant ydh1 cells grown at 23°C, or
after shift to 37°C for 2, 4 and 6 hours as indicated on top of each lane. The RNAs were separated on
formaldehyde/1.2% agarose gels (panels I-VI) or 8.3 M urea/8% polyacrylamide gels (panels VII-IX).
The filters were developed with random-primed labeled probe (panel I-V) or end-labeled
oligonucleotides (panels VI to IX) directed against the RNA species indicated at the right of each
panel.
B) Analysis of ACT1 poly(A) site usage in wild-type and mutant ydh1 cells. The drawing on the right
shows the relative positions of the different poly(A) sites. Total RNA extracted from wild-type and
mutant ydh1 cells after growth at 23°C, or following shift to 37°C as indicated on top of each lane, was
treated with an oligonucleotide complementary to the 3’ region of the ACT1-mRNA (ACT1-RnaseH)
and RNaseH. The RNAs were separated on an 8 M urea/6% polyacrylamide gel and the filters were
incubated with random primed labeled probe directed against the 3’ end of the ACT1 mRNA. RNA
levels were quantified by PhosphorImager scanning (Molecular Dynamics); the ratios of poly(A) site I
: site IV usage for each lane are indicated at the bottom.
C) Western analysis of wild-type and ydh1 mutant extracts prepared from cells grown at 23°C, or after
shift to 37°C for 3 and 6 hours. Equal amounts of total protein were loaded in each lane. Lane 1 shows
purified CPF (panels I-VII) and CF IA (panels (VIII and IX). The filters were treated with antibodies
directed against the proteins indicated at the right.
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6.3.4 Ydh1p interacts with the C-terminal domain of RNA
polymerase II
The CTD of RNAP II plays an important role in coupling transcription and 3’ end
formation (reviewed in (Proudfoot and O'Sullivan, 2002; Bentley, 2002). We were
interested whether Ydh1p contributes to this process by physically interacting with
the CTD. To test this, we carried out GAL4 based yeast two hybrid tests and assayed
for the activation of expression of the HIS3 and lacZ reporter genes. Strain Y190 was
co-transformed with plasmids carrying the GAL4 DNA binding domain fused to the
CTD (pBD-CTD) and the GAL4 activation domain fused to test genes. As positive
controls we analyzed the known CTD interactors YHH1/BRR5 (pACT2-YHH1) and
PCF11 (pACT2-PCF11) (Dichtl et al., 2002b; Licatalosi et al., 2002; Sadowski et al.,
2003) and pACT2-YSH1 as negative control. As shown in Figure 6.4A the plasmids
carrying YDH1, YHH1 and PCF11 in combination with the plasmid pBD-CTD
enabled cells to grow on medium lacking histidine under stringent conditions (in the
presence of 35 mM 3’-aminotriazole). In contrast, no growth was observed with
pACT2-YSH1 or when empty pBD and pACT2 plasmids were tested.  These results
were confirmed by an X-Gal filter lift assay, which monitors β-galactosidase
expression (results not shown). Thus, YDH1 showed a two-hybrid interaction with the
CTD of RNAP II.
To confirm that Ydh1p interacts with the CTD, and to test whether this
interaction is influenced by the phosphorylation state of the CTD we performed GST
pull-down experiments with in vitro translated radioactively labeled proteins and
recombinant GST-CTD fusion protein. Ydh1p interacted with the CTD (Figure 6.4B,
lane 3) and this interaction was enhanced upon phosphorylation of the CTD (lane 4);
no signal was observed with GST alone (lane 2). Ysh1p/Cft1p interacted with neither
form of the GST-CTD protein. These results suggested that Ydh1p binds the CTD and
that the interaction is enhanced upon phosphorylation of the CTD.
Correct transcription termination by RNAP II requires a functional poly(A)
site on the nascent RNA and the CTD plays an important role in coupling
transcription and pre-mRNA processing (reviewed in Proudfoot, 1989). The
observations that Ydh1p is involved in poly(A) site recognition and that it interacted
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with the CTD raised the possibility that Ydh1p might also be involved in
transcriptional termination. Therefore, we carried out transcriptional run-on analysis
with the well-characterized GAL1/10 controlled CYC1 gene in vivo (Birse et al.,
1998). We did not observe a significantly increased RNAP II density downstream of
the CYC1 terminator in ydh1-1 and ydh1-3 cells grown at 25°C or following shift to
37°C compared to wild-type (results not shown). Similarly, we did not detect the
accumulation of read-through products in ydh1 strains in reverse transcription
experiments with primers annealing downstream of the cleavage site of different
snoRNA species (snR39b, snR45, snR3, snR50, snR71; (Steinmetz et al., 2001). This
suggested that Ydh1p is not generally required for termination of RNAP II during
transcription of pre-mRNAs and snoRNAs.
Figure 6.4 Ydh1p interacts with the CTD of RNAP II
A) GAL4 based two hybrid analysis. Y190  cells were co-transformed with a plasmid encoding the
GAL4 DNA binding domain fused to the CTD (pBD-CTD) and plasmids (pACT2) encoding the GAL4
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activation domain fused to the genes indicated. Transformants were tested for expression of the HIS3
reporter gene on medium lacking histidine, and containing 35 mM 3-amino-1,2,4-triazole. As control,
pBD CTD was co-transformed with the empty pACT2 plasmid respectively pACT2-YDH1 with the
empty pBD plasmid.
B) Pull-down experiments with 1 µg GST (lane 2), GST-CTD (lane 3) and phosphorylated GST-CTD
(lane 4) and in vitro translated, [35S]methionine labeled proteins (indicated on the left). Lane 1 shows
10% of the in vitro translated reactions used in the assay. Bound proteins were separated by SDS-
PAGE and visualized by autoradiography.
6.3.5 Ydh1p interacts with other subunits of CPF and with Pcf11p, a
subunit of CF IA
As Ydh1p is part of a multi-protein complex we were interested to examine with
which of the other CPF subunits the protein interacts. Therefore, we expressed a N-
terminally GST-tagged and C-terminally His-tagged version of the Ydh1 protein (G-
Ydh1-H) in E. coli and carried out GST pull-down experiments with radioactively
labeled in vitro translated proteins. As shown in Figure 6.5A, G-Ydh1-H interacted
with itself and with the CPF subunits Yhh1p/Cft1, Ysh1p/Brr5p, Pta1p, Pfs2p,
Ssu72p, YDL094cp (panels I – VII) and the CF IA subunit Pcf11p (panel X). G-
Ydh1-H did not pull-down the CPF subunits Fip1p and Yth1p (panels VII and IX) nor
the CF IA subunits Rna14p, Clp1p and Rna15p (panels XI – XIII), Nab4p/Hrp1 (CF
IB) or Pab1p (panels XIV and XV). Since we identified a large number of potential
Ydh1p interaction partners, we decided to investigate whether these interactions were
specific and therefore assignable to distinct regions of Ydh1p. For this purpose the
pull-downs were repeated with C-terminally truncated Ydh1p proteins (Figure 6.5B).
Figure 6.5A shows that the very C-terminus was required for interaction of Ydh1p
with itself (panel II) as most of the interaction was lost upon deletion of the C-
terminal 137 amino acids. The N-terminal 246 amino acids were sufficient for
interaction with Pfs2p (panel V) and central protein sequences most likely mediated
interactions with Yhh1p/Cft1p, Ysh1p/Brr5p, Pta1p, Ssu72, pYDL094c and Pcf11p
(panels I, III, IV, VI, VII and X). These results suggested that the Ydh1p subunit
might contribute to the stability and structural order of CPF and bridges the two
factors CPF and CF IA.
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Figure 6.5.Ydh1p interacts with other subunits of CPF and with Pcf11p, a subunit of CF IA
A) GST pull-down experiments with 0.5 µg GST, 100 ng G-Ydh1-H (Ydh1p) or 100 ng of the different
C-terminally truncated, GST-tagged Ydh1 fragments (as indicated on top of each lane) and in vitro
translated, [35S]methionine labeled proteins (indicated on the right). The first lane shows 10% of the in
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B) Schematic drawing of the full length and C-terminal truncations of Ydh1p. The numbers indicate
the length of the constructs in amino acids.
C) GST pull-down experiment with GST-tagged recombinant proteins (indicated on top of each lane)
and in vitro translated, [35S]methionine labeled proteins (indicated on the right).
D) Model of protein-protein interaction surface (not all CPF subunits and protein interactions are
shown).
To obtain a better understanding of how CPF interacts with CF IA we decided to
assay for further interactions between the two factors. Figure 6.5C shows a GST pull-
down with in vitro translated protein and GST-tagged recombinant proteins. Of the
analyzed CPF subunits we found that only Yhh1p/Cft1p interacted strongly with
Rna14p. Yhh1p/Cft1p also bound to Pcf11p and more weakly to Clp1p (lane 3).
Ydh1p pulled-down only Pcf11p (lane 4). Ysh1p/Brr5p interacted strongly with
Clp1p and Pcf11p (lane 5). A weak signal was observed for the interaction between
Pta1p and Pcf11p (lane 6).
These results suggested that Ydh1p, Yhh1p/Cft1p, Ysh1p/Brr5p and possibly also
Pta1p are involved in forming a protein-protein interaction surface between CPF and
CF IA. Our combined results indicate that Ydh1p plays an important role in
determining the RNA binding specificity of CPF and in the assembly of the 3’ end
formation machinery and its tethering to RNAP II.
6.4 Discussion
The yeast and mammalian 3’ end formation machineries display a surprisingly
complex subunit composition. At present up to twenty polypeptides are known that
constitute the factors that catalyze the yeast 3’ end formation reaction in vitro (Gavin
et al., 2002; Dichtl et al., 2002b). The ongoing characterization of the components
suggests distinct and specialized tasks of the individual polypeptides in both steps of
the 3’ end processing reaction as well as in the coupling of 3’ end formation to
transcription. In this work we characterized the role of the yeast CPF subunit Ydh1p
in these processes.
To analyze if Ydh1p is necessary for cleavage and polyadenylation we
produced conditional ydh1 mutant strains and carried out in vitro assays. The
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experiments revealed a deficiency of the mutant extracts in both steps of the 3’ end
processing reaction. The activity could be rescued upon addition of purified CPF.
mRNAs without a poly(A) tail are prone to rapid degradation in vivo. Northern
analysis revealed that the levels of a number of different mRNAs were reduced at
restrictive temperature in Ydh1p mutants. The results support a requirement for
Ydh1p in both steps of 3’ end processing. However, we do not expect Ydh1p to be
directly involved in the catalysis of the 3’ end processing reaction, because it took
several hours at the restrictive temperature before the mRNA levels were reduced.
Furthermore, the ACT1 poly(A) site selection assay revealed that a substantial amount
of pre-mRNA appeared to be cleaved and polyadenylated in vivo at the restrictive
temperature in all mutants.
We reported previously that Ydh1p binds to a CYC1 pre-mRNA around the
poly(A) site; this suggested a role for the protein in poly(A) site selection (Dichtl and
Keller, 2001). Here we show that Ydh1p is involved in poly(A) site selection of ACT1
pre-mRNA in vivo, as all analyzed ydh1 mutant strains displayed more frequent use of
alternative poly(A) sites compared to the wild-type strain. These results underscore
our previously postulated model that Ydh1p contributes to poly(A) site selection
(Dichtl and Keller, 2001). In contrast to mammalian polyadenylation signals, the cis
acting sequences in yeast are highly degenerate (reviewed in Zhao et al., 1999a; Guo
and Sherman, 1995). We proposed that the RNA binding subunits of CPF act in
concert to achieve specific recognition of the correct poly(A) site (Dichtl and Keller,
2001). The preferential use of cleavage sites located downstream of the major site in
Ydh1 mutants may be caused by the coupling of transcription elongation and 3’ end
processing. Reduced RNA binding efficiency of CPF containing mutant Ydh1p could
lead to skipping of the first cleavage site of the nascent pre-mRNA emerging from the
elongating RNAP II. Ydh1p (Dichtl and Keller, 2001), Yhh1p/Cft1p (Dichtl et al.,
2002b) and Yth1p (Barabino et al., 2000) were shown to bind preferentially to U-rich
elements localized directly upsteam and downstream of the poly(A) site, thus
colocalizing with the region to which the complete CPF factor binds (Dichtl and
Keller, 2001). These interactions with the RNA substrate are thought to be crucial for
poly(A) site selection and for cleavage activity. Thus, the observed in vitro cleavage
deficiency of the ydh1 mutant cells might result from insufficient poly(A) site
selection. It remains to be determined how Ydh1p interacts with RNA. The primary
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sequence of the protein does not display any clear similarities to known RNA binding
domains. Preliminary RNA binding experiments with portions of Ydh1p indicated
that the RNA binding activity is distributed throughout the entire length of the protein
(results not shown). However, detailed analyses have not been done yet. Interestingly,
RNA binding activity has not been demonstrated for the mammalian homologue of
Ydh1p, CPSF 100 kDa. Considering the highly conserved cis acting elements in
mammalian pre-mRNAs (reviewed in Zhao et al., 1999a) it seems possible that a
smaller set of proteins is sufficient for specific poly(A) site recognition, whereas in
yeast a cooperative interplay of more RNA binding proteins is required to recognize
the more degenerate sequence elements in a specific fashion.
We have shown that Ydh1p interacted with the CTD of RNAP II both in a
two-hybrid test and in a GST pull-down assay. This interaction was enhanced upon
phosphorylation of the CTD. The only other CPF subunit found to interact with the
phosphorylated CTD is Yhh1p/Cft1p (Dichtl et al., 2002b). We suggest that Ydh1p
might be involved in tethering CPF to transcribing RNAP II and thereby contributes
to the coupling of 3’ end processing and transcription. However, the ydh1 mutants did
not reveal a defect in transcriptional termination at the CYC1 terminator. As this was
the only pre-mRNA that was tested by transcriptional run-on analysis we cannot
exclude that Ydh1p might be involved in transcriptional termination of other genes.
Moreover, reverse transcription analysis on snoRNAs in ydh1 mutant strains did not
reveal 3’ extended transcripts, indicating that Ydh1p was not required for snoRNA
termination either. We propose that Ydh1p helps to tether CPF to elongating RNAP II
but that it is not needed for general transcription termination. Ydh1p and Yhh1p/Cft1p
show a phenotypic similarity in that both proteins bind RNA, are involved in poly(A)
site recognition and bind to the CTD (Dichtl et al., 2002b). However, the observation
that mutants in yhh1 are severely impaired in transcription termination at the CYC1
gene (Dichtl et al., 2002b) whereas ydh1 mutants have no general termination defect,
indicates that the functional roles of the individual 3’ end formation factor subunits
can be substantially different.
It is not well understood how the subunits of the CPF and CF IA factors
assemble to form functional 3’ end processing complexes on the RNA substrate. CPF
consists of up to fifteen polypeptides, which interact with each other and form a stable
factor. We found that Ydh1p interacted with the CPF subunits Yhh1p/Cft1p,
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Ysh1p/Brr5p, Pta1p, Pfs2p, Ssu72p, and pYDL094c. These many interactions
indicate that the protein contributes substantially to the assembly and structural order
of the CPF factor. Strikingly, Ydh1p also bound strongly to itself in the GST pull-
down assays. This may indicate that there is more than one Ydh1p molecule present
per 3’ end processing unit. However, silver stain analysis of purified CPF factor
suggested an apparent stoichiometric presence of Ydh1p compared to other CPF
subunits (Dichtl et al., 2002b). Interestingly, we found that the CF IA subunit Pcf11p
interacted with the CPF components Ydh1p, Yhh1p/Cft1p, Ysh1p/Brr5p and weakly
with Pta1p. In addition, we showed that the CPF subunits Yhh1p/Cft1p and
Ysh1p/Brr5p interacted with the CF IA subunits Rna14p and Clp1p, respectively. The
latter interactions were also observed between the homologous subunits of the
mammalian 3’ end formation machinery. CPSF 160 kDa interacts with the CstF 77
kDa protein (Murthy and Manley, 1995) and CPSF 73 kDa interacts with hClp1p (de
Vries et al., 2000). So far, only Pfs2p and Fip1p were shown to bridge CPF and
CF IA (Preker et al., 1995; Ohnacker et al., 2000). We propose that Ydh1p,
Yhh1p/Cft1p, Ysh1p/Brr5p, Pfs2p, Fip1p and possibly Pta1p contribute to a protein-
protein interaction surface which acts in the assembly of the 3’ end formation
machinery and which appears to be conserved in evolution (Figure 5D).
Our analysis of Ydh1p suggests that the protein is an important constituent of
protein interaction surfaces which act in the association of 3’ end processing factors
with RNAP II, the recognition of poly(A) signal sequences and the assembly of an
active 3’ end formation complex on the RNA substrate.
6.5 Experimental procedures
6.5.1 Yeast strains
For random mutagenesis of YDH1, mutagenic PCR was carried out with a low
concentration of ATP (Ohnacker et al., 2000). The primers used for PCR were: Ydh1-
N (5’  CCCTTACGGATTGAAGTCATT 3’)  and Ydh1-C (5’
TTGAACCTTTTATTTGTGCTG 3’). Plasmid pBD63 (YDH1-LEU2-CEN) was
obtained by subcloning of the YDH1 gene from pIA115 (YDH1-URA3-CEN; 53) into
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the BamHI and SacI restriction sites of pRS415. The plasmid was digested with the
restriction enzymes NsiI and SpeI. The fragment containing plasmid sequences and
sequences flanking the YDH1 gene was co-transformed together with the mutagenized
PCR product into the yeast strain YPP106 (Preker et al., 1997). Transformants were
selected on minimal medium lacking leucine and replica-plated onto 5-FOA plates in
order to shuffle out the pIA115 plasmid. The colonies were then replica-plated onto
YPD-plates and incubated at 25˚C, 33˚C or 37˚C respectively. Plasmids of candidate
colonies that showed a ts phenotype were isolated by standard procedures. The
conditional growth phenotype was then verified by retransformation of the isolated
plasmids into YPP106, 5-FOA treatment and growth tests at elevated temperatures.
Genotypes of yeast strains used in this study were: YPP106: MAT∝; ura3-1;
ade2-1; leu2-3,112; his3-11,15; trp1∆; ydh1::TRP1 [pIA 115; CEN4 – URA3 –
YDH1] (Preker et al., 1997); YAK1: MAT∝; ura3-1; ade2-1; leu2-3,112; his3-11,15;
trp1∆; ydh1::TRP1 [pAK21 CEN - LEU2 – ydh1-1]; YAK2: MAT∝; ura3-1; ade2-1;
leu2-3,112; his3-11,15; trp1∆; ydh1::TRP1 [pAK22 CEN - LEU2 – ydh1-2]; YAK3:
MAT∝; ura3-1; ade2-1; leu2-3,112; his3-11,15; trp1∆; ydh1::TRP1 [pAK23 CEN -
LEU2 – ydh1-3]; Y190: ura3-52; trp1-901; ade2-101; leu2-3; 112 his3-200r; gal4D;
gal 80D; URA3:GAL1-lacZ; LYS2::GAL1-HIS3; cyhr; Clonetech.
6.5.2 Plasmids and primers
The plasmids encoding the C-terminally truncated Ydh1p fragments were obtained by
digestion of plasmid pBD71 (Dichtl and Keller, 2001) with restriction enzymes AccI
(pBD91; encoding the recombinant protein ∆C338), BamHI/ XbaI (pBD92; encoding
∆C182), BamHI/ SpeI (pAK5; encoding ∆C137), BamHI/ AflII (pAK6; encoding
∆C555), BamHI/ AgeI (pAK7; encoding ∆C613). GST-Ysh1p was encoded by
pBD38, which was obtained by subcloning of Ysh1p into p20 (GST expression
vector) using the restriction enzymes NdeI and BamHI. GST-Tev-Pta1p was encoded
by pBD51, which was obtained by PCR amplification of Pta1p followed by digestion
with NdeI and BamHI and ligation into p26 (GST-Tev expression vector). GST-
Yhh1p-H6 was encoded by pBD75 (Dichtl et al., 2002b).
The plasmid encoding the protein used to produce antibody directed against
Ydh1p was constructed by digestion of pQE-9 (His 6 expression vector Qiagen) with
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BamHI/ HindIII. The insert was constructed by PCR, amplifying the sequence
between primer Ydh5’ (5’ ATCGCGGATCCATGACTTATAAATACAATTG 3’)
and Ydh3’ (5’ AGCCCAAGCTTATTTACTCAATTCGTTTGGT 3’) of YDH1. For
details about pBD-CTD, pACT2-YHH1, pACT2-YSH1 and pACT2-PCF11 see
(Dichtl et al., 2002b).
6.5.3 Expression of recombinant proteins in E. coli
BL21 E.coli cells carrying the respective plasmid were grown at 25˚C in 2xYT until
they reached an OD600 of approximately 1. Following induction by 0.5 mM IPTG
incubation was continued for 6 hours. The proteins were purified at 4˚C on
glutathione-Sepharose 4B as recommended (Pharmacia) and the protein was eluted
with GST-elution buffer (75 mM KCl, 50 mM Tris-HCl (pH 7.9), 10% glycerol, 10
mM glutathione (reduced), 0.01% NP-40, 1 mM DTT).
6.5.4 Protein-protein interactions
In vitro translations were performed with the TNT-coupled transcription-translation
system (Promega). 100 ng GST fusion protein was incubated with in vitro translated
[35S]methionine labeled proteins for 1 hour. The mixture was bound in a total volume
of 860 µl to 20 µl glutathione sepharose (Pharmacia), which was previously
equilibrated in 1 ml PBS, 0.01% NP40 and 100 µg BSA. The matrix was washed 3
times with IPP150 (150 mM KCl, 20 mM Tris-Cl (pH 8.0), 0.01% NP-40) and the
proteins were eluted by addition of protein loading buffer and incubation at 95˚C.
Bound proteins were separated by SDS-PAGE and visualized by autoradiography.
Phosphorylation of GST-CTD was performed as described previously (Hirose and
Manley, 1998) and the assay of the CTD interaction was carried out as described
(Dichtl et al., 2002b). The two hybrid tests were carried out as described (Fromont-
Racine et al., 1997).
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6.5.5 Extract preparation and in vitro cleavage and polyadenylation
assays
Extracts competent for in vitro processing were prepared following the procedure
previously described (Ohnacker et al., 2000). The cleavage and polyadenylation
assays were carried out as described by (Minvielle-Sebastia et al., 1994). To restrict
the assay to cleavage only, EDTA replaced MgAc and CTP replaced ATP. For each
reaction 30-40 µg total protein were used and, in the case of the reactions carried out
at 34°C, pre-incubated at this temperature for 5 min. The RNA substrates were
prepared by run-off transcription following the previously described procedure
(Dichtl and Keller, 2001).
6.5.6 RNA analyses
Northern analyses and RNase H experiments were carried out as described (Dichtl et
al., 2002b). In addition we employed the oligonucleotides anti-U24
( 5 ’   T C A G A G A T C T T G G T G A T A A T  3 ’ )  a n d
anti−snR13 (5’ GGCAAAAGCCAAACAGCAACTCGAGCCAAATGCACTCATA
TTCATCATAT 3’), which were labeled with γ-[32P]-ATP by T4 polynucleotide
kinase.
The reverse transcription analysis was performed as described (Dichtl et al.,
2002b) with primers downstream of snoRNA genes as previously described
(Steinmetz et al., 2001).
6.5.7 Protein extraction for Western blotting
The cells were grown at 25˚C and shifted to 37˚C, during incubation their growth was
kept in the log phase. At each time point 40 ml of the culture (OD600 = 0,4) were
harvested. The following procedure was carried out on ice. The cells were
resuspended in IPP150 (150 mM KCl, 20 mM Tris-Cl; pH 8.0, 0.01% NP40) and an
equal volume of glass beads was added. The cells were opened by rigorous vortexing.
5 ml IPP150 and protease inhibitors were added and the mixture was centrifuged for 1
hour at 10’000 rpm. 4 ml of the supernatant were thereafter centrifuged for 2 hours at
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41’000 rpm and the protein was concentrated by centrifugation in a centricon YM10
(Millipore). The protein concentration was determined by Bradford analysis and equal
amounts of total proteins were separated by SDS-PAGE.
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Final Discussion
For many years 3’ end processing, capping, splicing and transcription have been
studied separately from each other. It was and is very useful to be able to carry out the
different reactions independently, in order to solve questions about the individual
steps. Nevertheless, in vivo the pre-mRNA processing steps and transcription are
coupled and it is important to understand their influence on each other. For example,
in mammals a big number of genes can be alternatively spliced leading to a much
broader number of diverse proteins than what could be obtained without alternative
splicing, and transcription was shown to be involved in this process.
Even though it is known that all these reactions are coupled in vivo there is
quite little information about how exactly this coupling is mediated. A big player
seams to be the CTD of RNAP II given that proteins of all pre-mRNA processing
steps have been found to interact with it.
In this work we focused on the coupling between splicing and 3’ end
processing. We found that direct interactions between the U2 snRNP and CPSF are
involved in coupling the two processes. At present we do not know the molecular
mechanism of this coupling. However, CPSF is an important factor for poly(A) site
selection and the U2 snRNP is known to be involved in the binding to the branch
point sequence. Therefore, it is an intriguing idea that the two factors help recruit and
stabilize each other onto the pre-mRNA.
Proteins of the spliceosome and 3’ end processing factors travel with the
elongating RNA polymerase. Therefore, it is possible that 3’ end formation subunits
influence the splicing of not only the last but also of internal introns. Recently
coupled splicing and transcription assays have been published and it would be
fascinating to establish a coupled transcription, splicing and 3’ end formation assay.
With such a system one could for example address the question if the coupling
between 3’ end processing and splicing comes into play only at the last intron if the
reactions take place cotranscriptionally.
3’ end formation and splicing are highly conserved from mammals to yeast
and the model system S. cerevisiae allows easier in vivo analysis and genetic
manipulations than mammalian cells. Furthermore, there is almost nothing known
about the coupling of splicing and 3’ end formation in this organism. Given that only
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very few yeast genes carry introns and that these introns are most often located close
to the 5’ end of the pre-mRNA did not prompt too much research in this field.
However, our results suggest that there is indeed coupling between 3’ end processing
and splicing taking place in yeast and we think that it would be very promising to
continue with the research in this area.
Even though many RNA processing reactions are coupled this is not the case
for all of them. It was proposed that tRNA splicing and pre-mRNA 3’ end processing
are interlinked also. However, we showed here that this hypothesis is most likely not
true.
Before one can look at coupling mechanisms between different processes it is
important to understand at least the basics of the individual reactions. Most of the
proteins involved in 3’ end processing in yeast have been identified. In this work we
characterized the function of the CPF subunit Ydh1p in 3’ end formation. However,
the role of other subunits of the 3’ end processing machinery are still not known. And
more questions need to be answered before we have a better understanding of how
exactly 3’ end processing is taking place. For example it is still not known which
enzyme catalyzes the endonucleolytic cleavage and Ysh1p, the homologue of CPSF73
is a hot candidate at present. Interestingly, like Ysh1p, Ydh1p belongs to the ß-
lactamase families which have been implicated in nucleotide cleavage. Unlike Ysh1p,
Ydh1p contains mutations in the sequences believed to be important for activity.
These enzymes were shown to act as dimers. It is possible that Ysh1p could form a
homodimer but it could also be that Ydh1p and Ysh1p have to interact together in
order to obtain enzymatic activity. We showed here that the two proteins indeed
directly interact with each other. Furthermore, Ydh1p binds RNA, whereas Ysh1p has
not been shown to directly interact with the substrate. It is therefore an interesting
model that Ydh1p could interact with Ysh1p and thereby make the enzyme active and
tether it to the RNA.
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